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Abstract 
DNA methylation refers to an addition of a methyl group to the 5 position of 
the cytosine pyrimidine ring. As the best characterized epigenetic mark, DNA 
methylation plays an important role in a plethora of biological functions, including 
gene repression, genomic imprinting, silencing of retro-transposons and X 
chromosome inactivation. Genomic imprinting refers to the mono-allelic expression 
of certain genes according to their parent-of-origin. In mammals, the expression of 
imprinted genes is controlled by the cis-acting regulatory elements, termed imprinted 
control regions (ICRs). ICRs are marked by parent-of-origin-specific DNA 
methylation and loss of DNA methylation at ICRs also causes aberrant expression of 
imprinted genes. Therefore it is believed that the genomic imprinting is a DNA 
methylation-associated epigenetic phenomenon. As accurate expression of imprinted 
genes is essential for normal embryonic growth, energy homeostasis, development 
of the brain and behaviour and abnormal expression of imprinted genes leads to 
numerous clinical phenotype and human disorders, it is important to investigate how 
the imprinted DNA methylation is stably maintained in mammals.  
DNA methyltransferases (DNMTs) are the main enzymes that play a in the 
establishment and maintenance of imprinted DNA methylation. In primordial germ 
cells (PGCs), DNMT3A and DNMT3L are involved in the establishment of 
imprinted DNA methylation. Whereas once established, the imprinted DNA 
methylation is maintained by DNMT1, DNMT3A and DNMT3B, but mainly by 
DNMT1. In addition, some other enzymes and DNA binding proteins also play a 
role in this process. One of the best examples is ZFP57, which forms a complex with 
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KAP1 and SETDB1. ZFP57 maintains imprinted DNA methylation by recognizing a 
methylated hexa-nucleotide and recruits DNMTs to the ICRs in mammalian 
embryonic stem  (ES) cells. Interestingly, DNA methylation analysis combined with 
promoter microarrays carried out in our lab suggested that imprinted DNA 
methylation is absent from some of the maternal ICRs in ES cells genetically null for 
G9a, a histone H3 lysine 9 methylase. This indicates that G9a might also play a role 
in the maintenance of imprinted DNA methylation.  
In my work, I found that the repressive H3K9me2 and imprinted DNA 
methylation are absent from several analysed ICRs in embryonic stem (ES) cells 
genetically null for either G9a or its partner histone methyltransferase GLP. A 
knockdown of G9a in ES cells reproduced these observations suggesting that 
G9a/GLP complex is required for the maintenance of imprinted DNA methylation. I 
also found that neither wild type nor catalytically inactive G9a can restore the loss of 
imprinted DNA methylation in G9a-/- ES cells. Chromatin immunoprecipitation 
(ChIP) combined with bisulfite DNA sequencing showed that imprinted DNA 
methylation was present on the H3K9me2-marked allele indicating a direct role for 
G9a in maintenance of genomic imprinting. Using a pharmacological inhibitor of 
G9a and mutagenesis analyses, I found that G9a maintains the imprinted DNA 
methylation independently of its catalytic activity and recruits DNMTs to the ICRs 
via its ankyrin repeat domain. Dimerization of G9a with GLP is also essential for the 
maintenance of genomic imprinting in ES cells. In summary, in addition to establish 
H3K9me2, histone methyltransferases G9a and GLP also play an essential role in the 
maintenance of genomic methylation imprints in ES cells.  
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Chapter 1 Introduction 
1.1  Epigenetics 
1.1.1 Genetics and epigenetics 
      In the mid-19th century, by tracing the phenotypic patterns in pea plants 
statistically, Gregor Mendel observed that organisms could inherit their traits in a 
discrete way. It is this cornerstone observation initiated the era of Mendelian genetics. 
Following Mendel’s discoveries, scientists tried to determine which molecule is 
essential for the genetic inheritance. In 1911, due to the observation of a sex-linked 
white-eye mutation in Drosophila, Thomas Hunt Morgan revealed that genes are 
located on chromosomes. However, which macromolecule severs as the genetic 
material and is essential for the inheritance was still unclear.  
 Inspired by the discoveries of transformation phenomenon, Alfred Hershey and 
Martha Chase labeled the protein capsule and DNA of bacteriophages separately. They 
then performed an infectious assay and concluded that in eukaryotes, DNA is the 
essential genetic material, which is responsible for the inheritance (Hershey and Chase, 
1952). However, it was still unclear why the differentiated tissue-specific cells, which 
contain identical genetic information, appear to have distinct morphologies and exert 
different physiological functions. Actually, it is this basic question that has advanced 
the understanding of epigenetics, a science about the genetic mechanisms beyond or 
upon the alteration of DNA sequences.  
The history of epigenetics is associated with the study of evolution and 
developmental biology. Since the late 19th century, the functions of nature and nurture 
in the determination of organism development became a topic of hot debates. Although 
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DNA was confirmed to play a crucial role in genetics (Avery et al., 1944; Hershey and 
Chase, 1952), emerging evidence could not be explained by the classic genetic theory. 
For instance, in Drosophila, it was found that the eye colour variegates when 
rearrangements juxtapose the white gene with heterochromatin regions. In addition, the 
patterns of cilia in ciliates have also been found vary among individuals and are 
inherited clonally (Beisson and Sonneborn, 1965). These phenomena indicated that 
apart from genetics, some other mechanisms might also exist and together with the 
classic genetic mechanisms control the phenotype of the organism.  
The original definition of epigenetics is “the study of heritable changes in the 
gene function, which cannot be explained by the changes of the genetic sequences” 
(Bird, 2002). Recently, Adrian Bird refined the definition of epigenetics as “the 
structural adaptation of chromosomal regions so as to register, signal or perpetuate 
altered activity states” (Bird, 2007). In general, the mechanisms of epigenetics operate 
via two types of modifications: DNA methylation and post-translational histone 
modifications (PTHMs). In addition, since the structural remodelling of chromatin 
always coincides with the changes of histone modifications, chromatin remodelling is 
also considered as another aspect of epigenetic regulation. Today, emerging evidence 
has shown that epigenetic mechanisms play a role in a great number of biological 
processes, including gene and retrotransposon regulation, genomic imprinting, X 
chromosome inactivation and maternal effects (Bird, 2002; Jones, 2012).  	  
1.1.2 Molecular mechanisms of epigenetics 
Epigenetic marks refer to post-replication nucleic acid or post-translational 
protein modifications, which could influence the status of certain genes without altering 
the DNA sequences. The main epigenetic marks in mammals include DNA methylation 
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and post-translational histone modifications. Traditionally, DNA methylation is 
suggested to be associated with gene silencing. However, recent observations have 
shown that DNA methylation present at the gene body regions might facilitate 
transcription (Jones, 2012). Compared with DNA methylation, histone modifications 
could play either the positive or negative role in the regulation of gene expression. For 
example, H3K4me3 and H3K36me3, which present at promoters and the gene body 
regions respectively, play a role in genes activation, whereas some other histone 
modifications are associated with gene repression, including H3K9me3, H3K27me3 and 
H4K20me1.  
Since to adapt to the different biological conditions, the expression of particular 
genes is dynamically regulated, it is undoubted that the deposition and removal of 
epigenetic marks are also dynamic, especially in the early developmental stage in 
mammals. However, most of the changes of epigenetic marks occurred within the 
course of an individual organism lifespan and only those occurred in the gametes might 
be transmitted to the next generation.  
1.2 DNA methylation  
  In animals, DNA methylation refers to an addition of a methyl group to the 5-
position carbon within the cytosine pyrimidine ring (Figure 1.1A). Although DNA 
methylation was originally uncovered approximately five decades ago (Bird, 2002), the 
underlying functions behind this mark were still obscure until the late of 1970s. 
Nowadays, DNA methylation has been found to play a pivotal role in many biological 
processes, including controlling of gene expression, X chromosome inactivation, 
maintenance of genome stability, regulation of genomic imprinting and even in the 
normal development of embryos and cell differentiation (Bird, 2002; Jones, 2012).  
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1.2.1 Distribution of DNA methylation  
Knowing how the DNA methylation is distributed across the genome is essential 
for understanding its function(s). The landscapes of DNA methylation in flowering 
plants and mammals are similar but nuanced. Actually among all the eukaryotes, plants 
contain the highest level of DNA methylation, with up to 50% of all the cytosine 
methylated in some species (Montero et al., 1992). In maize, the high frequency of 
methylated DNA in the genome is thought to be associated with extremely large 
numbers of transposons (Palmer et al., 2003; SanMiguel et al., 1996). In mammals, the 
proportion of the methylated cytosine within the genome is less than the proportion in 
plants. Take mouse for example, there is only 8% of the total cytosines are methylated. 
The majority of the methylated cytosines in mammals occur in the context of CpG 
dinucleotides, whereas in the context of CpHpG or CpHpH, where H represents a non-
guanine nucleotide, the cytosines can also be methylated in plants (Bird, 2002; Bird, 
1986). However, in eukaryotes, there is no DNA methylation in some species, such as 
Saccharomyces cerevisiae and Drosophila.  
In plants, the vast majority of studies on DNA methylation were carried out in 
Arabidopsis thaliana, in which the distribution of DNA methylation displays as discrete 
islands, with all transposons and at least 20% of protein coding genes being methylated 
(Tran et al., 2005). Additionally, in Arabidopsis thaliana, the DNA methylation is 
preferentially biased away from promoters and the 3’ ends of the protein coding genes. 
Since distribution of DNA methylation is inverses of the density of RNA polymerase II 
(Pol II), it was suggested that DNA methylation impedes transcriptional elongation by 
Pol II and predicted that DNA methylation plays a negative role in the regulation of 
transcription (Zilberman et al., 2007).  
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In animals, the majority of the studies of DNA methylation are carried out in 
mammalian systems, in which 60-90% of all the CpG sites are methylated (Ehrlich et 
al., 1982). Unlike in plants, most of the methylated cytosines in vertebrates are present 
within a context of CpG dinucleotides (Bird, 2002; Bird, 1986). Genome-wide mapping 
of DNA methylation indicated that some genomic regions, especially the regions that 
contains high enrichment of the CpG dinucleotides, prefer to be highly methylated, 
including repetitive elements (transposons, SINEs, LINEs), satellite DNA, intergenic 
regions and the exons of the genes. However, a conspicuous exception to the global 
distribution of DNA methylated is CpG islands (CGIs), which refer to a short un-
methylated CpG rich region locates in the genome (Bird et al., 1985) (Figure 1.1B). 
Actually, it has been found that approximately 60% of the annotated genes contain the 
CGIs and the length of the CpG island ranges from hundreds of base pairs to several 
kilo-base pairs (Larsen et al., 1992; Saxonov et al., 2006; Zhu and Yao, 2009).  
1.2.2 DNA methyltransferases  
DNA methyltransferases (DNMTs) play a role in transferring and covalently 
attaching a methyl group onto the 5-position carbon of the cytosine pyrimidine ring by 
using S-adenosyl-L-methionine (SAM) as the methyl group donor. According to their 
function, there are two typical classes of DNA methyltransferases: one is involved in 
the establishment of DNA methylation, whereas the other is essential for the 
maintenance of DNA methylation (Chen and Riggs, 2011; Goll and Bestor, 2005). The 
first identified mammalian DNA methyltransferase was DNMT1, followed by DNMT2, 
DNMT3A, DNMT3B and DNMT3L (Bestor et al., 1988; Gruenbaum et al., 1982; 
Okano et al., 1998b; Van den Wyngaert et al., 1998; Yoder and Bestor, 1998).  
All the DNMTs contain a conserved C-terminal domain, which is essential for 
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their methyltransferase activity, apart from DNMT3L (Cheng, 1995; Cheng and 
Blumenthal, 2008; Jeltsch, 2002; Jurkowska and Bal, 2001). The catalytic domain 
includes five conserved motifs, among which I and X are involved in the interactions 
between the DNMTs and their cofactors, whereas motifs IV, VI and VIII exert the “real 
catalytic” function. In addition, a non-conserved region, which is located in the middle 
of the catalytic domain, is required for accurate targeting (Cheng, 1995; Cheng and 
Blumenthal, 2008; Jeltsch, 2002). Furthermore, the N-terminal regions of DNMTs are 
suggested to be responsible for protein-DNA binding and protein-protein interaction 
(Jurkowska and Bal, 2001).  
DNA methyltransferase 1 (DNMT1) 
Bestor et al cloned and characterized the first mammalian DNMT from mouse 
(Bestor, 1988). Actually, the first identified DNA methyltransferase, DNMT1, is the 
most abundant DNA methyltransferase in mammalian cells. It has been found that the 
N-terminus of DNMT1 is essential for its stable expression and function in vivo (Tucker 
et al., 1996). In addition, since the N-terminus of DNMT1 contains several functional 
domains, including a proliferating cell nuclear antigen-binding domain (PBD), a nuclear 
localization signal (NLS), an cysteine-rich ATRX zinc finger DNA-binding motif and a 
Plant homeo domain (PHD), this domain is also involved in the discrimination of the 
hemimethylated from the unmethylated DNA strands.  
During cell division, DNMT1 has been found to form a complex with the 
proliferating cell nuclear antigen (PCNA) and selectively localized to the replication 
foci in S phase (Iida et al., 2002; Leonhardt et al., 1992; Margot et al., 2001). Actually, 
apart from the centromere region, the chromatin loading patterns of DNMT1 spread all 
over the genome (Easwaran et al., 2004). Recently, it was found that the catalytic 
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activity of DNMT1 might be inhibited when its N-terminal region is bound to the 
unmethylated DNA (Bacolla et al., 1999). In addition, DNMT1 predominantly binds to 
the hemimethylated DNA and shows reduced specificity towards the unmethylated 
substrates (Fatemi et al., 2001). In vitro, DNMT1 displays 7- to 100-fold higher activity 
towards the hemimethylated DNA when compared to the methylated or the 
unmethylated double stranded DNA (Bestor, 1988; Fatemi et al., 2002; Gowher et al., 
2005b; Pradhan et al., 1999).  
Although DNMT1 has also been demonstrated to play a role in the 
establishment of DNA methylation by interaction with de novo DNA methyltransferase 
DNMT3A, it is considered to be the most important DNA methyltransferase for the 
maintenance of DNA methylation (Bestor, 1988; Fatemi et al., 2002; Gowher et al., 
2005b). During mitosis, DNMT1 selectively binds to the parental strands with the help 
of UHRF1, a RING finger-associated protein, and establishes DNA methylation on the 
newly synthesized strands according to the patterns of the parental strands. Deletion of 
Dnmt1 leads to the impairment of global DNA methylation in ES cells and embryos 
(Beard and Wilson, 1995; Danam et al., 2001; Li et al., 1993; Li et al., 1992). The 
Dnmt1-/- ES cells proliferate in culture, but undergo apoptosis upon differentiation (Li et 
al., 1992; Tsumura et al., 2006). In addition, deletion of Dnmt1 is embryonic lethal and 
the Dnmt1-/- embryos die at embryonic day 9.5 (E9.5) (Beard and Wilson, 1995; 
Danam et al., 2001; Li et al., 1993; Li et al., 1992). 
In mammals, there are three isoforms of DNMT1, including the somatic isoform 
of DNMT1 (DNMT1s), DNMT1b and an oocyte-specific isoform of DNMT1 
(DNMT1o). Among these isoforms, DNMT1s is only present in the nucleus, whereas 
the DNMT1o is always synthesized and stored in the cytoplasm of mature oocytes. 
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However, after fertilization, the DNMT1o could be transferred into the nucleus and both 
maternal and zygotic DNMT1 are essential for the maintenance of genomic imprinting 
in embryos (Hirasawa et al., 2008). The expression levels of DNMT1 vary between 
different tissues and throughout the cell cycles in vivo. In general, DNMT1 is more 
abundant in the highly proliferating tissues and in S phase, there is relative more 
DNMT1 expressed in the cells (Robertson et al., 2000; Szyf et al., 2001). Additionally, 
DNMT1 is also associated with tumorigenesis and plays a role in both de novo and 
maintenance of DNA methylation in the cancer cells (Ting et al., 2006).  
DNA methyltransferases 3A (DNMT3A) and 3B (DNMT3B) 
Through a search of the expressed sequence tag (EST) databases with the 
conserved motifs of the cytosine DNA methyltranferases, three additional proteins were 
found, which share the homology within the catalytic domain of DNMT1, including 
DNMT2, DNMT3A and DNMT3B. Deletions of either Dnmt3a or Dnmt3b lead to the 
impairment of DNA methylation at repetitive elements and de novo methylation of the 
introduced retroviral DNA (Okano et al., 1999). In addition, as both the enzymes 
display activity towards the unmethylated DNA and play a role in the de novo DNA 
methylation during mammalian development (Okano et al., 1999), it has been suggested 
that both the DNMT3A and DNMT3B play an essential role in the establishment of the 
DNA methylation.   
During cell divisions, since DNMT1 alone is unable to maintain all the 
methylated cytosines within the genome and Dnmt3a and Dnmt3b double knockout ES 
cells progressively lose DNA methylation at the repetitive elements, DNMT3A and 
DNMT3B are also suggested to play a role in the maintenance of DNA methylation 
(Liang et al., 2002). Furthermore, both enzymes have also been found to be able to 
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methylate the cytosines within non-CpG context (Gowher & Jeltsch, 2001; Ramsahoye 
et al., 2000). In mouse, there are three isoforms of DNMT3B. DNMT3B1 is highly 
expressed in ES cells, whereas DNMT3B2 and DNMT3B3 are expressed throughout 
most of the spermatogenesis (Oakes et al., 2007; Okano et al., 1998a).  
Apart from the shorter N-terminal domain of DNMT3B, the amino acid 
sequences of DNMT3A and DNMT3B are quite similar and both of the two enzymes 
display no preference for methylating the unmethylated or the hemimethylated DNA in 
vitro (Okano et al., 1998a). The expression levels of these two enzymes are also quite 
similar and both of the two enzymes are highly expressed in early embryos and ES 
cells, but not highly expressed in somatic cells (Okano et al., 1998a). However, the 
knockout mice for either Dnmt3a or Dnmt3b display significant differences in 
phenotypes and physiological functions (Okano et al., 1999). For instance, knockout of 
Dnmt3a is postnatal lethal with the newly born mice dying between 4-8 weeks, whereas 
the Dnmt3b-/- mice die around embryonic day 14.5 (E14.5) and exhibit severe vascular 
and liver defects (Bachman et al., 2001; Hansen et al., 1999; Xu et al., 1999). Moreover, 
the functions of DNMT3A and DNMT3B in de novo DNA methylation are also 
different, since DNMT3A is essential for the establishment of germline imprinting, 
whereas DNMT3B plays a role in the establishment of DNA methylation at the minor 
satellite in mice and at the repetitive elements and pericentromeric heterochromatin 
regions in humans (Kaneda et al., 2004; Okano et al., 1999).  
Similar to the Dnmt1-/- embryos, the embryos that lacking both the Dnmt3a and 
Dnmt3b display defects in the de novo DNA methylation during development and die 
around embryonic day 11.5 (E11.5) (Okano et al., 1999). However, the Dnmt3a and 
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Dnmt3b double knockout ES cells are viable, which indicated that DNA methylation is 
dispensable for the self-renewal of ES cells (Tsumura et al., 2006).  
DNA methyltransferase 2 (DNMT2) 
As mentioned above, DNMT2 is considered to be one of the DNA 
methyltransferases, since it contains a similar catalytic domain to DNMT1. However, 
DNMT2 displays extremely weak DNA methyltransferase activity (Hermann et al., 
2003; Jurkowski et al., 2008; Tang et al., 2003). Deletion of Dnmt2 had no discernable 
effect on the patterns of the global DNA methylation. Actually, DNMT2 displayed 
methyltransferase activity towards neither the unmethylated nor the hemimethylated 
DNA in vitro. A recent study found that DNMT2 methylates cytosine within the 
anticodon loop of the aspartic acid transfer RNA (tRNA-Asp), which indicates that 
DNMT2 plays a role as an RNA, rather than a DNA, methyltransferase in mammals 
(Ndlovu et al., 2011).  
DNA methyltransferase 3L (DNMT3L) 
DNMT3L is a catalyticaly inactive DNA methyltransferase. In mammals, it has 
been found that DNMT3L co-localizes with DNMT3A and DNMT3B in vivo (Nimura 
et al., 2006). In addition, DNMT3L could stimulate the activity of DNMT3A and 
DNMT3B (Chedin et al., 2002; Gowher et al., 2005a). Similar to DNMT3A, DNMT3L 
also plays a role in the establishment of genomic imprinting in the primordial germ cells 
(Hata et al., 2002; Bourc’his et al., 2001). Although both the male and female DNMT3L 
knockout mice are viable, its deletion results in sterility (Webster et al., 2005; Bourc’his 
and Bestor, 2001).  
	   24	  
1.2.3 Functions of DNA methylation  
The earliest literature, which suggested that DNA methylation could serve as an 
epigenetic mark in vertebrates, was published approximately 40 years ago (Holliday and 
Pugh, 1975; Riggs, 1975). In these papers, the authors proposed that the DNA 
sequences could be de novo methylated and there must be some enzymes, which play a 
role in the maintenance of DNA methylation. Furthermore, it was also suggested that 
the stable DNA methylation could be interpreted by DNA-binding protein and 
consequently, the presence of DNA methylation could directly result in transcriptional 
repression (Holliday and Pugh, 1975; Riggs, 1975). In evolutionary biology, DNA 
methylation is also thought to be essential for the acceleration of evolutionary 
processes, since spontaneous or catalytic deamination of methylated cytosine could 
create a thymine-guanine mismatch and the advantageous mismatch that occurred in the 
germ cells could be inherited by the next generation (Petersen-Mahrt and Neuberger, 
2003).  
The role of DNA methylation in gene regulation 
In mammals, DNA methylation plays an essential role in the regulation of gene 
expression (Figure 1.1B), however the outcome of its role in the gene regulation is 
strongly associated with its positions. In general, DNA methylation that is present at the 
promoter of a given gene inhibits transcription, whereas the gene body DNA 
methylation plays an opposite role (Jones, 2012). In humans, there is no DNA 
methylation at the promoters of approximately 60% of the annotated protein coding 
genes. The unmethylated high CpG density regions that are present at these 
unmethylated promoters are known as CpG islands (CGIs) (Illingworth et al., 2010) 
(Figure 1A). It has been found that the genes that contain the CGIs are normally 
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characterized by the nucleosome-depleted regions (NDRs) around their transcription 
start site (TSS) and the NDRs are often flanked by the H3K4me3 marked nucleosomes 
(Kelly et al., 2010). However, genes that contain high levels of DNA methylated at their 
promoters also exist in humans, such as maternal imprinted genes and the genes that 
located on the inactive X chromosome in females (Figure 1B) (Jones, 2012). Currently, 
it is accepted that the high levels of DNA methylation at the promoters allow a long-
term maintenance of the silenced state of the genes (Jones, 2012).  
In contrast to the genes that contain the CGIs within their promoters, the CGIs-
poor genes display variable patterns of DNA methylation at their promoters. For 
instances, there are low levels of DNA methylation at the promoters of some genes, 
which are highly transcribed in primordial germ cells (PGCs). In addition, some genes 
that selectively express in the ES cells contain high levels of DNA methylation around 
their promoters in the sperm, but not in oocytes or somatic cells (Farthing et al., 2008). 
However, the underlying functions of the DNA methylation that present at the 
promoters of the non-CGI genes are still obscure.  
Being a feature of the transcribed genes, the early literature concluded that the 
gene body DNA methylation plays an active role for the transcription (Jabs et al., 1984). 
Recently, observations of the whole genome bisulfite DNA sequencing in plants and 
animals had confirmed the active correlations between the gene body DNA methylation 
and transcription (Cokus et al., 2008; Feng et al., 2010; Hellman and Chess, 2007; 
Lister and Ecker, 2009). In addition, it has been found that compared with the initiation 
of transcription, elongation is less sensitive to the gene body DNA methylation. 
Moreover, since actively transcribed genes also contain H3K36me3 at their gene bodies 
and H3K36me3 is able to recruit the DNMTs, the elongation process might even 
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contribute to the de novo DNA methylation in the gene bodies (Hahn et al., 2011). 
Furthermore, gene body DNA methylation also plays a role in silencing of the repetitive 
elements (Yoder et al., 1997).  
The role of DNA methylation in genomic imprinting 
Genomic imprinting is an epigenetic phenomenon, which refers to the mono-
allelic expression of certain genes according to their parent-of-origin. In mammals, the 
majority of the imprinted genes are present in clusters and each cluster contains at least 
one non-coding RNA gene. In addition, all the imprinting clusters contain a unique 
differentially methylated region (DMR), which carries the parental allele-specific DNA 
methylation. Since loss of DNA methylation at ICRs causes aberrant expression of 
imprinted genes, these DMRs are known as the imprinting control regions (ICRs) and it 
has been found that the mono-allelic expression of imprinted genes is directly controlled 
by the DNA methylation that present at the ICRs (Shemer et al., 1997; Suzuki et al., 
2002; Yatsuki et al., 2002) In addition, maternal and paternal ICRs located at different 
regions within the genome (Figure 1.2).  
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Although the regulatory mechanisms for paternal and maternal ICRs in the 
regulation of the imprinted genes are different, mis-regulation of either paternal or 
maternal imprinted genes will lead to the severe disorders in humans (Cassidy and 
Driscoll, 2009). Therefore, it is essential to investigate how the imprinted DNA 
methylation is stably maintained in mammals. Previous studies have found that DNMTs 
are the main enzymes for the maintenance of the imprinted DNA methylation (Hirasawa 
et al., 2008). In addition, some other enzymes and DNA binding proteins also play a 
role in the maintenance of the imprinted DNA methylation (Li et al., 2008; Quenneville 
et al., 2011; Nakamura et al., 2012; Xin et al., 2003). However, take histone 
methyltransferase G9a for example, whether it plays a global role in the maintenance of 
imprinted DNA methylation and the underlying mechanism(s) for G9a in the 
maintenance of imprinted DNA methylation are still elusive.  
The role of DNA methylation in X-chromosome inactivation 
Placental mammals compensate the different dosages of X chromosome by 
randomly silencing one of the two X chromosomes in the female cells. To explain the 
mottled phenotype of female cats, which contain the heterozygous coat color genes on 
the X chromosome, the underlying mechanism of X chromosome inactivation was 
originally proposed in 1960s (Lyon et al., 1961). During the past 50 years, the 
mechanism of X chromosome inactivation has been the subject of numerous 
investigations. Today, it has been shown that the random X chromosome inactivation 
occurs at the late blastocyst stage and the majority of the genes located on the inactive 
X chromosome (Xi) are silenced (Ariel et al., 1995; Loh et al., 2007).  
X chromosome inactivation is controlled by the expression of a noncoding RNA 
gene, called Xist. In adult females, Xist is one of the few genes that expressed from the 
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inactivated X chromosome (Xi). Since DNA methylation present at the X-pairing region 
(Xpr) plays a role in the regulation of Xist, it has been found that X chromosome 
inactivation is another epigenetic phenomena, which is directly controlled by DNA 
methylation (Loh et al., 2007).  Recently, it has been found that the expression of Xist 
might also accumulate DNA methylation to the Xi and further condenses it. In addition, 
another noncoding RNA, named Tsix, has also been found to interact with Xist and both 
of these noncoding RNAs play a role in the X chromosome inactivation. In mammals, X 
chromosome inactivation occurs in the early developmental stage, however the timing 
of determination of X chromosome inactivation is different between species. In mouse, 
the X chromosome inactivation occurs in the late blastocyst stage (Xu et al., 2007).  
The role of DNA methylation in genome stability 
DNA methylation also plays a role in the maintenance of genome stability. The 
majority of the observations that indicate the DNA methylation functions in genome 
stability are carried out in human disorders. For instance, mutations within DNMT3B 
are found in patients with immunodeficiency, centromere instability and facial 
anomalies (ICF) syndrome and result in the reduction of the global levels of DNA 
methylation (Dodge at al., 2005; Ehrlich, 2003). Consistently, the hypomethylated 
cancer cells often display genome unstability. For instance, the mouse aggressive T-cell 
lymphomas contain extremely low levels of DNA methylation and are accompanied by 
a high frequency of trisomy of chromosome 15 (Eden et al., 2003).  
The possible explanation for the role of DNA methylation in genome stability 
could be the DNA methylation is essential for the accurate segregation of the 
chromosomes. Therefore, loss of DNA methylation might lead to the initiation or 
progression of the tumorigenesis. Additionally, since DNA methylation also plays a role 
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in the suppression of retrotransposons, the role of DNA methylation in genome stability 
might also be achieved through preventing the transposition of retrotransposons and 
protecting the chromosomes from aberrant recombination.  
1.2.4 Dynamics of DNA methylation   
Compared with histone modifications, DNA methylation is a relatively stable 
epigenetic mark. However, during the early embryonic development and the maturation 
process of germ cells, DNA methylation undergoes dynamic reprogramming (Figure 
1.3). In general, there are two waves of global DNA demethylation occurring in the 
developing embryos, with the first one commences soon after the fertilization and the 
second one occurs in the primordial germ cells (PGCs) in the embryos at E13.5 (Feng et 
al., 2010).  
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During the stage from zygote to blastocyst, both paternally and maternally 
derived chromosomes undergo DNA demethylation. Since paternal genome undergoes a 
rapid and cell division-independent DNA demethylation, it has been proven that DNA 
methylation presents on the paternally derived genome is erased through an active DNA 
demethylation. By contrast, maternally derived genome is thought to undergo a passive 
DNA demethylation, since its DNA methylation undergoes a cell-division dependent 
DNA demethylation. Actually, after fertilization, the global level of DNA methylation 
in the maternally derived genome is continuously being reduced during cleavages until 
the late blastocyst stage. Interestingly, a recent study indicated that the oocyte genome 
displays substantial hypomethylation even before fertilization, which raises the question 
of when the DNA demethylation of the maternally derived genome actually occurred 
(Smith et al., 2012).  
However, some specific genomic loci, such as the germline differentially 
methylated regions (DMRs), have been found to be resistant to the first wave of DNA 
demethylation that occurs soon after fertilization. It has been shown that compared with 
the DNA methylation that presents at the boundary regions of DMRs, imprinted DNA 
methylation that established in the germ cells is maintained or at least partially 
maintained during the first wave of DNA demethylation (Kobayashi et al., 2012; Smith 
et al., 2012). In addition, a proportion of the DNA methylation that presents at the 
promoters of oocyte-specific genes is also protected, which suggested that germline 
DMRs are not the only regions that escape from DNA demethylation in the early 
embryos (Venter et al., 2011).   
Since the DNA methylation present at the repetitive elements is essential for the 
maintenance of genome stability, for a long time, it was believed that this DNA 
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methylation should be protected during the first wave of DNA demethylation. However, 
recent observations indicate that both the long interspersed repeats (LINEs) and the 
short interspersed repeats (SINEs) partial lose DNA methylation by the blastocyst stage 
(Kobayashi et al., 2012; Smith et al., 2012). Admittedly, these observations imply that 
the DNA methylation present at the different genomic regions might be distinctly 
regulated during the early mammalian development. 
The first wave of DNA demethylation terminates at the blastocyst stage and the 
global DNA methylation by this point reaches the lowest level. Upon implantation, de 
novo DNA methylation occurs in the epiblast with the silencing of the majority of the 
germline-expressed genes (Isagawa et al., 2011). In addition, by gaining of the DNA 
methylation at promoters, some tissue specific genes in the pluripotent inner cell mass 
(ICM) are also silenced during this stage. Together with the DNA methylation that is 
present on the inactive X chromosome, DNA methylation established during this stage 
plays an essential role in the further embryonic development (Isagawa et al., 2011).  
The second wave of DNA demethylation occurs in the primordial germ cells 
(PGCs) followed by a wave of de novo DNA methylation. In mice, PGCs arise from 
approximately 45 cells in the epiblast at around embryonic day 7.5 (E7.5). PGCs then 
migrate through the hindgut and extra-embryonic regions and finally arrive at the 
primordial gonad in the proximity of the genital ridge by E10.5 to E11.5 (Buehr, 1997). 
It has been found that nearly the entire genome loses DNA methylation in the 
developing PGCs, including the germline DMRs. After removal of the parentally 
inherited DNA methylation, a wave of de novo DNA methylation occurs globally and 
consequently, DNA methylation is established at the appropriate regions within the 
genome (Kagiwada et al., 2013). These also include the germline imprinting control 
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regions (ICRs), where the allele-specific patterns of DNA methylation are deposited 
depending on the sex of the developing germ cells (Kagiwada et al., 2013).  Notably, 
once established, the DNA methylation that presents at the germline DMRs is stably 
maintained throughout life.  
1.3 Genomic imprinting 
The diploid organisms carry two copies of the genome, with one copy inherited 
from each parent. In mammals, for the vast majority of genes, the expression occurs 
from both copies. However, there is a small group of genes whose expression only 
occurs from one copy of the two genes and these genes are called imprinted genes. 
However, recent studies indicated that nearly 10% of the autosomal genes can also be 
mono-allelically expressed in mammals and these randomly monoallelically expressed 
genes can lead to unique cell identity (Chess, 2012).  
In mammals, nearly 80% of the imprinted genes are located in the imprinting 
clusters and each imprinting cluster contains a germline imprinting control region 
(ICR). Since removal of parent-specific DNA methylation from the germline ICRs leads 
to aberrant expression of imprinted genes, it has been found that mono-allelically 
expression of imprinted genes is controlled by the DNA methylation that presents at the 
germline ICRs. However, apart from the DNA methylation that presents at the germline 
ICRs, the DNA methylation that presents at the secondary DMRs is also involved in the 
regulation of the imprinted genes.  
1.3.1 Discovery of imprinted genes 
In the 1980s, by carried out the pronuclear transplantation experiments, it has 
been found that maternally and paternally uniparental embryos can only develop into 
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the predominantly embryonic tissues or larger extra-embryonic tissues, respectively 
(Surani and Barton, 1983). These observations indicate that normal mammalian 
embryonic development requires both maternally and paternally derived genome. 
Furthermore, it has also been found that accurate expression of imprinted genes, which 
locate on the maternally and paternally derived chromosomes, actually plays an 
essential role in the normal development of the embryos. However, a recent study 
demonstrated that a mature oocyte combined with a maternally derived nucleus could 
also generate viable mice (Kawahara et al., 2007). In addition, using the non-growing 
oocytes, which contain mutations at two individual imprinted loci as the nuclei donor, it 
has been found that the frequency of the viable offspring is associated with the dosage 
of the imprinted genes (Kawahara et al., 2007). Taken together, these observations 
suggest that in mammals, the accurate expression of the imprinted genes is essential for 
the normal embryonic development.  
The first identified imprinted gene, Igf2r, encodes the insulin-like growth factor 
type 2 receptor (Barlow et al., 1991). Apart from Igf2r, other imprinted genes were also 
identified in gene targeting experiments, such as Igf2, the insulin-like growth factor type 
2 (DeChiara et al., 1991) and Mest, also known as Peg1 (Lefebvre et al., 1998). Based 
on a different strategy, maternal imprinted gene H19 was identified using single 
nucleotide polymorphisms (SNPs) that reside in the H19 RNA (Bartolomei et al., 1991). 
Today, since a great number of the SNPs have been found in various mouse strains, the 
whole transcriptome analysis has been employed to identify the potential imprinted 
genes. This led to the identification of many monoallelically expressed RNAs (Babak et 
al., 2008; Wang et al., 2008). Currently, there are at least 80 imprinted genes known in 
humans and mice. Notably, the vast majority of the imprinted genes are distributed in 
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clusters and the average length of each cluster is about 1Mb. In addition, nearly every 
cluster contains paternal and maternal imprinted genes and at least one gene, which 
encodes for a non-coding RNA.  
1.3.2 Functions of imprinted genes 
In mammals, imprinted genes are predominantly expressed in the prenatal stage 
and down regulated after birth. Within the embryos, imprinted genes are expressed in 
the placenta and brain, which is consistent with their functions in controlling of the 
embryonic growth, the development of the nervous system and behaviour (Davies et al., 
2008).  The main function of imprinted genes is to maintain the normal development of 
the embryos and the placenta. It has been found that silencing of Igf2 causes aberrant 
transport of nutrients from the placenta to the growing embryo (Sibley et al., 2004). In 
addition, paternal imprinted gene Ascl2 is responsible for the normal differentiation of 
the spongiotrophoblast cells in the developing placenta (Guillemot et al., 1995). 
Furthermore, paternal imprinted genes peg10 and Rtl1 are required for the normal 
development of the placenta (Ono et al., 2006; Sekita et al., 2008).  
Consistently, aberrant expression of imprinted genes leads to the abnormal 
embryonic growth. It has been found that the mis-regulation of Delta-like homolog 1 
(Dlk1) in embryos causes over-growth of the fetus, although there is no change of its 
expression in the placenta (da Rocha et al., 2009). Dlk1 also plays a role in the lineage 
specification, since mutations of Dlk1 in mice lead to growth retardation, skeletal 
abnormalities, adipose tissue defects and aberrations in the hematopoietic lineage cells 
(Raghunandan et al., 2008). Another imprinted gene, Cyclin dependent kinase inhibitor 
1c (Cdkn1c), is intensively expressed in the somatic tissues during development, 
including muscle, lung, kidney and eye in mammals. Since CDKN1C plays an essential 
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role in the regulation of cell cycle and knockout of Cdkn1c in mice leads to placentomes, 
spongioblastoma, proliferation of labyrinthine and fibrin deposition of the intervillous 
space, it has been found that Cdkn1c plays an essential role in the early stages of 
mammalian development (Takahashi et al., 2000).  
Apart from playing a role in the development of the placenta and the embryos, 
imprinted genes are also required for the normal development of the brain. It has been 
found that mutations of imprinted genes lead to aberrant behaviour and mental 
retardation in mammals. In mice, apart from growth retardation, females that lack either 
Peg1 or Peg3 display abnormal maternal behaviour (Lefebvre et al., 1998). In addition, 
imprinted genes have also been found to play a role in energy homeostasis. One of the 
best instances is paternal imprinted gene Gsα, which encodes a G protein that controls 
the production of cAMP. It has been found that the abnormal expression of Gsα from 
the maternal allele in the brain leads to the glucose intolerance, insulin resistance and 
obesity in mice (Weinstein et al., 2010). 	  
1.3.3 Regulation of mono-allelic expression of imprinted genes  
As discussed above, the maternal imprinted genes always contain a differentially 
methylated region (DMR) at their promoters. Without any exception, these DMRs are 
unmethylated on the active allele, but methylated on the inactive one. By contrast, there 
is no DMR that have been found at the promoters of paternal imprinted genes. However, 
paternal imprinted clusters contain an intergenic germline DMR. The distribution of 
these DMRs around the imprinted genes raised the hypothesis that mono-allelically 
expression of imprinted genes might be regulated by the DNA methylation that present 
at the relevant DMRs. In mice, targeted deletion studies suggest that the mono-
allelically expression of the imprinted genes is directly controlled by the imprinted 
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DNA methylation (Wutz et al., 1997) and all the germline DMRs are likely to regulate 
the imprinted genes in a cis-regulatory pathway. However, the paternal and maternal 
imprinted genes are regulated by the different mechanisms.  
The best studied paternal imprinted genes located at the Igf2-H19 locus. 
Although Igf2 and H19 are located 90 kb away in the genome, they share the same 
enhancer, which locates at downstream of H19. Normally, Igf2 is expressed from the 
paternal allele, whereas H19 is expressed from the maternal allele (DeChiara et al., 
1991). It has been found that a germline DMR that resides 2-4 kb upstream from the 
TSS of H19 plays a direct role in the regulation of the monoallelic expression of these 
two genes (Tremblay et al., 1997). In addition, this germline DMR was found to contain 
multiple binding sites for a zinc finger insulator protein CTCF and CTCF only binds to 
the unmethylated germline DMR, which presents at the Igf2-H19 locus on the maternal 
allele (Bell and Felsenfeld, 2000). Since the binding of CTCF to the unmethylated 
germline DMR inhibits the interaction between enhancer and promoter of Igf2, maternal 
copy of Igf2 is inactive. By contrast, the enhancer induces expression of H19 on the 
maternal allele. Without binding of CTCF to the methylated DMR on the paternal allele, 
enhancer induces expression of Igf2, whereas H19 is not expressed in this situation.  
Since maternal germline DMRs are located at promoters, compared to the paternal 
imprinted genes, it has been found that the maternal imprinted genes are regulated by a 
different mechanism. For instance, germline DMR located within an intron of Igf2r 
overlaps with the promoter of Airn, which encodes a large non-coding RNA and is 
exclusively expressed from the paternal allele (Wutz et al., 1997). It has been found that 
the expression of Airn correlates with the methylation state of its promoter (Sleutel et al., 
2002). In addition, the non-coding RNA has also been found to play a role in the 
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regulation of the imprinted genes located at the Kcnq1, Snrpn and Gnas clusters 
(Chotalia et al., 2009). 	  
1.3.4 Establishment of germline imprinting 
Among the approximately 80 identified imprinted genes that reside in 26 different 
imprinting clusters, only 3 paternal imprinting clusters are found: Igf2-H19, Dlk1-Dio3 
and Rasgrf1 loci. Although maternal and paternal germline DMRs are located at 
different genomic regions, all the imprinted DNA methylation is established during 
gametes development (Figure 1.4). In male mammals, the establishment of paternal 
imprinted DNA methylation occurs during the period of mitotic arrest and birth in the 
diploid gonocytes, whereas in female mammals, the maternal imprinted DNA 
methylation is established in the developing oocytes that are arrested in the diplotene 
stage of meiosis prior to ovulation (Davis et al., 1999; Lucifero et al., 2002).  
Apart from the Rasgrf1 germline DMR, it has been found that all the imprinted 
DNA methylation that present at the ICRs is established by de novo DNA 
methyltransferases DNMT3A and DNMT3L (Bourc’his and Bestor, 2006). However, 
how the germline DMRs are accurately recognized and discriminated from the rest of 
the genome is still poorly understood. By X-ray crystallography, it has been found that 
DNMT3A and DNMT3L prefer to form a tetrameric complex, which contains of two 
copies of each enzyme and this complex specifically targets to a pair of CpG 
dinucleotides, which are separately 8-10 bp (Smith et al., 2007). In the maternal 
imprinted DMRs, this specific spacing has already been identified, although it is also 
comprehensively distributed across the whole genome. In addition, DNMT3L may play 
a role in chromatin loading of the DNMT3A/DNMT3L complex at the imprinted DMRs, 
since DNMT3L only interacts with the histone H3 that lacks of the H3K4 methylation 
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(Ooi et al., 2007). Furthermore, transcription through the imprinted DMRs in the 
oocytes has also been found to be essential for the accurate establishment of DNA 
methylation that presents at the maternal imprinted loci (Chotalia et al., 2009).  
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1.3.5 Maintenance of genomic imprinting  
Once the imprinted DNA methylation is established in the germ cells, the patterns 
of imprinted DNA methylation are stably maintained throughout life (Figure 1.4). Since 
inappropriate expression of the imprinted genes leads to the defects of the embryonic 
development and causes the human disorders, it is important to investigate how the 
imprinted DNA methylation is maintained. The most challenging period for the 
maintenance of genomic imprinting is in the early developmental stage, since both 
paternally and maternally derived chromosomes undergoes DNA demethylation. 
Strikingly, although most of the global DNA methylation is erased and subsequently 
reestablished, the DNA methylation that presents at the germline DMRs is stably 
maintained during this period. In addition, the patterns of imprinted DNA methylation 
are also inherited precisely by the newly synthesized genome during the cleavages. 
These observations indicate that there must be some specific mechanisms, by which 
imprinted and non-imprinted DNA methylation could be discriminated and only the 
imprinted DNA methylation is maintained in the pre-implantation embryos.  
Currently, several enzymes have been found to play a role in the maintenance of 
imprinted DNA methylation. DNMT1 is the first identified factor, which is required for 
the maintenance of imprinted DNA methylation. In the pre-implantation embryos, apart 
from the existence of a somatic form of DNMT1 (DNMT1s), an oocyte specific form of 
DNMT1 (DNMT1o) is also present and both of DNMT1o and DNMT1s are suggested 
to play a role in the maintenance of imprinted DNA methylation. However, a recent 
study indicated that DNMT1s alone is sufficient for the maintenance of imprinted DNA 
methylation in the early embryos (Howell et al., 2001; Hirasawa et al., 2008). In 
addition to DNMT1, DNMT3A and DNMT3B are also been found to play a role in the 
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maintenance of genomic imprinting, since deletion of Dnmt3a and Dnmt3b in ES cells 
leads to the DNA demethylation at the imprinted loci (Chen et al., 2003; Liang et al., 
2002; Okano et al., 1999). 
Apart from DNMTs, a KRAB zinc finger protein ZFP57 has also been found to 
play a role in the maintenance of imprinted DNA methylation (Temple and Shield, 
2002). The role of ZFP57 in the maintenance of imprinted DNA methylation was 
initially discovered in patients with transient neonatal diabetes (TND) (Mackay et al., 
2008). In addition, it was found that deletion of Zfp57 even leads to the embryonic 
lethality and causes the mis-regulation of the imprinted genes (Li et al., 2008; 
Quenneville et al., 2011). In mouse ES cells, ZFP57 and its cofactor KAP1 exclusively 
bind to the methylated allele and recruit SETDB1 to selectively establish H3K9me3 on 
the methylated allele at imprinted loci (Quenneville et al., 2011). Furthermore, it was 
shown that ZFP57 maintains the imprinted DNA methylation through recognition of a 
methylated hexanucleotide sequence, TGCCGC, which presents at some of the ICRs 
(Quenneville et al., 2011).   
In addition, STELLA, also known as PGC7 or GADD3, has also been found to 
play a role in the maintenance of genomic imprinting (Nakamura et al., 2007). STELLA 
was first found to protect the imprinted DNA methylation in embryos. Although the 
Stella-/- oocytes contain the normal patterns of imprinted DNA methylation, embryos 
derived from these oocytes display hypomethylation at multiple imprinted DMRs 
(Nakamura et al., 2007). Recently, it was shown that STELLA binds to the H3K9me2, 
which presents at the maternally derived genome and germline DMRs within the 
paternally derived chromosomes, and protects the DNA methylation at ICRs from 
TET3-mediated active DNA demethylation in the mouse zygote (Nakamura et al., 2012).  
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Furthermore, the members in the CATERPILLER protein family have also been 
found to play a role in the maintenance of imprinted DNA methylation. Female patients, 
who suffer the familial recurrent hydatidiform mole, a rare maternal effect autosomal 
recessive disease, display the abnormal patterns of DNA methylation at some of the 
germline DMRs in their oocytes. Since mutations in NLRP7 protein lead to the 
hydatidiform mole, it is likely that NLRP7 plays a role in the maintenance of genomic 
imprinting (Kou et al., 2008). Moreover, investigation of two siblings with Beckwith-
Wiedemann syndrome implicated that NLRP2, another member in the CATERPILLER 
protein family, plays a role in the maintenance of imprinted DNA methylation at the 
KCNQ1 cluster (Moser et al., 2009).  
Recently, two Rb-binding protein-related genes, Arid4a and Arid4b, were also 
found to be involved in the maintenance of imprinted DNA methylation at the Prader-
Willi syndrome imprinting center (PWS-IC) and Angelman syndrome imprinting center 
(AS-IC) (Wu et al., 2006). Interestingly, mice combine the homozygous deficiency of 
Arid4a and the heterozygous deficiency of Arid4b display reduced levels of H4K20me3 
and H3K9me3 at the PWS-IC and AS-IC. Additionally, since maintenance of DNA 
methylation at the PWS-IC in ES cells requires the presence of G9a and one of the 
imprinted genes locate in the PWS-IC, named Snrpn, is bi-allelically expressed in the 
G9a-/- ES cells (Xin et al., 2003), it is suggested that G9a might also play a role in the 
maintenance of imprinted DNA methylation in mammals.  
1.3.6 Genomic imprinting and human disorders  
          Since epigenetic mechanisms play an essential role in many biological events, it 
is undoubted that inappropriate alteration of epigenetic modifications might lead to the 
human disorders. Actually, after the mechanisms of the Prader-Willi syndrome and the 
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Angelman syndrome have been revealed, several human genetic diseases have been 
reported, which are associated with the mutations of imprinted genes. Although these 
disorders include various types of disruptions, such as the chromosomal duplication and 
deletion, most of them are caused by the aberrant dosage of the imprinted genes.  
Prader-Willi syndrome (PWS) 
PWS is a multi-manifestation human genetic disorder. The patients of the PWS 
display variant pathological characteristics, including abnormal development in infancy, 
mental retardation, aberrant growth hormone secretion, hypogonadism and even obesity 
(Cassidy and Driscoll, 2009). As the first discovered human imprinting disorder, the 
estimated frequency of the PWS is about one in 15,000 to 25,000 (Buiting, 2010). The 
phenotype of PWS patients includes mild intellectual disability, lower birth weight, 
poor suckling and hypotonia to the voracious appetite (Cassidy and Driscoll, 2009). 
Some of the PWS patients contain an imprinted defect, which is associated with the 
failure to erase of the grandparental derived DNA methylation from their paternal germ 
cells (Buiting, 2010). Although 70% of the PWS have been reported to have a loss of 
paternally derived chromosome region 15q11-13 and 25% of them display maternal 
uniparental disomy (UPD) of chromosome 15, it is still unclear which specific gene(s) 
contribute to the phenotype of PWS (Buiting, 2010). Recently, a gene that codes a small 
nuclear RNA (snoRNA), named SNORD116, was suggested to play a role in the 
aetiology of PWS (Ding et al., 2008).  
Angelman syndrome (AS) 
   The clinical phenotypes of the AS in humans involve severe intellectual 
disability, delayed weaning, microcephaly, frequent smiling and laughing (Buiting, 
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2010). Similar to the PWS, 70% of the AS patients display deletions in the proximity of 
the 15q11-13 locus.  Interestingly, absence of 15q11-13 locus in majority of the AS 
patients occurs on the maternal allele. In addition, 10% of the patients contain a 
mutation within the maternal imprinted gene, UBE3A, which encodes an E3 ubiquitin 
ligase (Buiting, 2010). Furthermore, 2-4% of the AS patients display the abnormal 
patterns of the imprinted DNA methylation within the 15q11-13 locus and a small 
proportion of the patients carry a bi-directional imprinted control region (ICR) 
(Horsthemke and Wagstaff, 2008).  
 Silver-Russell syndrome (SRS) 
 SRS occurs in approximately one in 3,000 to 100,000 children and the patients 
display characteristic pre- and/or postnatal growth restriction, skeletal asymmetry and 
small triangular shaped face (Abu-Amero et al., 2008). Mutations within the 7q32 and 
7p12.2-3 chromosomal regions that contain imprinted genes MEST and GRB10, 
respectively, are responsible for the SRS (Abu-Amero et al., 2008). In addition, since 
the SRS patients also display abnormal patterns of imprinted DNA methylation at other 
ICRs, it has been found that the SRS patients are unable to establish and maintain the 
overall patterns of imprinted DNA methylation properly (Kannenberg et al., 2012). 
 Beckwith-Wiedemann syndrome (BWS)  
 Down-regulation of the imprinted genes that locate at the 11p15.5 locus is 
involved in 85% of the BWS and the incidence of BWS is estimated about one in 
13,700 in the live births (Gicquel et al., 2005). Opposite to the SRS, the phenotypes of 
the BWS patients include pre- and/or postnatal overgrowth, placental overgrowth, 
macroglossia and embryonal carcinoma (Choufani et al., 2010). In addition, around half 
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of the BWS patients show hypomethylation at the KvDMR1 locus, whereas 5% of the 
patients display hypermethylation at the H19-Igf2 ICR (Miho et al., 2012). Although 
most of the BWS cases are sporadic, 15% of the patients have inherited a mutation, 
among whom, 40% contain the mutations within the CDKN1C locus (Choufani et al., 
2010).   
 In addition to the ICRs, mutations of the epigenetic marks that occurred at the 
other genomic regions can also lead to the human disorders. It has been found that 
alterations of DNA methylation and histone acetylation that present at the gene body 
regions could cause human prostate cancer (Cang et al., 2009; Kloth et al., 2012). In 
addition, other studies have found that a gene called mixed lineage leukemia (Mll) could 
cause the AML in humans by rearranging and fusing with the other genes that present 
on the different chromosomes. Furthermore, loss of DNA methylation that presents at 
the polymorphic D4Z4 repeat region on the chromosome 4 could also cause the 
facioscapulohumeral muscular dystrophy (FSHD) (van Overveld et al., 2003). 
Moreover, aberrant DNA methylation that presents at the retrotransposons could also 
lead to the human disorders (Sekigawa et al., 2003). Taken together, it is important to 
investigate the underlying mechanisms that link the epigenetic marks with the human 
disorders.  
1.4 Histone modifications 
   In eukaryotes, the nucleosome serves as the basic component for the packaging 
of DNA into the chromatin. The core of a nucleosome is an octameric protein complex, 
which contains two copies of each histone, including H2A, H2B, H3 and H4. Since the 
tails of histones can further be modified (Figure 1.5), the structure of chromatin is 
strongly associated with the local histone modifications and varies in the nucleus. In 
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general, there are two categories of histone posttranslational modifications (HPTMs). 
The first includes the small chemical groups, such as the acetyl, methyl and phosphate 
groups. By contrast, the other involves the larger peptides, including the ubiquitin and 
the SUMO.  
Histone post-translational modifications were first identified in the 1960s. 
However, the underlying functions of these marks were poorly understood for a long 
time. In recent years, many studies have shown that similar to DNA methylation, the 
HPTMs also play an essential role in the regulation of gene expression. Today, two 
underlying mechanisms of the HPTMs are considered. First, the HPTMs per se may 
facilitate the direct interaction between the effector proteins and the chromatin. Second, 
the HPTMs may alter the structure and block the accessibility of the chromatin at a 
given locus. Till now, a great number of the HPTMs have been found in mammals 
(Figure 1.5), among which some are transient, whereas the others are likely to be 
epigenetically heritable.  
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1.4.1 Distribution of histone modifications 
Similar to DNA methylation, the distribution of HPTMs also varies across the 
chromatin and active and silenced genes contain different profiles of HPTMs (Figure 
1.6). For a given gene, HPTMs are not only present at promoter or enhancer, but also in 
the gene body region (Figure 1.6) (Barth and Imhof, 2010). For instance, H3K4me2 and 
H3K4me3 usually exist at the promoters of actively transcribed genes and H3K4me1 
and H3K27Ac normally co-exist at the enhancers (Sim III and Reinberg, 2006; Zentner 
et al, 2011). By contrast, H3K9me2 and H3K9me3 are usually present at the inactive 
genes and the peripheral regions within the nucleus (Barski et al., 2007). Furthermore, 
H3K27me3 and H4K20me3 are also normally present at the inactive genes (Cao et al., 
2002; Rice et al., 2003). According to the distinct profiles of the HPTMs, it has been 
suggested that the positioning of the HPTMs is strongly associated with their functions.  
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However, some observations demonstrate that the distribution profiles of the 
HPTMs are inconsistent in some cases. For example, together with the heterochromatin 
protein 1 gamma (HP1gamma), the repressive marks H3K9me2 and H3K9me3 have 
also been found at some active genes and the positioning of both the HP1gamma and 
the H3K9me2/3 depends on the transcription elongation (Vakoc et al., 2005; Vakoc et 
al., 2006). Additionally, some other repressive marks are also present at the active 
genes, including H3K27me1 and H3K20me1 (Carrozza et al., 2005; Vakoc et al., 2006). 
Furthermore, it has been found that H3K36me3 is enriched in the gene body regions and 
facilitates the transcription elongation (Carrozza et al., 2005; Joshi and Struhl, 2005; 
Keogh et al., 2005; Kizer et al., 2005). Another interesting observation is the bivalent 
chromatin state, where both the H3K4 and H3K27 methylation co-exist at the promoters 
of many protein coding genes in human and mouse ES cells (Cankovic et al., 2007). 
Since the bivalent domains tend to coincide with the transcription factor (TF) associated 
genes, the possible mechanism is that the bivalent domains suppress the differentiation 
associated genes in the pluripotent cells, while keeping them poised for activation in the 
differentiated cells (Bernstein et al., 2006).  
1.4.2 Histone modifiers and the functions of histone modifications 
In eukaryotes, histone modifications were first identified approximately 50 years 
ago (Murray, 1964) and actually, histone was the first protein that had been revealed to 
contain the ubiquitin mark. Although the correlations between the histone modifications 
and the transcriptional activity have been observed, the functions of these modifications 
were still obscure. Today, it has been found that histone modifications could regulate 
the gene activity in either direct or indirect ways. In addition, some histone 
modifications are only associated with gene expression, such as acetylation and 
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phosphorylation, whereas the others can play either a positive or a negative role in the 
regulation of the gene expression. 	  
Histone lysine methyltransferases  (KMTs), demethylases (KDMs) 
and the functions of histone lysine methylation 
Although histone methylation was first discovered in the 1960s (Murray, 1964), 
histone lysine methyltransferases (KMTs) and histone lysine demethylases (KDMs) 
have only been identified relatively recently. The first HKMTs, SUV39H1 and its 
fission yeast homolog Clr4, were identified in 2000 (Rea et al., 2000), and since then a 
great number of enzymes have been found to exert a KMT function. All of these 
enzymes use S-adenosyl-L-methionine (SAM) as the methyl group donor and contain a 
conserved catalytic SET domain, apart from DOT1 (Martin and Zhang, 2005; Rea et al., 
2000).  
Prior to the discovery of KDMs, the histone methylation was widely considered 
to be irreversible, since the methyl group is quite stable, especially at the 
heterochromatin regions (Bannister et al., 2002). However, this idea was changed by the 
discovery of the first KDM, the amine oxidase-domain-containing mammalian protein 
LSD1 (lysine-specific demethylase 1), which could remove the methyl groups from the 
H3K4me2 and H3K4me3 (Shi et al., 2004). In addition, it has also been found that 
LSD1 could form a complex with androgen receptor (AR) and play a role in the 
removal of H3K9 methylation in mammals (Metzger et al., 2005).  
Following LSD1, five other demethylases were identified and all these enzymes 
contain a common catalytic structure, the JmjC-domain. Among these enzymes, 
JHDM1 demethylates H3K36me1 and H3K36me2, whereas JHDM2A demethylates 
H3K9me1 and H3K9me2 (Klose et al., 2006; Tsukada and Zhang, 2006). However, the 
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tri-methylation state of these modified residues, including H3K36me3 and H3K9me3, 
could only be removed by JHDM3A or JMJD2A (Klose et al., 2006; Tsukada and 
Zhang, 2006). In addition, since no JmjC-domain has been found in the LSD1, the 
JmjC-domain demethylases must exert their function through a different mechanism 
from that of LSD1.  
Unlike histone acetylation, histone methylation at lysine residues can play either 
a positive or a negative role in gene regulation. So far, there are six residues that have 
been well studied, including the lysine 4, 9, 27, 36 and 79 on the tail of histone H3 and 
lysine 20 on the tail of histone H4. In general, the methylation marks present at the 
H3K4, H3K36 and H3K79 sites are associated with gene expression, whereas the rest of 
them play a negative role in the gene expression. For instance, the H3K4 methylation, 
which was first identified in the vicinity of the chicken β-globin locus and at the active 
mating-type loci in budding yeast (Litt et al., 2001; Noma et al., 2001), is always 
associated with gene expression.  
In mammals, H3K4me1 is present at enhancers, whereas H3K4me3 is present at 
the promoters of the transcriptionally active genes. Structurally, H3K4me can be 
recognized by either the tandem set of chromodomains or PHD finger containing 
proteins (Sims et al., 2006). However, other proteins without these domains, such as 
ISWI ATPase, may also bind to the H3K4 methylation in an indirect way. 
Mechanistically, there are three components that play a role in the establishment of the 
H3K4 methylation. First, the RNA Polymease II (Pol II) that containing serine-5 
phosphorylation at its C-terminal domain could promote the establishment of H3K4 
methylation by recruitment of SET1 to the promoters. In addition, via the interaction 
with the Pol II, the PAF complex could indirectly recruit the SET1 and coordinate the 
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setting of H3K4me3 (Zhu et al., 2005). Furthermore, the monoubiquitylation of H2B at 
lysine 123 in yeast (lysine 120 in human) also plays a role in the establishment of 
H3K4me3 (Dover et al., 2002; Sun and Allis, 2002).  
H3K9 methylation is another well-characterized histone modification, since one 
of its modifiers, SUV39H1, was the first histone lysine methyltransferase to be 
identified (Rea et al., 2000). As the Drosophila homolog, Su(var)39, was initially 
identified as a suppressor of the position effect variegation, it was suggested that the 
SUV39 plays a negative role in gene transcription. In mammals, SUV39H1 and 
SUV39H2 methylate the lysine 9 on histone H3 to H3K9me3 state, which provides the 
binding sites for the chromodomain within the heterochromatin protein 1 (HP1) 
(Nielsen et al., 2001). However, HP1 not only binds to the H3K9me3, but also interacts 
with the SUV39, leading to the methylation of the lysine 9 within the neighbouring 
nucleosomes. Therefore, the heterochromatin patterns tend to be spread bi-directionally 
(Nakayama et al., 2001).  
The presence of H3K9 methylation is often associated with DNA methylation. 
In the DNMTs-deficient cancer cells, apart from loss of DNA methylation globally, the 
level of the H3K9me3 is also reduced dramatically. This observation can be attributed 
to the fact that the stability of the histone methyltransferase SETDB1, which is required 
for the establishment of H3K9me3, depends on the presence of the methylated DNA 
binding protein 1 (MBD1) in mammalian cells (Martin and Zhang, 2005; Zhang and 
Reinberg, 2001). Unlike H3K9me3, which is predominantly present at the 
heterochromatin regions, H3K9me2 is present at the euchromatic regions and the 
nuclear periphery (Yokochi et al., 2009). In mammals, the main modifiers for 
depositing of the H3K9me2 are G9a and GLP. In addition, it has been found that the 
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G9a/GLP complex is the predominant form of these two enzymes that exist in vivo 
(Tachibana et al., 2005; Ueda et al., 2006).   
H3K27 methylation is another repressive epigenetic mark, which is associated 
with gene silencing and X chromosome inactivation. The H3K27me3 modifier EZH2 is 
a component of the Polycomb repressive complex 2 (PRC2). Therefore, the H3K27me3 
is associated with the Polycomb-mediated repression. In animals, the Polycomb group 
proteins are required for the repression of development-associated genes, including the 
genes within the Hox loci (Kirmizis et al., 2004). In addition, H3K27me3 is also 
associated with the malignant tumours, since the EZH2 is overexpressed in many types 
of the cancer cells (Martin and Zhang, 2005). Interestingly, histone demethylase 
JARID1D is thought to interact with the PRC2 and plays a role in the removal of the 
H3K4 methylation from the euchromatin regions (Pedersen and Helin, 2010). Apart 
from PRC2, Polycomb repressive complex 1 (PRC1) could also recognise H3K27me3 
through its chromodomain and deposit ubiquitination at the H2AK119 site (Wang et al., 
2004).  
The H3K36 methylation is highly enriched on the gene body regions of the 
actively transcribed genes and promotes the efficient elongation. The RNA pol II that 
contains the serine-2 phosphorylation within its C-terminal domain could recruit the 
SET2, which is essential for the establishment of H3K36me3. In addition, H3K36me3 
also plays a role in the suppression of the aberrant transcription in yeast (Carrozza et al., 
2005; Joshi and Struhl, 2005). On one hand, H3K36me3 could recruit EAF3 and 
RPD3S (a homolog of mammalian HDAC2) to the gene body regions. Since RPD3S 
could later remove the histone acetylation, which is required for the initiation of 
transcription, the presence of the H3K36me3 at the gene body regions may prevent the 
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binding of Pol II to the cryptic promoters. On the other hand, since H3K36me3 also 
prevents the histone exchanges within the gene bodies (Venkatesh et al., 2012), lack of 
the active mark in the gene body regions may also prevent the initiation of the cryptic 
transcription.  
 Since the lysine 79 of histone H3 is located within the core of the nucleosome, 
H3K79me is an unusual mark. From yeast to eukaryotes, it has been found that the 
H3K79me is present on the coding regions of the active genes, which suggests that the 
H3K79me is a mark of active transcription (Fingerman et al., 2007). In budding yeast, 
H3K79me prevents the binding of repressive proteins to euchromatin, such as the SIR2 
and SIR3 (Frederiks et al., 2008). H4K20me2 and H4K20me3 present at the 
pericentrometic heterochromatin regions and the levels of these marks are associated 
with the levels of H3K9me3. H4K20me1 plays a role in transcriptional repression and 
X inactivation (Karachentsev et al. 2005; Kohlmaier et al. 2004). Recent study has 
found H4K20me1 also enriched at the actively transcribed genes (Vakoc et al, 2006).    
1.4.3 H3K9 methyltransferases 
The catalytic domain of histone methyltransferases is SET domain, which stands 
for suppressor of variegation, enhancer of zeste and trithorax (Tschiersch et al, 1994). 
Actually, after SUV39H1 (KMT1A) was found as the first KMTs, proteins containing 
SET domain have been identified in various organisms, including viruses, bacteria, 
yeast, fungi and multi-cellular organisms and all these proteins have been shown to be 
able to methylate histone and non-histone substrates in vivo (Pontvianne et al., 2010; 
Reyes-Dominguez et al., 2008). In addition to SUV39H1 and SUV39H2, there are some 
other HKMTs that also play a role in the establishment of H3K9 methylation in 
mammalian cells, including G9a (EHMT2), GLP (EHMT1), SETDB1 (ESET), PRDM3 
	   58	  
and PRDM16 (Pinheiro et al., 2012; Tachibana et al., 2001). Biochemically, both 
SUV39H1 and G9a can deposit mono-, di-, and trimethylation at the lysine 9 of histone 
H3 in vitro (Kubicek et al., 2007). However, investigations that carried out in the 
Suv39h1 and Suv39h2 double knockout or the G9a-deficient cells illustrate that the 
main function of SUV39H1 and SUV39H2 in vivo is to deposit H3K9me3 at the 
pericentromeric heterochromatin regions, whereas G9a plays a critical role in the 
establishment of H3K9me1 and H3K9me2 in euchromatin (Tachibana et al., 2002; 
Peters et al., 2003; Rice et al., 2003).  
Similar to the SUV39H1 and SUV39H2, SETDB1 (ESET) is another HKMTs, 
which also plays a role in the establishment of H3K9me3 in mammalian cells. It has 
been found that SETDB1 is essential for the survival of the ES cells and plays an 
essential role in the development of the pre-implantation embryos (Dodge et al., 2004). 
In addition, in the Setdb1 tissue specific knockout animals and ES cells, it was found 
that SETDB1 is also required for the maintenance of articular cartilage (Lawson et al., 
2013a) and plays a role in the regulation of the osteoblast differentiation during the 
bone development (Lawson et al., 2013a; Lawson et al., 2013b).  
Originally described as the G9a-like protein, GLP has been found to possess the 
same substrates specificity to those of G9a in vitro (Tachibana et al., 2005). In 
mammals, although G9a and GLP share the same histone substrates and exert their 
methyltransferase activities independently, the levels of H3K9me1 and H3K9me2 are 
significantly reduced in either G9a or Glp knockout ES cells (Tachibana et al., 2005). 
Furthermore, since the levels of H3K9me1 and H3K9me2 in the G9a or GLP single 
knockout or the double knockout cells are comparable, it has been suggested that G9a 
can not compensate for the functions of GLP and vice versa (Tachibana et al., 2005).  
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Furthermore, it has been found that G9a and GLP can form either homodimers 
or heterodimers in vivo via the interactions of their SET domains. In mouse ES cells, the 
endogenous G9a and GLP exist predominantly as a stoichiometric G9a/GLP 
heterodimer and a C2H2 zinc finger protein WIZ serves as another stable component in 
the G9a/GLP complex (Tachibana et al., 2005; Tachibana et al., 2008) (Figure 1.7). In 
addition, the NHLC motif located in the pre-SET domain of either G9a or GLP is 
essential for the dimerization of these two enzymes (Figure 1.7)	   and the mutations 
within this motif cause both reduction of H3K9me2 and loss of DNA methylation at the 
G9a targeted loci (Tachibana et al., 2008).  
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Moreover, it has been found that the ankyrin repeat (ANK) domains within G9a 
and GLP are able to recognise and bind to the H3K9me1 and H3K9me2 through the amino 
acids within the fourth and the fifth ankyrin repeat loop, including W839, W844, W877 
and E847 (Collins et al., 2007). In addition, among these amino acids, any mutation could 
completely disrupt the interactions between the G9a/GLP complex and H3K9 methylation  
(Collins et al., 2007).  
Apart from G9a and GLP, PRDM3 and PRDM16 also play a role in the 
establishment of H3K9me1 in mouse embryonic fibroblasts (MEFs) (Pinheiro et al., 
2012). Interestingly, apart from exists within the nucleosomes, the non-nucleosomal 
form of H3K9me1 also presents in the cytoplasm and nucleus. This makes H3K9me1 
different from the other histone methylations, since all the other histone methylations 
cannot be detected in a non-nucleosomal manner (Loyola et al., 2006). However, apart 
from H3K9me1, PRDM3 and PRDM16 also contribute to the H3K9me3, since in the 
Prdm3 and Prdm16 knockout cells, H3K9me3 cannot be fully established at the major 
satellite regions (Pinheiro et al., 2012).  
1.4.4 H3K9 methylation and DNA methylation  
The first evidence that indicating H3K9 methylation is required for DNA 
methylation was reported in the fungus Neurospora crassa (Tamaru and Selker, 2001). 
In Neurospora, DIM-5 functions as the main KMT, which is essential for the 
establishment of H3K9me3. Since the heterochromatin protein 1 (HP1) is able to 
recognise and bind to the H3K9me3, which can further recruit DNA methyltransferase 
(DIM-2) to the H3K9me3-marked regions, the presence of H3K9me3 is required for the 
de novo DNA methylation in Neurospora (Tamaru and Selker, 2001; Rountree and 
Selker, 2010).  
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In plants, H3K9 methylation is also associated with DNA methylation (Johnson 
et al., 2007). In Arabidopsis thaliana, the histone methyltransferase KRYPTONITE 
(KYP) is able to directly bind to the methylated DNA and establish H3K9me2 at the 
targeted loci. Since the newly established H3K9me2 can further recruit the de novo 
DNA methyltransferase CMT3 to the chromatin, DNA methylation and H3K9 
methylation mutually reinforce each other.  
The methylation of H3K9 is also linked to DNA methylation in mammals. It has 
been found that DNA methylation that presents at the major, but not minor, satellite 
repeat region is reduced in the Suv39h1 and Suv39h2 double knockout ES cells 
(Lehnertz et al., 2003). Moreover, since H3K9me3 is required for the recruitment of 
HP1α and HP1β and these HP1 proteins are able to further recruit DNMT3B to the 
chromatin, the DNA methylation that presents at the pericentromeric heterochromatin 
region is partially dependent on the presence of SUV39H1/2-mediated H3K9me3.  
Additionally, it has also been found that both H3K9me2 and the global DNA 
methylation are reduced in the G9a or Glp knockout ES cells (Dong et al., 2008; 
Epsztejn-Litman et al., 2008; Tachibana et al., 2008). Interestingly, since the loss of 
DNA methylation in the G9a-/- ES cells can be restored partially by the catalytically 
inactive G9a, it has been found that G9a promotes DNA methylation independently of 
its catalytic activity (Dong et al., 2008). Actually, G9a is able to directly interact with 
the DNMTs in mammalian cells. For instance, the N-terminal domain of GFP-tagged 
G9a directly interacts with the his-tagged DNMT1 in Cos-7 cells (Esteve et al., 2006) 
(Figure 1.8), whereas in human colon cancer cells, G9a forms a complex with DNMT1 
(Fraga et al., 2004). Furthermore, in Hela cells, the chromatin binding patterns of G9a is 
correlated with the chromatin positioning of DNMT1 (Esteve et al., 2006).  
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By contrast, in mouse ES cells, the chromatin binding patterns of G9a is 
independent of the positioning of DNMTs on the chromatin (Oda et al., 2006). 
Moreover, it has been found that both DNMT3A and DNMT3B are able to directly 
interact with G9a/GLP complex in vivo (Epsztejn-Litman et al., 2008). By co-
expression of the truncated forms of G9a and DNMT3A in 293 cells, it was reported 
that the ANK domain within G9a is essential for the interaction between G9a and the 
methyltransferase domain (MTD) of DMNT3A (Epsztejn-Litman et al, 2008) (Figure 
1.8). In addition, the hemi-methylated DNA binding protein UHRF1 was also found to 
interact with DNMT1 and H3K9 methylation. During DNA replication, UHRF1 forms a 
complex with DNMT1 (Sharif et al., 2007) and binds to the H3K9me2 and H3K9me3 
via its tandem tudor domain and the plant homeo-domain (PHD) (Rottach et al., 2010).  
1.4.5 H3K9 methylation and imprinted DNA methylation 
Previous studies have found that H3K9me3 is enriched not only at the ICRs on 
the methylated allele, but also at the promoters of several imprinted genes, including 
H19 and Cdkn1c (Ager et al., 2008). Recently, Quenneville et al reported that the zinc 
finger protein ZFP57 and its cofactor KAP1 are able to selectively bind to the 
H3K9me3-marked methylated allele at the ICRs and play an important role in the 
maintenance of the imprinted DNA methylation in ES cells (Quenneville et al., 2011).  
G9a is also essential for the maintenance of DNA methylation at the imprinted 
loci in mammals. In mouse G9a-/- ES cells, H3K9me2 is reduced at the PWS associated 
ICR. In addition, one of the imprinted genes that located within this imprinting cluster, 
named Snrpn, is bi-allelically expressed in the G9a-/- ES cells (Xin et al., 2003). 
However, it has been reported that in the Dnmt1-/- ES cells, H3K9me2 alone is 
sufficient for the maintenance of the monoallelic expression of Snrpn (Esteve et al., 
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2006). Taken together, these observations indicate that the absence of imprinted DNA 
methylation is not sufficient to cause biallelic expression of Snrpn in mouse ES cells. 
Furthermore, G9a has also been found to be responsible for the allele-specific 
repression of imprinted genes in the placenta, particularly the genes that are imprinted 
in the trophoblast, but not in the embryos (Nagano et al, 2008; Wagschal et al., 2008). 
However, since the imprinted genes that lost imprinting in the absence of G9a were not 
dependent on the DNA methylation, the role for G9a in the maintenance of genomic 
imprinting in the placenta seems requires the heterochromatin marks, such as H3K9me2 
or H3K9me3.  
1.5 Patterns of promoter DNA methylation in G9a-/- ES cells 
   It has been shown that in the G9a-/- ES cells, some genomic regions display 
hypomethylation, including the major satellite repeats, endogenous retroviruses and 
promoters of a few protein coding genes (Shinkai and Tachibana, 2011)However, the 
extent to which the DNA methylation is lost in the absence of G9a was still unknown. 
Previous work in the lab has shown that approximately 50% of the global DNA 
methylation is lost in the G9a-/- ES cells when compared to the wild-type ES cells 
(Myant et al., 2011). In addition, the promoters of a number of the protein coding genes, 
including the trophectoderm-specific Elf5 and Rhox genes, display detectable 
hypomethylation (Myant et al., 2011).   
      
	   66	  
 
 
	   67	  
 
To investigate whether G9a is required for DNA methylation at the promoters of 
protein coding genes, Ausma Termanis, a former PhD student in the lab, carried out 
affinity purification of methylated DNA from wild-type and G9a-/- ES cells. The 
purified methylated DNA was then hybridized to the microarrays, which contains the 
high density of the oligonucleotide within the promoters of all the annotated mouse 
protein coding genes. These experiments identified 170 hypo- and 89 hyper-methylated 
promoters in the G9a-/- ES cells when compared with the wild-type control (Figure 
1.9A) (Ausma Termanis, unpublished). Strikingly, the promoters of some maternal 
imprinted genes were identified among the hypo-methylated loci (Figure 1.9B) (Ausma 
Termanis, unpublished). This interesting observation suggests that the histone 
methyltransferase G9a may play a role in the protection of the imprinted DNA 
methylation in mouse ES cells. 	  
1.6 Aims of the project 
It has been shown that loss of the DNA methylation at ICRs leads to the aberrant 
expression of the imprinted genes. Therefore, it has been found that the imprinted genes 
are directly regulated by the imprinted DNA methylation. In addition, since once 
established, the patterns of the imprinted DNA methylation are maintained stably 
throughout life and numerous human disorders have been found to be associated with 
the abnormal expression of the imprinted genes, it is important to investigate how the 
imprinted DNA methylation is maintained in mammals.  
Previous observations have suggested that apart from depositing H3K9me2, the 
histone methyltransferase G9a and its partner GLP also affect the global levels of DNA 
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methylation in mammalian cells (Dong et al., 2008). In addition, G9a is also involved in 
the maintenance of imprinted DNA methylation at some imprinted loci (Xin et al., 
2003). Furthermore, the chromatin binding protein STELLA requires the G9a 
associated H3K9me2 in the maintenance of DNA methylation during the early 
developmental stage (Nakamura et al., 2007; Nakamura et al., 2012). Together with the 
initial observation suggesting that maternally derived ICRs are hypomethylated in G9a-
/- ES cells (Ausma Termanis, unpublished), these evidence led to the hypothesis that 
G9a may play an important role in the protection of the imprinted (and also the non-
imprinted) DNA methylation in mouse embryonic stem (ES) cells from demethylase 
activities.  
Therefore, the first aim of my project was to validate independently the 
microarray data and investigate whether G9a is required for the DNA methylation at 
some or all the ICRs in ES cells. As paternal ICRs, including Igf2/H19, Dlk1/Dio3 and 
Rasgrf1, are located at the intergenic regions, while maternal ICRs are at the promoters, 
I also would like to determine whether both maternal and paternal ICRs lose DNA 
methylation in the G9a-/- ES cells. Since the imprinted DNA methylation is established 
in the primordial germ cells (PGCs) and is normally stably maintained throughout life 
(Lucifero et al., 2002), the third aim of my project was to investigate whether and how 
does G9a maintain the imprinted DNA methylation in ES cells. Given that G9a serves 
as the main modifier for depositing H3K9me1 and H3K9me2 in ES cells and the 
previous studies showed that G9a protein, but not its catalytic activity, affects the 
patterns of DNA methylation in ES cells (Dong et al., 2008), I also aimed to investigate 
whether the catalytic activity of G9a is essential for the protection of the imprinted 
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DNA methylation and, if so, to determine how does G9a protect the DNA methylation 
at the ICRs in ES cells.  
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Chapter 2    Materials and Methods 
2.1 Materials 
2.1.1 Buffers and solutions: 
Phosphate buffered saline (PBS): 140 mM NaCl, 3 mM KCl, 2 mM KH2PO4, 10 
mM Na2HPO4. Stored at room temperature. 
Tris-EDTA (TE): 10 mM Tris pH 7.5, 1 mM EDTA pH 8.0. 
Tris-acetate EDTA (TAE): 40 mM Tris, 20 mM glacial acetic acid, 1 mM EDTA 
and adjusted to pH 8.0. 
Bisulfite conversion solution: 3.8 g sodium bisulfite was dissolved in 5 ml H2O 
and 1.5 ml freshly made 3 M NaOH in the dark. 110 mg hydroquinone was dissolved in 1 
ml water at 55 °C for 10 minutes and subsequently added to the sodium bisulfite solution. 
Special PCR buffer: 166 mM (NH4)2SO4, 670 mM Tris pH 8.0 and 100 mM 
Beta-mercaptoethanol. 
2.5 × Sequencing buffer: 20 mM Tris-HCl pH 8.0, 5 mM MgCl2. 
Protein manipulation solutions: 
Hypotopic NE1 buffer: 20 mM HEPES pH7.0, 10 mM KCl, 1 mM MgCl2, 0.1% 
(v/v) Triton X-100, 20% (v/v) glycerol, 0.5 mM DTT and complete protease inhibitors. 
DTT and complete protease inhibitors were added immediately prior to use. Stored at 
4°C.  
SDS-PAGE loading buffer (5 ×): 0.5 M Tris pH 6.8, 10% (v/v) glycerol, 2% SDS, 
0.05% bromophenol blue, 250 mM DTT. Stored at room temperature, DTT added just 
prior to use. 
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SDS-PAGE separating gel: 0.1% SDS, 0.05% ammonium persulfate, desired 
concentration of acrylamide and 375 mM Tris pH 8.8 and made up to 10 ml with distilled 
H2O. 
SDS-PAGE stacking gel: 0.1% SDS, 0.05% ammonium persulfate, 4% 
acrylamide, 125 mM Tris pH 6.8 and made up to 10 ml with distilled H2O. 
Western blotting running buffer: 25 mM Tris, 250 mM Glycine, 0.1% SDS. 
Western blotting transfer buffer: 25 mM Tris, 250 mM Glycine. 
Ponceau S staining solution: 1% (v/v) glacial acetic acid, 0.5% (w/v) Ponceau S. 
TBS solution: 50 mM Tris-Cl, pH 7.6; 150 mM NaCl 
MeDIP solutions: 
10 × IP buffer: 100 mM NaH2PO4 pH 7.0, 1.4 M NaCl, 0.5% Triton X-100 
Digestion buffer: 50 mM Tris pH 8.0, 10 mM EDTA, 0.5% SDS.  
ChIP solutions:  
10 × cross-linking solution: 500 mM HEPES pH 7.9, 1.5 M NaCl, 10 mM EDTA, 
5 mM EGTA. 
L1 buffer: 50 mM HEPES pH 7.9, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 
0.5% NP-40, 0.25% Triton X-100. 
L2 buffer: 10 mM Tris pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA. 
L3 buffer: 10 mM Tris pH 8.0, 1 mM EDTA, 0.5 mM EGTA. 
ChIP dilution buffer: 20 mM Tris pH 8.0, 150 mM NaCl, 2 mM EDTA, 1% 
Triton X-100. 
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Wash buffer 1: 20 mM Tris pH 8.0, 150 mM NaCl, 2 mM EDTA, 1% Triton X-
100, 0.1% SDS. 
Wash buffer 2: 20 mM Tris pH 8.0, 500 mM NaCl, 2 mM EDTA, 1% Triton X-
100, 0.1% SDS. 
Equipment: Quantitative PCR instrument (Lightcycle 480, Roche), Odyssey 
scanner (Licor), Biorupter (Diagenode), PCR instruments (Biometra), CO2 incubator 
(Thermo Scientific).  
2.1.2 Antibodies 
anti-G9a (Mouse monoclonal Perseus Proteomics PP-A8620A-00): 1:1000 
working concentration in 4% milk + 0.1% Tween 20. 
anti-GLP (Mouse monoclonal Perseus Proteomics PP-B0422-00): 1:1000 working 
concentration in 4% milk + 0.1% Tween 20. 
anti-HDAC1 (Rabbit polyclonal Santa Cruz sc-7872/D171): 1:1000 working 
concentration in 4% milk + 0.1% Tween 20. 
anti-DNMT3a (Mouse monoclonal Abcam ab13888): 1:1000 working 
concentration in 4% milk + 0.1% Tween 20. 
anti-DNMT3b (Mouse monoclonal Abcam ab13604): 1:1000 working 
concentration in 4% milk + 0.1% Tween 20. 
anti-DNMT1 (Rabbit polyclonal Santa Cruz sc-20701/H300): 1:1000 working 
concentration in 4% milk + 0.1% Tween 20. 
anti-H3K9me1 (Rabbit polyclonal Upstate 07-450): 1:2000 working concentration 
in 4% milk + 0.1% Tween 20. 
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anti-H3K9me2 (Mouse monoclonal Abcam ab1220): 1:2000 working 
concentration in 4% milk + 0.1% Tween 20 and 1:2000 working concentration for ChIP. 
anti-H3K9me3 (Rabbit polyclonal Upstate 07-442): 1:2000 working concentration 
in 4% milk + 0.1% Tween 20. 
anti-H4 (Rabbit polyclonal Upstate 06-866): 1:500 working concentration in 4% 
milk + 0.1% Tween 20. 
anti-Ran (Mouse monoclonal Abcam ab11693): 1:5000 working concentration in 
4% milk + 0.1% Tween 20. 
anti-Stella (Rabbit polyclonal Santa Cruz sc-67249/M150): 1:1000 working 
concentration in 4% milk + 0.1% Tween 20. 
anti-LSH (Mouse monoclonal Santa Cruz sc-46665/H0205): 1:500 working 
concentration in 4% milk + 0.1% Tween 20. 
anti-5meC (Mouse monoclonal Eurogentec BI-MECY-1000): 1:2000 working 
concentration for MeDIP. 
IRDye 800CW Donkey anti-Mouse IgG: 1:10000 working concentration in 4% 
milk + 0.1% Tween 20. 
IRDye 800CW Donkey anti-Rabbit IgG: 1:10000 working concentration in 4% 
milk + 0.1% Tween 20. 
IRDye 680RD Donkey anti-Rabbit IgG: 1:10000 working concentration in 4% 
milk + 0.1% Tween 20. 
2.1.3 Primers 
All primers were synthesised from MWG Eurofins. Lyophilised primers were 
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diluted in distilled H2O to 100 µM stock concentration and stored at -20 oC. The final 
concentration of the primers for the normal PCR and qPCR is 5 µM and 2.5 µM, 
respectively. 
Primers for bisulfite DNA sequencing: 
Ankrd50 
mAnkrd50-BS-F1 (out) GGATGTGGTGGATTTGTTGTTA 




mIgf2r-BS-F (out) TTAGTGGGGTATTTTTATTTGTATGG 
mIgf2r-BS-F (in) GTGTGGTATTTTTATGTATAGTTAGG 
mIgf2r-BS-R AAATATCCTAAAAATACAAACTACAC 
Snrpn 
mSnrpn-BS-F (out) GGGTTGTTAAAAATTTTAATAAGTTTAAAT 
mSnrpn-BS-F (in) TTTAGAATGTTTTGGTTAAATAGGATGTAT 
mSnrpn-BS-R AAAAAAACAAAAACCCCTACATTAC 
H19 
mH19-BS-F (out) GTTTGAGGAGTTTTAAGGTAGAAGG 
mH19-BS-F (in) TTTTGTTGAATTTGGGGTATTTAAA 
mH19-BS-R TCACTCAAACATAACATTCAATAATTC 
Zac1 mZac1-BS-F ATTTGTTATTTAGTTTGGGTTGGG 
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mZac1-BS-R1 (in) CCCAAATTCAAAATTTATCACCTC 
mZac1-BS-R2 (out) ATTCTCCCAAAAATTCTTAAAAATC 



















Peg3 IP-Peg3-F CAGAGGACCCTGACAAGGAG 
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IP-Peg3-R AGCACAGCACTCTACGCACA 
Peg10 
IP- Peg10-F TCCTGACCAACTACGACCTG 
IP- Peg10-R CCATACTCACCACACGAGGA 
Peg13 
IP- Peg13-F AGCTGAGCGAACCCCTTTAC 






































































G9a G9a-Seq-F AGGTACGGCTGCAGCTCTACCG 







G9a WT-G9a-F3-6-mut GGTTTACTGCATTGATGCCCG 








Primers for DNA sequencing: 
pJET Seq-pJET-F GCCTGAACACCATATCCATCC 
G9a Seq-G9a-MUT-F GGACGGGCGGCTGCTCCAGGAGTTTAAC 
G9a Seq-G9a-MUT-R CCGGGTGGGGGTCCAGCCGGGCCAGGCGG 
G9a Seq-G9a-F AGGTACGGCTGCAGCTCTACCG 
G9a Seq-G9a-R CTGGGAGGGGAGACAAGGAAC 
 
2.1.2 Embryonic stem (ES) cell lines 
G9a knockout ES cell line: Generated by gene conversion of heterozygous G9a+/- 
ES cells through stringent antibiotic selection (Yoichi Shinkai). 
G9a knockout wild-type G9a rescued ES cell line: G9a knockout ES cells were 
selected by 1 µg/ml puromycin after transfection with a linearized plasmid expressing 
Flag-tagged wild-type G9a (Yoichi Shinkai).  
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G9a knockout catalytically inactive G9a rescued ES cell line: G9a knockout ES 
cells were selected by 1 µg/ml puromycin after transfection with a linearized plasmid 
expressing catalytically inactive (H1092A) G9a (Yoichi Shinkai).  
G9a knockdown ES cell lines: Short hairpin RNA knockdown of G9a in TT2 or 
E14 ES cells through 1 µg/ml puromycin selection (Tuo Zhang). 
Exogenous wild-type G9a (short hairpin RNA resistant) expression and 
endogenous G9a knockdown ES cell line: Wild-type ES cells were selected by 1 µg/ml of 
puromycin and 200 µg/ml of hygromycin after transfection with a linearized plasmid 
expressing a wild-type short hairpin RNA resistant form of G9a and a linearized plasmid 
expressing short hairpin RNA (Tuo Zhang). 
Exogenous ANK domain mutant (ANKm) G9a (short hairpin RNA resistant) 
expression and endogenous G9a knockdown ES cell line: Wild-type ES cells were 
selected by 1 µg/ml puromycin and 200 µg/ml of hygromycin after transfection with a 
linearized plasmid expressing an ANK domain mutant (W844A, E847A) short hairpin 
RNA resistant form of G9a and a linearized plasmid expressing short hairpin RNA (Tuo 
Zhang). 
Exogenous ANK domain deleted (ANKdel) G9a (short hairpin RNA resistant) 
expression and endogenous G9a knockdown ES cell line: Wild-type ES cells were 
selected by 1 µg/ml puromycin and 200 µg/ml of hygromycin after transfection with by a 
linearized plasmid expressing an ANK domain deleted (Δ692-943aa) short hairpin RNA 
resistant form of G9a and a linearized plasmid expressing short hairpin RNA (Tuo 
Zhang).  
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Exogenous dimerization mutant ANKm (dmANKm) G9a (short hairpin RNA 
resistant) expressing and endogenous G9a knockdown ES cell line: Wild-type ES cells 
were selected by 1µg/ml of puromycin and 200 µg/ml hygromycin after transfection with 
a linearized plasmid expressing an ANK domain mutant (W844A, E847A) and 
dimerization mutant (N1165L, H1166E) short hairpin RNA resistant form of G9a and a 
linearized plasmid expressing short hairpin RNA (Tuo Zhang). 
Exogenous dimerization mutant ANKdel (dmANKdel) G9a (short hairpin RNA 
resistant) expressing and endogenous G9a knockdown ES cell line: Wild-type ES cells 
were selected by 1µg/ml puromycin and 200 µg/ml of hygromycin after transfection with 
a linearized plasmid expressing an ANK domain deleted (Δ692-943aa) and dimerization 
mutant (N1165L, H1166E) short hairpin RNA resistant form of G9a and a linearized 
plasmid expressing short hairpin RNA (Tuo Zhang). 
2.2 Methods 
2.2.1 Molecular cloning  
Polymerase chain reaction (PCR): polymerase chain reaction was performed in 1 
× buffer IV containing 12 mM MgCl2, 2.5 mM dNTPs, 7% (v/v) DMSO, polymerase (2.5 
units in 50 µl), 5 µM primers and desired amount of template. Denaturation, annealing 
and elongation were dependent on application. For bisulfite sequencing, the buffer IV 
was replaced by the special PCR buffer. The results of PCR were assessed by agarose gel 
electrophoresis.  
Restriction enzyme digestion: Restriction enzyme digests were carried out in a 
suitable volume according to the manufacturer’s instructions. Incubation times varied 
from 2 hours to overnight at desired temperature, typically 37 oC. Completion of 
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digestion was assessed by agarose gel electrophoresis. 
Gel extraction: the gel slice containing the desired DNA fragments was dissected 
and melted at 55 °C for 10 minutes. Then the DNA was extracted following the 
manufacturer’s instruction using the GeneJET Gel Extraction Kit (K0692, Thermo 
Scientific).  
Ligation (for general cloning):  Purified DNA fragments were blunted in the 1 × 
ligation buffer containing system at 70 oC for 5 minutes and the pJET1.4 linearized 
plasmid backbone and T4 DNA ligase were added.  The ligation reaction was performed 
at 16 °C for 12-16 hours and the ligation results were assessed by competent cell 
transformation and selection.  
Plasmid Precipitation: Plasmids were purified from 5 ml or 500 ml overnight (12-
14 hours) E.coli cultures according to manufacturer’s instruction by using the Quiagen 
Miniprep or Maxiprep Kits, respectively. Plasmid DNA was eluted in desired volume of 
1 × TE buffer and kept at -20 °C.  
2.2.2 Sodium bisulfite DNA sequencing  
Genomic DNA extraction: Cells cultured in T175 flask were resuspended in 1 ml 
of 1 × TE buffer. Proteinase K and SDS were added to a final concentration of 200 µg/ml 
and 1% respectively. Lysed cells were digested by Proteinase K at 55 °C overnight. RNA 
was degraded by 10 µl of 100 µg/ml RNase incubated at 37 °C for 4 hours. The salt 
concentration was subsequently adjusted to 200 mM by adding 40 µl of 5 N NaCl. 
Digested peptides were removed through two rounds of phenol:chloroform:isoamyl 
alcohol extractions followed by chloroform extraction. Genomic DNA was precipitated 
in 1 volume isopropanol containing 1/10 volume of 3 M NaOAc (pH 5.4) solution. 
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Finally, the DNA pellet was washed by 70% (v/v) ethanol and dissolved in a desired 
volume of 1 × TE buffer. 
Bisulfite conversion of genomic DNA: 2 µg of genomic DNA was resuspended in 
1 × TE buffer with a total volume of 25 µl. DNA was denatured at 110 °C for 5 minutes 
and chilled immediately on ice. 2.5 µl of freshly made 3 M NaOH was added and then the 
samples were incubated at 37 °C for 20 minutes. Finally, 270 µl of sodium bisulfite 
solution (see solutions section) was added to each sample. Overlaid with mineral oil, the 
samples were incubated overnight for sulfonation at 55 °C.  
Isopropanol precipitation and desulfonation: The treated genomic DNA was 
precipitated in isopropanol and sodium acetate solution with 2.5 µg of glycogen. DNA 
pellets were resuspended in 25 µl of 1 × TE buffer and desulfonated by 3 M NaOH for 15 
minutes at 37 °C. Samples were then precipitated by 32.5 µl of 5 M ammonium acetate 
(pH 7.0) and 180 µl 100% ethanol. Finally, DNA pellet was dissolved in 25 µl of 1 × TE 
buffer. 
PCR amplification of interest regions: Design nested PCR primers using 
Methprimer software aiming for amplification regions across CpG di-nucleotides rich 
region and PCR products around 300-400 base pairs long. Before setting up the PCR 
reactions, denature the DNA at 100 °C for 10 minutes and place it on ice. Use 1-2 µl of 
sodium bisulfite treated DNA as template for the first round PCR reaction (50 µl system). 
For the nested PCR (50 µl system), take 2 µl of the first round PCR product as template 
for the PCR reaction. The following program was used for both the first round and the 
nested PCR reactions: 95 °C for 5 minutes and 22 (first round) or 30 (nested) cycles of 
cycling with each cycle at 95 °C for 30 seconds, appropriate annealing temperature for 30 
seconds and 72 °C for 30 seconds. Finally elongate the PCR product at 72 °C for 10 
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minutes.  
PCR product purification: The PCR products are checked by electrophoresis, 
usually use 1.5% of agarose gel containing 0.05% (v/v) ethidium bromide (E1510, 
Sigma). Cut the clear band and purify the PCR product according to manufacturer’s 
instructions by using the GeneJET Gel Extraction Kit (K0692, Thermo Scientific).  
Ligation (for bisulfite sequencing): Measure the concentration of the PCR product 
using Picodrop microliter spectrophotometry (Picopet01, BobBatty). Calculate the 
desired amount of PCR product depends on the length of PCR products and ligate with 
pJET1.4 linearized plasmid backbone according to manufacturer’s instructions by using 
CloneJET PCR Cloning Kit (K1231, Thermo Scientific).  
Transformation: 10 µl of ligation product is transformed into 50 µl of competent 
DH5α E.coli cells at 42 °C for 90 seconds. After recovering at 37 °C for 30 minutes, 
transformed E.coli were grown overnight on LB Ampicillin selected plates.   
Colony PCR: Use the forward and reverse primers of pJET1.4 cloning plasmid 
and the positive transformed E.coli as the primers and the template for colony PCR, 
respectively. The following program was used for colony PCR reactions: 95 °C for 5 
minutes and 28 cycles of cycling with each cycle at 95 °C for 30 seconds, 56 °C for 30 
seconds and 72 °C for 1 minute. Finally elongate the PCR product at 72 °C for 10 
minutes.  
Clean up of the colony PCR product: Generation of the mixture containing 2 µl of 
Exonuclease I, 20 µl of Shrimp Alkaline Phosphatase and 78 µl of H2O. Take 10 µl of 
colony PCR product and mix with 4 µl of Exonuclease I and Shrimp Alkaline 
Phosphatase mixture. Incubate at 37 °C for 20 minutes and then at 80 °C for 15 minutes.  
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DNA sequencing: Big Dye Reactions were set up in a 10 µl system including 3 µl 
of 1 × sequencing buffer, 2 µl of BigDye Terminator v3.1 (4337457, Life-technologies), 
1 µl of sequencing primer (3.2 µM), and 4 µl of cleaned up of the colony PCR product. 
The following program was used for the reactions: 96 °C for 1 minute and 25 cycles of 
cycling with each cycle at 96 °C for 10 seconds, 50 °C for 5 seconds and 60 °C for 4 
minutes. Finally, DNA sequencing was carried out in the Genepool Sanger Sequencing 
Service department at the University of Edinburgh.  
2.2.3 Methylated DNA immunoprecipitation (MeDIP) 
50 µg of genomic DNA was diluted into a 1.5 ml volume with 1 × TE buffer and 
sonicated by biorupter device (B01010002, Diagenode) at high frequency for 25 cycles 
with each cycle of 30 seconds on and off. The size of the sonicated DNA was assessed 
by agarose gel electrophoresis. For MeDIP, the expected size is around 300-500 base 
pairs. 4 µg of sonicated DNA was made into a final volume of 450 µl followed by 
addition of 5 µg of either anti-5meC or anti-mouse IgG antibody. The sonicated DNA 
fragments and the antibody were incubated for 2 hours at 4 °C. 50 µl of Sheep anti-
mouse Dynabeads were added and incubated for another 2 hours at 4 °C. The beads 
were collected by a magnet and washed in 500 µl of 1 × IP buffer for 3 times. Finally, 
the beads were resuspended in 100 µl of digestion buffer with Proteinase K and 
incubated at 55 °C overnight. After digestion, the DNA fragments were extracted by 
PureLink Quick PCR Purification Kit  (K310002, Invitrogen) and resuspended with 100 
µl of distilled water.  
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2.2.4 Chromatin immuoprecipitation (ChIP) 
Crosslinking: cell pellets from a confluent T175 flask were resuspended in 10 ml 
of warm DPBS and 1/10 volume of 10 × crosslinking buffer was added. The final 
concentration of formaldehyde was adjusted to 1% and the cell suspension was incubated 
for 5 minutes at room temperature. The crosslinking reaction was stopped by 125 mM 
freshly made Glycine and the cells were collected by spinning at 1 400 rpm for 6 minutes 
at 4 °C and washed twice by cold DPBS containing 0.1 mM PMSF. The aliquoted cells 
(2 × 106 cells/tube) were stored at  -80 °C. Cells (2 × 106) were resuspended in 5 ml cold 
L1 buffer containing 0.1 mM PMSF and placed on a spinning wheel for 10 minutes at 
4 °C. Cells were collected by spinning at 3 000 rpm for 10 minutes at 4 °C. Then the cells 
were washed with cold L2 buffer containing 0.1 mM PMSF and spun down as above. 
Finally, cells were resuspended with 1850 µl of cold L3 buffer containing 0.5% SDS.  
Sonication: the cell suspension was sonicated by biorupter device (B01010002, 
Diagenode) at high frequency for 45 cycles with each cycle of 30 seconds on and off. 50 
µl of the sonicated chromatin was spun at 13 000 rpm for 10 minutes and the supernatant 
was moved into a new tube. Equal volume of 1 × TE buffer with 1% SDS and 5 µl of 
proteinase K were added. Then the sample was digested overnight at 65 °C. The rest of 
the sonicated chromatin sample was divided into equal aliquots (100 µl) and stored at  -
80 °C. After digestion, the DNA was extracted by the phenol/chloroform method (see 
methods for genomic DNA extraction) and the size of the sonicated chromatin was 
assessed by agarose gel electrophoresis. For ChIP, the expected size was around 300 base 
pairs.  
Immunoprecipitation: the appropriate volume of sonicated chromatin samples, 
which equals to 2.5 µg of DNA, was diluted in ChIP dilution buffer in order to reduce the 
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SDS concentration to 0.1%. The volumes of the different samples were adjusted to equal 
amounts and desired antibody was added (1 µg/ 200 µl IP reaction). Then the sonicated 
chromatin samples and the antibody were incubated for 2 hours at 4°C. 50 µl of Protein G 
Dynabeads (10004D, Lifetechnologies) beads were added and incubated together for 
another 2 hours at 4°C. The beads were collected by a magnet and washed by Wash 
buffer 1 and 2 for 4 times and 3 times, respectively. The beads was then resuspended in 
100 µl 1 × TE buffer with 1 µl of RNase (29 mg/ml) and incubated at 37 °C for 15 
minutes. Finally, 5 µl of Proteinase K (20 mg/ml) was added and the beads were 
incubated at 55 °C overnight. After digestion, the DNA fragments were extracted by 
PureLink Quick PCR Purification Kit  (K310002, Invitrogen) and resuspended with 100 
µl of distilled water.  
Quantitative PCR (qPCR) detection: the enrichment of the DNA fragments after 
ChIP was next checked by qPCR. qPCR was carried out by LightCycler 480 (Roche) 
with 1 × SYBR Green I Master-mix buffer containing 2.5 µM primers and desired 
amount of template with the conditions of denature, annealing and elongation. For all the 
ChIP samples, use 3 µl of purified DNA fragments as template, whereas for the input 
samples, use 1 µl of purified DNA fragments as template. Finally, the qPCR results were 
calculated by comparative Ct method, also known as the 2–[delta] [delta] Ct method, with 
different dilution factor of ChIP and input samples.  
2.2.5 Quantitative reverse transcription PCR (qRT-PCR) 
Total RNA extraction: Cell pellets from the confluent T75 flasks were 
resuspended in 1 ml of Trizol reagent (15596-026, Lifetechnologies) and 200 µl of 
chloroform added. Samples were mixed and spun at 13 000 rpm for 15 minutes at 4 °C. 
The top aqueous phase was removed and precipitated with an equal volume of 
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isopropanol for 10 minutes at room temperature. Then the precipitated samples were spun 
at 13 000 rpm for 15 minutes at 4 °C. RNA pellets were washed in cold 75% (v/v) 
ethanol and air dried for 5 minutes at room temperature. Finally, the RNA pellets were 
dissolved in RNAse free water with RiboLock RNase inhibitor (EO0381, Thermo 
Scientific). The trace amount of DNA was digested with 2 µl of DNase I (EN0521, 
Thermo Scientific) in a 50 µl volume at 37 °C for 20 minutes and then the DNase was 
inactivated at 95 °C for 3 minutes. 
cDNA synthesis: 1 µl of oligo(dT) primer (0.5 µM) was added into 4 µg of total 
RNA in a final volume of 11 µl. Samples were incubated at 65 °C for 5 minutes and 
cooled immediately on ice. 8 µl of mixture solution, including 1 µl of dNTPs (10 mM), 4 
µl of 5 × FS buffer; 2 µl of DTT (0.1 M) and 1 µl of RNase inhibitor (40 units/µl), was 
added into each sample and incubated together at 42 °C for 2 minutes. Finally, 1 µl of 
Superscript II Reverse Transcriptase (18064-014, Lifetechnologies) was added 
selectively into the positive RT reactions and the reaction was performed at 42 °C for 2 
hours. 
Quantitative PCR: Quantitative PCR was carried out by LightCycler 480 (Roche) 
with 1 × SYBR Green I Master-mix buffer containing 2.5 µM primers and desired 
amount of template with the conditions of denature, annealing and elongation. Finally, 
the qPCR results were calculated by comparative Ct method, also known as the 2–[delta] 
[delta] Ct method, with different dilution factor of ChIP and input samples. 
2.2.6 Nuclear protein extraction and Western blotting 
Nuclear extracts: Cell pellets collected from two confluent T175 flasks were 
resuspended in 1 ml of cold hypotonic NE1 Buffer with proteinase inhibitor (P8340, 
	   89	  
Sigma) and homogenized in a 2 ml Dounce homogenizer. The disrupted cell suspension 
was transferred into a 2 ml Eppendorf tube and spun at 3 000 rpm for 5 minutes at 4 °C in 
order to collect nuclei. The supernatant was removed and the nuclear pellet was 
resuspended in a desired volume of cold NE1 buffer. The nuclear acids were digested on 
ice by 3 µl of Benzonase (70746, Merck Millipore) for 1 hour and the digestion was 
stopped by 450 mM NaCl. Samples were placed on a spinning wheel for 1 hour at 4 °C 
and then spun at 13 000 rpm for 15 minutes at 4 °C. Finally, the supernatant nuclear 
extract layer was transferred into a new tube. 
Protein quantification: Protein concentration was measured by Bicinchoninic 
Acid-Copper (II) Sulfate method. First, Bicinchoninic Acid Solution (Sigma, B9643) and 
Copper (II) Sulfate Solution (Sigma, C2284) were mixed according to a 50:1 ratio. For 
each sample, take 2 µl of protein and resuspend in 1 ml mixture of Bicinchoninic Acid 
Solution and Copper (II) Sulfate Solution. Heat and shake the samples at 65 °C at 800 
rpm for 15 minutes and place the sample on ice for 5 minutes. Measure the OD value at 
562 nm wavelength by Scanning Spectrophotometer (3000, CECIL Instruments) and 
calculate the protein concentration according to 0.04 absorbance units are approximately 
equivalent to 1 µg of protein. Quantified protein extracts were stored at -80 °C. 
SDS-PAGE electrophoresis: 4% or 15% separating gel was prepared and poured 
prior to the stacking gel. Protein was resuspended in a 1 × sample buffer system 
containing 0.1 M DTT and denatured at 95 °C for 5 minutes. Different sizes of the 
protein were separated in a suitable concentration SDS-PAGE gel at 270 V for 75 
minutes. 
Nitrocellulose membrane transfer: Protein separated in the SDS gel was 
transferred onto Nitrocellulose membrane (Bio-Rad) for 1 hour in 1 × cold transfer buffer 
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system at 270 V. 
Western blotting: Membrane was blocked in 1 × PBS with 4% milk and 0.1% 
Tween 20 for 1 hour at RT. Then the membrane was probed overnight at 4 °C in the 
freshly made blocking solution containing the desired concentration of primary antibody 
concentration (see materials for antibody concentrations). Membrane was washed three 
times with 1 × PBS with 0.1% Tween 20 and then blocked again for 1 hour as mentioned 
above. Secondary antibody was added to a desired concentration (see materials for 
antibody concentrations) and the membrane was incubated for another 2 hours. Finally, 
the membrane was washed as before to remove the unspecific binding of the secondary 
antibody and scanned by Odyssey 3.0 Scanner (Licor biosciences).  
2.2.7 Mouse ES cells culture  
The ES cells were cultured at 37 °C and 5% CO2 in the flasks or dishes coated 
with 0.5% sterile gelatin in Minimum Essential Medium (MEM, 11430-030, 
Lifetechnologies) supplemented with 10% (v/v) Fetal Bovine Serum (FBS), 1% (v/v) 
sodium pyruvate, 1% (v/v) non-essential amino acids, 1% (v/v) Penicillin-Streptomycin-
Glutamine (PSG), 0.05% (v/v) of 2-mercaptoethanol and desired amount of Leukemia 
inhibitory factor (LIF, usually 2 µl of LIF in 1 ml medium). Confluent cells were 
trypsinized with 0.05% warm trypsin (R001100, Lifetechnologies) and the cells were 
either be passaged or frozen in medium containing 10% (v/v) DMSO at -80 °C.  
2.2.8 Knockdown of G9a by short hairpin RNA (shRNA) 
One control and four G9a cDNA specific targeted short hairpin RNA (shRNA) 
expression plasmids are designed and synthesized from Creative Biogene (Figure 2.1). 
500 µg plasmids were linearized by ScaI (R0122S, NEB) and precipitated by ethanol. 
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Confluent growing ES cells were trypsinized and 5 × 106 cells were resuspended in 
DPBS containing 50 µg of linearized plasmid DNA in a Bio-Rad Transfection cuvette in 
a final volume of 800 µl. The cell suspension was gently mixed and immediately 
transfected by MicroPulser Electroporator (165-2100, Bio-Rad) at 800 V for 0.04 ms 
with a capacitance of 3 µF. After transfection, the cells were kept at room temperature for 
15 minutes and seeded into 10 cm gelatinized tissue culture dishes containing the 10 ml 
of ES cell culture medium. The medium was replaced by fresh medium containing the 
desired amount of antibiotics 24 hours after transfection. The positive cells were kept 
growing with antibiotics until the colonies appeared.  
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2.2.9 Generation of plasmids expressing mutant forms of G9a 
Design two pairs of primers, including G9a-BglII-F, G9a-shMUT-R, G9a-
shMUT-F, G9a-BglII-R (see 2.1.3 Primers) and make sure G9a-shMUT-R and G9a-
shMUT-F match with each other and contain seven nucleotide acid mutations, which 
involved in the short hairpin RNA targeted regions but without changing the coding G9a 
amino acid sequences. Using pCAG-G9a expressing plasmid as template, first amplify 
two fragments of DNA using the first (G9a-BglII-F and G9a-shMUT-R) and second 
(G9a-shMUT-F and G9a-BglII-R) pairs of primers individually. 
Purify the PCR products and perform the second round PCR using the first 
round two PCR products as template and G9a-BglII-F and G9a-BglII-R as primers. 
Purify the second round PCR product and cut by BglII. Purify the BglII cut PCR product 
and ligate with the pCAG-G9a expressing plasmid backbone, which is also cut by BglII. 
Transform the ligation product into competent E.coli cells and select the positive clones 
on LB ampicillin resistant plates. Pick and grow the positive bacteria clones and extract 
plasmids from them. Sequencing the plasmids and ensure the positive plasmid containing 
seven nucleotides acid mutations, which against the short hairpin RNA (shRNA) without 
altering the sequences of amino acid in G9a protein. 
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Next, using pCAG-G9a (resistant to shRNA) plasmid as template, generate of 
the ANK domain mutant (ANKm, W844A, E847A) and ANK domain deleted (ANKdel, 
Δ692-943aa) forms of G9a expressing plasmids by the similar strategy (Primers see 
2.1.3) (Figure 2.2). Furthermore, by individually create the NH to LE (1165-6) mutation 
in ANKm G9a and ANKdel G9a expressing plasmids, the dmANKm G9a and 
dmANKdel G9a expressing plasmids are generated (Primers see 2.1.3) (Figure 2.3).  
Finally, all the nucleotide mutations in the plasmids that mentioned above are confirmed 
by DNA sequencing.  
2.2.10 Generation of stable ES cell lines expressing mutant forms of 
G9a 
First, linearize the mutant forms of G9a expressing plasmids by BamHI (R0136, 
NEB). Purify the linearized plasmids and transfected into the wild-type ES cells using 
MicroPulser Electroporator (165-2100, Bio-Rad) (Details see 2.1.8). 24 hours after 
transfection, select the positive cells by 1 µg/ml puromycin. Pick and grow the positive 
cells and perform Western blotting in order to check the exogenous G9a expression 
levels.  
Choose the stable and highest exogenous G9a expression cells and transfected 
by the linearized G9a short hairpin RNA expressing plasmid. 24 hours after transfection, 
select the positive cells by 200 µg/ml hygromycin. Pick and grow the positive cells and 
perform Western blotting and qPCR in order to check the endogenous G9a expression 
levels. Choose the stable and lowest endogenous G9a expression cells for the 
downstream experiments.  
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2.2.11  Mouse embryos handling  
Pregnant mice were killed according to the manipulation instructions and the 
uterus with the embryos was collected. Embryos were dissected from the uterus without 
impairment of amniotic membrane and maternally derived blood was washed away by 
DPBS 5 times. The amniotic membrane was punctured and the embryos were dissected in 
individual dishes containing DPBS. Then the extraembryonic tissues were removed from 
the embryos. Finally, the embryos were washed 3 times by DPBS and used for 
downstream experiments.  
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Chapter 3 Loss of imprinted DNA methylation in G9a and 
GLP null ES cells 
3.1 Introduction 
In mammals, among identified histone lysine methyltransferases (HKMTs), G9a 
and GLP serve as the main modifiers for the establishment and maintenance of mono- 
and di-methylation at lysine 9 on the tail of histone H3 (H3K9me1 and H3K9me2). 
Genome-wide analysis of histone modifications demonstrated that H3K9me2 covers 
nearly half of the genome and both H3K9me1 and H3K9me2 are found to be associated 
with transcriptional repression (Lienert et al., 2011). In human cells, the large lamina 
associated chromatin domains, which are normally silenced, contain high levels of 
H3K9me2 (Liu et al., 2011). In mouse ES cells, the majority of G9a repressed genes are 
localized to H3K9me2 marked nuclear periphery and these genes can be re-activated by 
G9a inactivation (Kind et al., 2013).  
Actually, it is found that global distribution of H3K9me2 in pluripotent and 
differentiated ES cells are quite similar (Filion and van Steensel, 2010). In addition, both 
H3K9me2 and H3K9me3 cover pericentric and telomeric regions in many species, where 
they function in suppressing recombination and silencing the transposable elements 
(Bickmore and van Steensel, 2013). Furthermore, heterochromatin mark H3K9me2 not 
only plays a role in early developmental stages, but also in injury and tumourgenesis (Yu 
et al., 2013; Li et al., 2014). One of the best examples is H3K9me2 appears functionally 
during epithelial-mesenchymal transition (EMT). In Claudin-low breast cancer (CLBC) 
cells, it has been found that G9a is responsible for DNA methylation that is present at 
promoter of E-cadherin, resulting decreased expression of E-cadherin, a hallmark of 
EMT (Dong et al., 2012). In particular, H3K9me2 is also associated with repression of 
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tumor suppressor genes, since it is erased from promoters of reactivated tumor suppressor 
genes in cancer cells that have been treated with inhibitors of either DNMTs or HDACs 
(McGarvey et al., 2006). 
In fungi and plants, H3K9 methylation often associates with DNA methylation 
(Tamaru and Selker, 2001). In mammals, H3K9 di- and tri-methylation also play a role in 
the maintenance of DNA methylation. It has been found that knockout of G9a leads to a 
50% loss of DNA methylation in ES cells, especially at repetitive elements, such as 
retrotransposons and major satellite repeats (Dong et al., 2008; Leung et al., 2011). Apart 
from repetitive regions, histone methyltransferase G9a also plays a role in de novo and 
maintenance of DNA methylation at protein coding regions. For instance, during 
differentiation of G9a-/- ES cells, promoters of some pluripotent genes, such as Oct4 and 
Nanog, fail to gain DNA methylation (Athanasiadou et al., 2010; Epsztejn-Litman et al., 
2008; Feldman et al., 2006). In addition, at some imprinted control regions (ICRs), 
maintenance of imprinted DNA methylation also requires presence of G9a, since DNA 
methylation that is present at Prader-Willi syndrome ICR is reduced and the associated 
imprinted gene, Snrpn, is bi-allelically expressed in G9a-/- ES cells (Xin et al., 2003). 
Interestingly, loss of DNA methylation in G9a deficient ES cells can be partially restored 
by catalytically inactive G9a (Dong et al., 2008; Myant et al., 2011; Zhao and Epstein, 
2008). Taken together, these observations indicate that apart from depositing H3K9me1 
and H3K9me2, histone methyltransferase G9a also affect DNA methylation and the role 
of G9a in either the maintenance or establishment of DNA methylation is independent of 
its catalytic activity.   
A previous study in the lab combining methylated DNA affinity purification with 
microarray analysis suggested that some maternal ICRs are hypomethylated in G9a-/- ES 
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cells (Ausma Termanis, unpubished). Depending on this observation, the first aim of this 
chapter was to validate the data from this genome wide study. Second, since only 
maternal, but not paternal, ICRs are located at promoters of imprinted genes, I set out to 
investigate whether paternal ICRs also lose DNA methylation in G9a-/- ES cells. In 
addition, since catalytically inactive G9a can partially restore loss of DNA methylation in 
G9a deficient ES cells, I also set out to investigate whether loss of imprinted DNA 
methylation can be restored by re-expression of either wild-type or catalytically inactive 
G9a in G9a-/- ES cells. Finally, I was also interested in investigating the patterns of 
imprinted DNA methylation in Glp-/- ES cells, since G9a/GLP complex is predominant 
form of either G9a or GLP exist in vivo (Ueda et al., 2006). 
3.2 Results 
3.2.1 DNA methylation is lost from ICRs in G9a-/- ES cells     
Validation of promoter microarray data by bisulfite DNA 
sequencing 
I carried out bisulfite DNA sequencing at Ankrd50 promoter, which was identified 
to be highly methylated in both wild-type and G9a-/- ES cells in the genome wide study 
of affinity purification of methylated DNA coupled with hybridization to promoter 
microarrays. I found that Ankrd50 promoter is highly methylated in both wild-type and 
G9a-/- ES cells (Figure 3.1A), although compared with wild-type ES cells, there is a 
subtle reduction of DNA methylation at Ankrd50 promoter in G9a-/- ES cells. The 
maternal imprinted gene, Mest, also known as Peg1, contains a DMR within its promoter. 
In previous genome-wide study, compared with wild-type ES cells, Mest was one of 
imprinted genes, which showed hypo-methylation in G9a-/- ES cells. Igf2r is another 
maternal imprinted gene, which contains two DMRs. The first DMR (DMR1) is located 
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at its promoter, which plays a role in the regulation of mono-allelic expression of Igf2r. 
The second DMR (DMR2) is located within Igf2r gene body region and overlaps with 
promoter of Airn, a gene encodes a long non-coding RNA. DMR2 has been shown to be 
associated with the regulation of mono-allelic expression of Airn. In order to validate the 
previous genome-wide DNA methylation study, I performed bisulfite DNA sequencing at 
promoter of Mest as well as DMR2 of Igf2r. Compared with wild-type ES cells, I found 
that these two regions displayed hypo-methylation in G9a-/- ES cells, confirming 
requirement of G9a for the protection of DNA methylation at these maternal ICRs 
(Figure 3.1A).  
Paternal ICRs also display hypo-methylation in G9a-/- ES cells 
In mammals, paternal ICRs are located at the intergenic regions of imprinted loci. 
Since the microarray only spanned promoters of protein coding genes, conclusions could 
not be made about the patterns of imprinted DNA methylation at intergenic ICRs in G9a-
/- ES cells. In order to investigate imprinted DNA methylation patterns at paternal ICRs 
in G9a-/- ES cells, I performed bisulfite DNA sequencing at Igf2-H19 ICR. Compared 
with wild-type ES cells, Igf2-H19 ICR is hypo-methylated in G9a-/- ES cells, which 
indicates that not only maternal, but also some paternal ICRs lack imprinted DNA 
methylation in G9a-/- ES cells (Figure 3.1B).  
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3.2.2 G9a is required for the DNA methylation at a large number 
of ICRs 
In order to validate bisulfite DNA sequencing results and investigate imprinted 
DNA methylation patterns at more imprinted loci, I carried out 5meC methylated DNA 
immunoprecipitation (MeDIP) on wild-type and G9a-/- ES cells. Since Ndufa and 
Ankrd50 are two non-imprinted regions that display low and high levels of DNA 
methylation, respectively. In wild-type and G9a-/- ES cells, according to the promoter 
microarray data, these two regions served as negative and positive control regions for 
MeDIP experiments.  
5meC MeDIP results showed that Ndufa and Ankrd50 regions display low and 
high levels of DNA methylation as expected and these levels were comparable between 
wild-type and G9a-/- ES cells (Figure 3.2). Apart from these control regions, I also 
carried out MeDIP followed by qPCR at some ICRs, including five maternal ICRs, 
including Igf2r, Snrpn, Zac1, Peg3 and Peg10 and one paternal ICR Igf2-H19. Compared 
with wild-type ES cells, 5meC enrichment at all the tested ICRs displays significant 
reduction in G9a-/- ES cells, indicating a widespread loss of imprinted DNA methylation 
in G9a-/- ES cells. Therefore it could be deduced that G9a deficiency affects patterns of 
DNA methylation at all the imprinted loci in genome.    
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3.2.3 Imprinted DNA methylation is lost in the Glp-/- ES cells 
Since G9a/GLP complex is the predominant form of either G9a or GLP in vivo 
and GLP also plays a role in the establishment of H3K9 methylation, I set out to 
investigate the patterns of imprinted DNA methylation in Glp-/- ES cells. Similar to in 
G9a-/- ES cells, bisulfite DNA sequencing results showed that Ankrd50 promoter was 
highly methylated in Glp-/- ES cells (Figure 3.3). However, both the ICRs that I 
examined, including Igf2r DMR2 and promoter of Snrpn, displayed hypo-methylated in 
Glp-/- ES cells (Figure 3.3). This result indicates that both the histone methyltransferases, 
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3.2.4 Neither wild-type nor catalytically inactive G9a can restore 
the loss of imprinted DNA methylation in the G9a-/- ES cells  
It was previously shown that loss of DNA methylation could be partially restored 
by re-expression of either wild-type or catalytically inactive G9a in G9a-/- ES cells 
(Dong et al., 2008). In order to investigate whether loss of imprinted DNA methylation in 
G9a-/- ES cells can be restored, I used G9a-/- ES cell lines that re-expressing either Flag 
tagged transgene wild-type G9a (G9a-/- TgG9a) or mutant transgene G9a (G9a-/- 
TgG9aF1205Y) that carrying a single point mutation substituting phenylalanine 1205 with 
tyrosine. To determine G9a protein and H3K9 methylation levels, I performed Western 
blotting assays and found that wild-type ES cells express five isoforms of G9a protein, 
among which two are highly expressed (Figure 3.4A). Whereas G9a-/- TgG9a or G9a-/- 
TgG9aF1205Y ES cells expresses only one isoform of either Flag tagged wild-type G9a-
short protein or catalytic inactive G9a-short protein, respectively, and both of these 
exogenous forms of G9a-short protein were stably expressed in G9a-/- ES cells (Figure 
3.4A). In agreement with published data, H3K9me2 and H3K9me3 were restored in G9a-
/- ES cells that expressing wild-type G9a and the levels are comparable to wild-type ES 
cells. However, the levels of H3K9me2 and H3K9me3 were not restored in G9a-/- ES 
cells that expressing catalytically inactive G9a (Figure 3.4A).  
I then investigated the patterns of imprinted DNA methylation in these rescued 
G9a-/- ES cells. I carried out bisulfite DNA sequencing at four ICRs, including Igf2r 
DMR2, IG-DMR and promoters of Snrpn and Zac1 (Figure 3.4B and C and some data 
not shown). I found that neither wild-type nor catalytically inactive G9a restored loss of 
imprinted DNA methylation at ICRs in G9a-/- ES cells (Figure 3.4B-C), with the 
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exception of Igf2r DMR2, which displayed partially restored DNA methylation in G9a-/- 
TgG9a cell line.  
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In order to investigate the imprinted DNA methylation patterns at other imprinted 
loci, I carried out 5meC MeDIP on G9a-/-, G9a-/-TgG9a and G9a-/- TgG9aF1205Y ES 
cells. Again, Ndufa and Ankrd50 served as negative and positive control regions, 
respectively. At Ndufa locus, all these three ES cell lines display expected low DNA 
methylation levels. However, only in G9a-/- and G9a-/- TgG9a ES cell lines, Ankrd50 
locus displayed high levels of DNA methylation. Reduced DNA methylation at Ankrd50 
locus in G9a-/- TgG9aF1205Y ES cells could be caused by long time cell culturing in vitro 
that was required for generation of these cells.  
In addition to the control regions, six maternal ICRs: Igf2r, Snrpn, Zac1, Peg3, 
Peg10 and Peg13 and two paternal ICR Igf2-H19 and Rasfrf1 are also investigated. All of 
these analyzed ICRs displayed comparably low levels of DNA methylation, which did 
not differ significantly between G9a-/- ES cells and ES cells that expressing either 
TgG9a or TgG9aF1205Y (Figure 3.5). Taken together, these results are consistent with 
previous studies (Chotalia et al., 2009), showing that unlike non-imprinted DNA 
methylation, once imprinted DNA methylation is lost, it cannot be restored. This also 
applies in the case of G9a-/- ES cells.  
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3.3 Discussion 
By carrying out methylated DNA affinity purification coupled with hybridization 
to promoter microarrays, previous PhD student Ausma Termanis found that compared 
with wild-type ES cells, several maternal ICRs displayed hypo-methylation in G9a-/- ES 
cells (Figure 1.9A and B). In order to validate this observation, I performed bisulfite 
DNA sequencing at maternal ICRs, including Igf2r and Mest (Peg1) (Figure 3.1A). 
Together with the data at Ankrd50 locus, which displays no difference of DNA 
methylation in G9a-/- ES cells, I found that maternal imprinted DNA methylation is lost 
in G9a-/- ES cells. In addition, I found that paternal ICRs also underwent DNA 
demethylation in the absence of G9a in ES cells (Figure 3.1B). Furthermore, 5meC 
MeDIP allowed me to investigate the DNA methylation patterns at a larger group of ICRs 
and consistently with bisulfite sequencing results, I found that all the investigated ICRs 
displayed loss of DNA methylation in G9a-/- ES cells (Figure 3.2).  
I also carried out bisulfite DNA sequencing in Glp-/- ES cells and found that the 
levels of imprinted DNA methylation are also impaired (Figure 3.3). The possible 
explanation is that G9a/GLP complex serves as the predominant form of either G9a or 
GLP in ES cells and disruption of either G9a or GLP leads to instability of the other 
partner protein in heterodimeric complex (Tachibana et al., 2005; Ueda et al., 2006). 
Consistently, it has also been shown that G9a cannot compensate for the loss of GLP 
function in vivo and vice versa (Tachibana et al., 2005). Therefore, loss of imprinted 
DNA methylation in G9a-/- and Glp-/- ES cells indicates that both the histone 
methyltransferases, G9a and GLP, might play a role in the protection of imprinted DNA 
methylation in ES cells.  
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Actually, previous studies have demonstrated that histone methyltransferases G9a 
and GLP are required for DNA methylation in ES cells, since reduced DNA methylation 
at major satellite and unique loci, including Wfdc15 and Mega2a was found in G9a and 
GLP null cells (Dong et al., 2008; Epsztejn-Litman et al., 2008; Tachibana et al., 2008). 
Moreover, it was shown that G9a is essential for the maintenance of imprinted DNA 
methylation at ICR of Snrpn (Xin et al., 2003). I have expanded the previous 
understandings and demonstrated a more widespread role of G9a in the protection of 
imprinted DNA methylation in ES cells. As G9a-/- ES cells were generated by gene 
conversions (Tachibana et al, 2002) and the CpG sites are heavily methylated at G9a 
target promoters in wild-type ES cells, which is used to generate G9a-/- ES cells 
(Tachibana et al., 2008), these wild-type ES cells should contain the normal patterns of 
imprinted DNA methylation at ICRs originally. Since compared with wild-type ES cells, 
imprinted DNA methylation is lost in G9a and Glp knockout ES cells, it is likely that 
G9a and GLP are required for the maintenance of imprinted DNA methylation in ES 
cells.  
However, a question arises that by what mechanism G9a may facilitate the 
maintenance of imprinted DNA methylation in ES cells. Since G9a is essential for the 
establishment of H3K9me2 and STELLA, an H3K9me2 binding protein, is required for 
the protection of maternally inherited DNA methylation (including the imprinted DNA 
methylation) and imprinted DNA methylation present on the paternally derived 
chromosomes in zygote (Nakamura et al., 2007; Nakamura et al., 2012; Tachibana et al., 
2005; Ueda et al., 2006), it is possible that G9a maintains the imprinted DNA 
methylation by depositing H3K9me2 at ICRs. On the other hand, since G9a protein per 
se could interact with DNMTs via its N-terminal domain or its ANK domain (Bestor et 
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al., 1988; Fatemi et al., 2002; Gowher et al., 2005), another possibility is that G9a 
maintains imprinted DNA methylation by directly recruiting DNMTs to ICRs in ES cells.  
Since WIZ, a C2H2 zinc finger protein, is also involved in G9a/GLP complex and 
knockdown of Wiz leads to reduction of G9a and GLP (Tachibana et al., 2005; Ueda et 
al., 2006), it is possible that Wiz deficient cells would also display loss of imprinting. It is 
yet unknown whether WIZ can function as a potential DNA binding protein in vivo and 
which DNA motifs it may preferentially bind to. Therefore, it is not clear, whether ICRs 
may contain sequence specific motifs, which WIZ may bind to and recruit G9a/GP 
complex.  
Previous studies have shown that by reintroduction of a wild-type G9a, 
approximately 50% of the reduced DNA methylation in G9a-/- ES cells can be restored 
and the catalytic activity of G9a is not required for the de novo DNA methylation (Dong 
et al., 2008). However, in my study, I found that loss of imprinted DNA methylation fail 
to be restored in either wild-type or catalytically inactive G9a transgene expressing G9a-
/- cells (Figure 3.4B, C and 3.5).  
There are several possibilities that may explain the failure of re-establishment of 
imprinted DNA methylation in G9a-/- ES cells. First, after imprinted DNA methylation is 
lost, un-methylated DNA binding protein may occupy the previously methylated ICRs 
and prevent DNMTs to re-establish imprinted DNA methylation. In addition, many 
studies have demonstrated that DNMT3A and DNMT3L play an essential role in the 
establishment of imprinted DNA methylation during development of gametes (Bourc'his 
et al., 2001; Hata et al., 2002; Kaneda et al., 2004). Although both DNMT3A and 
DNMT3L are expressed in ES cells as well as in gametes, it is unknown whether 
DNMT3A and DNMT3L form the same complex in ES cells to allow the establishment 
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of accurate DNA methylation at ICRs. Furthermore, it has also been shown that 
DNMT3L can directly bind to the amino terminus of histone H3 and this interaction can 
be abolished by presence of H3K4me2 or H3K4me3. Therefore, defects of re-
establishment of imprinted DNA methylation in G9a-/- ES cells could also due to 
existence of distinct histone modifications at ICRs. Moreover, differences between 
transcriptomes in gametes and ES cells might serve as another explanation for the failure 
of restoring imprinted DNA methylation, since in some cases the oocyte-specific 
transcription across ICRs has been proposed to play a role in the establishment of 
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Chapter 4   G9a is essential for the maintenance of imprinted 
DNA methylation in ES cells 
4.1 Introduction  
Previous studies indicated that G9a is essential for the protection of imprinted 
DNA methylation at Snrpn locus and loss of G9a leads to bi-allelic expression of Snrpn 
(Dong et al., 2008). In my previous study, I found that all the investigated ICRs displayed 
hypo-methylation in G9a-/- ES cells. Taken together, these observations suggested that 
G9a plays an important role in the protection of DNA methylation at imprinted loci in ES 
cells.  
Since G9a-/- ES cells were derived from the wild-type ES cells by gene 
conversions (Tachibana et al., 2002) and imprinted DNA methylation is established 
during the development of gametes (Davis et al., 1999; Lucifero et al., 2002)(Figure 1.4), 
loss of imprinting in G9a-/- ES cells suggests that G9a might play a role in the 
maintenance of imprinted DNA methylation in ES cells. Therefore, the aim of this 
chapter is to generate stable G9a knockdown ES cell lines by expression of a short 
hairpin RNA (shRNA) and investigate whether G9a plays a role in the maintenance of 
imprinted DNA methylation in ES cells.  
4.2 Results 
4.2.1 Knockdown of G9a causes the reduction of DNA methylation 
and H3K9me at the ICRs  
In order to identify the most efficient G9a knockdown short hairpin RNA 
(shRNA), I first tested a set of four different shRNA expression plasmids (information 
see Figure 2.1). Together with one control shRNA expression plasmid, I linearized these 
	   117	  
plasmids by SalI and generated one shCont and four shG9a pool clonal ES cell lines in 
wild-type TT2 ES cells (see materials and method). I then performed Western blotting 
assays against G9a in these cell lines and found that compared with shCont ES cell line, 
shRNA-2 G9a knockdown pool ES cell line contains the lowest level of G9a among the 
four pool ES cell lines (Figure 4.1A). This result suggested that shRNA-2 cell line is the 
most efficient G9a knockdown pool clonal ES cell line.  
However, within shRNA-2 pool clonal ES cell line, since individual positive cell 
may integrate with different copies of linearized plasmids, it is required to pick single 
clonal G9a knockdown ES cell line. I picked six independent colonies from shRNA-2 
pool clonal ES cells and expanded these single cells for approximately two weeks in vitro. 
I then tested G9a mRNA levels by RT-qPCR and found that among the six independent 
single clonal shG9a cell lines, shG9a-2 displayed the lowest level of G9a mRNA when 
compared to control ES cell line (Figure 4.1B). In addition, the levels of G9a mRNA in 
wild-type and shCont ES cell lines were comparable, whereas shRNA-2 pool clonal ES 
cell line displayed reduction of G9a mRNA by 60%.  
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To confirm the level of G9a protein was also reduced in the shG9a-2 single clonal 
ES cell line, I extracted nuclear proteins and carried out Western blotting assays. The 
results indicated that shG9a-2 single clonal ES cells displayed a 70% reduction of G9a 
protein when compared with shCont ES cells (Figure 4.1C). In addition, the level of GLP, 
a partner protein of G9a, was also reduced in the shG9a-2 single clonal ES cells and is 
comparable to the level in G9a-/- ES cells. Since both the levels of G9a mRNA and 
protein were significantly reduced in shG9a-2 single clonal ES cells, shG9a-2 single 
clonal ES cell line has been chosen as the best single G9a knockdown clonal ES cell line 
for downstream experiments.  	  
Previous studies have shown that G9a and GLP function as the main histone 
methyltransferases for the establishment and maintenance of H3K9me1/2 and G9a/GLP 
complex is the predominant form of either G9a or GLP that exist in vivo (Tachibana et 
al., 2002; Tachibana et al., 2005; Ueda et al., 2006), therefore, knockdown of G9a was 
likely to affect the levels of H3K9me in ES cells. To investigate the levels of H3K9me in 
shG9a ES cells, I carried out Western blotting assays on nuclear extracts from shCont, 
shG9a-2 and G9a-/- ES cells (Figure 4.1C). As expected, H2K9me2 was reduced by 75% 
in shG9a-2 single clonal ES cells when compared with shCont ES cells. However, there 
was no significant reduction of H3K9me1 in shG9a-2 single clonal ES cells and the 
levels of H3K9me1 in shCont, shG9a-2 and G9a-/- ES cells were very similar (Figure 
4.1C). This result conflicts with previous observations (Peters et al., 2003; Rice et al., 
2003; Tachibana et al., 2002) and suggests that in addition to G9a and GLP, some other 
histone modifiers are also involved in the establishment and maintenance of H3K9me1. 
Furthermore, compared with shCont ES cells, the level of H3K9me3 was reduced by 
20% in shG9a-2 single clonal ES cells, yet higher than the level detected in G9a-/- ES 
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cells (Figure 4.1C). This result suggests that histone methyltransferases G9a and GLP are 
partially required for H3K9me3 in ES cells through providing H3K9me2 substrate for the 
other histone modifiers of H3K9, such as SETDB1 and SUV39H1/2.  
To further investigate the levels of H3K9me at ICRs in shG9a ES cells, I carried 
out ChIP of H3K9me1, H3K9me2 and H3K9me3 at some of the ICRs, Igf2r, Snrpn, H19-
Igf2, Zac1, Peg3, Peg10, Peg13, Rasgrf1, Kcnq1ot1 and GnasXL, in shCont, shG9a-2 and 
G9a-/- ES cells. For H3K9me2 ChIP, Ndufa and Wfdc15 served as negative and positive 
control regions, respectively. Consistent with Western blotting results, ChIP result of 
H3K9me2 indicated that compared with shCont ES cells, the level of H3K9me2 reduced 
more than 70% all the investigated ICRs in shG9a-2 ES cells. In addition, at some of the 
ICRs, including Igf2r, Snrpn, H19-Igf2, Zac1 and Peg3, the remaining levels of 
H3K9me2 in shG9a-2 ES cells are even comparable with the levels in G9a-/- ES cells 
(Figure 4.2). These results were consistent with the previous observations (Tachibana et 
al., 2002; Tachibana et al., 2005) and suggested that knockdown of G9a not only reduces 
the global level of H3K9me2, but also reduces the levels of H3K9me2 at ICRs in ES 
cells.  
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In addition, ChIP result of H3K9me1 indicated that compared with shCont ES 
cells, the levels of H3K9me1 in shG9a ES cells varied between loci, since the levels of 
H3K9me1 significantly reduced at some of the investigated ICRs but not at the others 
(Figure 4.3). These results indicated that histone methyltransferases G9a and GLP play a 
selective role in the maintenance of H3K9me1 at some of the ICRs. However at the other 
ICRs, some other histone modifiers must exist and play a role in the maintenance of 
H3K9me1.  
For the levels of H3K9me3, ChIP results indicated that compared with shCont ES 
cells, there was an approximately 50% reduction at all the investigated ICRs in shG9a-2 
ES cells, yet the remaining levels of H3K9m3 in shG9a-2 ES cells were still higher than 
the levels in G9a-/- ES cells (Figure 4.4). These results were consistent with previous 
Western blotting results and together suggested that histone methyltransferases G9a and 
GLP also contributes to the level of H3K9me3 in ES cells.  
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4.2.2 Imprinted DNA methylation is reduced in the shG9a ES cells 
In order to investigate the levels of imprinted DNA methylation in shG9a ES 
cells, I performed bisulfite DNA sequencing at Igf2r, Snrpn and H19-Igf2 ICRs in shCont 
and shG9a ES cells. The results showed that both Igf2r and H19-Igf2 ICRs displayed 
significant loss of imprinted DNA methylation in shG9a ES cells when compared with 
shCont ES cells (Figure 4.5). In contrast, there was only 15.6% of loss of imprinted DNA 
methylation at Snrpn ICR (46.5% in shCont and 30.9% in shG9a), which suggests that 
imprinted DNA methylation is less stable at Igf2r and H19-Igf2 ICRs when the level of 
G9a is reduced by shRNA.  
In addition, to validate bisulfite DNA sequencing results and investigate 
imprinted DNA methylation further, I carried out 5mC MeDIP at ten ICRs in shCont, 
shG9a and G9a-/- ES cells. Again, Ndufa and Ankrd50 served as negative and positive 
control regions, respectively. The results showed most of the investigated ICRs, including 
Igf2r, Snrpn, H19-Igf2, Zac1, Peg3, Peg13, Kcnq1ot1 and GnasXL, imprinted DNA 
methylation was reduced by approximately 30% in shG9a ES cells when compared to 
shCont ES cells (Figure 4.6). No significant changes at Peg10 and Rasgrf1 loci between 
shCont and shG9a ES cells might due to relative more CpG sites within these DMRs. 
Therefore, loss of DNA methylation occurred at a small proportion within these CpG 
sites could not be discriminated by 5meC MeDIP. However, unlike in G9a-/- ES cells, 
loss of imprinted DNA methylation was only partial in shG9a ES cells. These data are 
consistent with my bisulfite DNA sequencing experiments at Igf2r and Snrpn loci (Figure 
4.5).  
However, compared with shCont ES cells, 5meC MeDIP result showed 
approximately 30% reduction of DNA methylation at H19-Igf2 locus in shG9a ES cells 
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(Figure 4.5), whereas bisulfite DNA sequencing result showed nearly all the imprinted 
DNA methylation was lost at H19-Igf2 locus in shG9a ES cells (Figure 4.6). This conflict 
might due to technical difference between MeDIP and bisulfite DNA sequencing, since 
methylated CpG sites within the flanking regions of a specific locus might influence the 
MeDIP, but not the bisulfite DNA sequencing result. Taken together, these data indicate 
that G9a is essential for the maintenance of imprinted DNA methylation in ES cells.  
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4.2.3 Effect of G9a on imprinted DNA methylation is independent 
of genetic background of ES cells 
To investigate whether the effect of knockdown of G9a on imprinted DNA 
methylation could be reproduced in ES cells with different genetic background, I also 
stably knocked down G9a by shRNA in E14 wild-type ES cells. As previously, I first 
generated a pool clonal G9a knockdown ES cell line in E14 ES cells. Then, I picked six 
independent shG9a single clonal ES cell lines from pool clonal ES cell line, in which I 
tested the levels of G9a, GLP and H3K9me2 by Western blotting assays. The results 
showed that the levels of G9a, GLP and H3K9me2 were reduced in shG9a pool clonal ES 
cells when compared with shCont ES cells (Figure 4.7A). However, among individual 
shG9a single clonal cell lines, the levels of G9a, GLP and H3K9me2 varied (Figure 
4.7A). I selected shG9a-9 single clonal ES cell line for downstream experiments, as it 
displayed the most efficient knockdown of G9a and the lowest levels of GLP and 
H3K9me2 (Figure 4.7B). 
To investigate the patterns of imprinted DNA methylation in shG9a and shCont 
E14 ES cells, I carried out bisulfite DNA sequencing at Ankrd50 promoter and Igf2r 
DMR2 loci (Figure 4.8A). At Ankrd50 promoter, both shCont and shG9a ES cells 
displayed comparably high levels of DNA methylation. However, imprinted DNA 
methylation at Igf2r DMR2 was only reduced in shG9a E14 ES cells, but not in shCont 
ES cells, which indicates that G9a is also required for the maintenance of imprinted DNA 
methylation in E14 ES cells.  
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To validate bisulfite DNA sequencing data and investigate the patterns of imprinted 
DNA methylation at a larger number of ICRs, I performed 5meC MeDIP in shG9a and 
shCont E14 ES cells (Figure 4.8B). Again, Ndufa and Ankrd50 served as negative and 
positive control regions, respectively.  As expected, 5meC MeDIP results showed that 
both shCont and shG9a ES cells displayed hypo- and hyper-methylation at Ndufa and 
Ankrd50 loci. Dpep3 was employed as another positive control region, which also 
showed no changes of DNA methylation according to the promoter microarray data and 
5mC MeDIP results in both shCont and shG9a E14 ES cells (Figure 4.8B).  
In comparison with shCont ES cells, imprinted DNA methylation at all the 
investigated ICRs, including Igf2r, Snrpn, H19-Igf2, Zac1 and Peg3, was reduced by 
about 20-60% in shG9a ES cells (Figure 4.8B). These data are in agreement with bisulfite 
DNA sequencing results at Igf2r DMR2 locus (Figure 4.8A). Whereas some of the DMRs 
that have been checked in shG9a TT2 ES cells (Figure 4.6), including Peg10, Peg13, 
Kcnq1ot1, GnasXL and Rasgrf1, are not investigated here. Taken together, these data 
confirmed that G9a is essential for the maintenance of imprinted DNA methylation in ES 
cells. In summary, experiments performed within two independent ES cells lines that 
have different genetic background consistently demonstrate that reducing levels of G9a 
by shRNA leads to reduction of imprinted DNA methylation at ICR in ES cells.  
4.3 Discussion  
Both bisulfite DNA sequencing and 5meC MeDIP experiments clearly 
demonstrate that knockdown of G9a leads to the reduction of DNA methylation at most 
of the ICRs in ES cells (Figures 4.5, 4.6 and 4.8). Since G9a-/- ES cells are derived from 
wild-type ES cells by gene conversions, which should carry normal patterns of imprinted 
DNA methylation originally, impairment of imprinted DNA methylation in shG9a and 
	   133	  
G9a-/- ES cells confirmed that G9a plays an important role in the maintenance of 
imprinted DNA methylation.  
In addition, previous studies have suggested that even in wild-type ES cells, 
culturing for a long time in vitro could affect the normal patterns of imprinted DNA 
methylation (Dean et al., 1998; Zvetkova et al., 2005). Since shG9a single clonal ES cells 
were generated together with shCont single clonal ES cells and all these cells were 
cultured for approximate the same length of time in vitro, reduction of imprinted DNA 
methylation in shG9a ES cells is not due to extended passaging (Figures 4.5, 4.6 and 4.8). 
In addition, my data also clearly show that the effect of knockdown of G9a on the 
imprinted DNA methylation is independent of genetic background of ES cells, as both 
shG9a TT2 and E14 ES cells displayed similar reduction of imprinted DNA methylation 
when investigated by bisulfite DNA sequencing and 5mC MeDIP.   
Since the process of generation of shG9a single clonal ES cell line required 
approximate 4 weeks, it is unclear that how imprinted DNA methylation is lost form 
ICRs in shG9a ES cells, by active or passive DNA demethylation? To address this 
question, G9a conditional deficient ES cell line is required and the patterns of imprinted 
DNA methylation need to be investigated soon after G9a is removed. Alternatively, since 
active DNA demethylation requires oxidase and/or glycosylase, such as ten-eleven 
translocation (TET) oxidases and thymine DNA glycosylase (TDG) (Ito et al., 2010), 
knockdown of G9a in the active DNA demethylation-associated enzymes deficient ES 
cells following by investigation of the patterns of imprinted DNA methylation may shed 
light on whether loss of the imprinted DNA methylation in G9a deficient ES cells 
through active DNA demethyaltion.  
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As mentioned above, G9a and GLP are the predominant histone 
methyltransferases for the establishment and maintenance of H3K9me2 in mammals 
(Rice et al., 2003; Tachibana et al., 2002). Therefore, it is not surprising that knockdown 
of G9a causes reduction of global H3K9me2 in ES cells. Since my ChIP experiments 
demonstrate that the levels of H3K9me2 are also reduced at ICRs in shG9a ES cells, it is 
possible that G9a is somehow directly function at ICRs and deposits H3K9me2, which 
protects ICRs from either active or passive DNA demethylation in ES cells. This is 
consistent with study of STELLA (also known as PGC7), a maternal factor, which could 
recognise and bind to H3K9me2 and protect maternal and paternal ICRs, including Mest, 
Peg3, Peg5, Dlk1-Gtl2, H19-Igf2 and Rasgrf1, from loss of DNA methylation in zygote 
(Nakamura et al., 2007; Nakamura et al., 2012).  
In addition, although previous studies have shown that G9a and its partner GLP 
also play a role in the establishment and maintenance of H3K9me1 in vivo (Tachibana et 
al., 2002; Tachibana et al., 2005; Ueda et al., 2006), my results suggest that global level 
of H3K9me1 is not significantly reduced and the levels of H3K9me1 only reduced at 
some of the ICRs in shG9a ES cells. These observations conflict with previous studies 
and indicate that histone methyltransferases G9a and GLP are not the only histone 
modifiers for the establishment and maintenance of H3K9me1 in ES cells. Actually, a 
recent study has shown that histone methyltransferases PRDM3 and PRDM16 also serve 
as the histone modifiers for the establishment and maintenance of H3K9me1 in ES cells 
(Pinheiro et al., 2012). In addition, since non-nucleosomal H3 that contains H3K9me1 
also exist in cytoplasma (Loyola et al., 2006), my shG9a ES cells might also undergo loss 
of H3K9me1 globally. However, by some unknown mechanism, nucleosomal histone H3 
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within the majority of genomic loci that lost H3K9me1 are replaced by the free 
H3K9me1 modified histone H3.  
Furthermore, my experiments also detected the reduction of H3K9me3 at ICRs 
in shG9a ES cells. This result is consistent with the previous observation and together 
suggests that apart from H3K9me2, histone methyltransferase G9a is also required for the 
maintenance of H3K9me3 in vivo (Yokochi et al., 2009). A possible explanation is that 
H3K9me2 serves as a substrate for the histone methyltransferases of H3K9me3, such as 
SETDB1 and SUV39H1/2. Therefore reduction of H3K9me3 could be caused by the 
reduced amount of H3K9me2 in shG9a ES cells. Interestingly, it was recently shown that 
all the histone modifiers of H3K9me, including G9a, GLP, SETDB1, SUV39H1 and 
SUV39H2, could form a mega-complex in vivo and together regulate the levels of 
H3K9me in ES cells (Fritsch et al., 2010).  
Additionally, my data is also consistent with the previous observations, which 
indicated that apart from G9a and GLP, other histone methyltransferases also function at 
the methylated allele at ICRs. It was demonstrated recently that a zinc finger protein 
ZFP57 is able to bind to the methylated DNA at ICRs and maintains imprinted DNA 
methylation by recruitment of H3K9 tri-methyltransferase SETDB1, its cofactor KAP1 
and DNMTs (Quenneville et al., 2011). Therefore, reduction of H3K9me3 in shG9a ES 
cells indicates that G9a either upstream of SETDB1 or has an independent role in the 
maintenance of imprinted DNA methylation in ES cells.  
However, since previous studies have shown that H3K9me2 per se is sufficient 
for the regulation of imprinted genes in Dnmt1-/- ES cells and G9a protein itself can 
directly interacts with DNMTs in vivo (Esteve et al., 2006; Epsztejn-Litman et al., 2008), 
reduction of imprinted DNA methylation in shG9a ES cells in my study raised the 
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questions that how does G9a maintain imprinted DNA methylation in ES cells and is 
H3K9me2 essential for the maintenance of imprinted DNA methylation by G9a? 	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Chapter 5   G9a protects the ICRs from loss of DNA 
methylation independently of its catalytic activity 
5.1 Introduction  
In mammals, the main modifiers for the establishment and maintenance of 
H3K9me2 are histone methyltransferases G9a and its partner protein GLP (Tachibana et 
al., 2005; Ueda et al., 2006). However, apart from the histones, emerging evidence 
suggests that G9a and GLP could also target to the non-histone proteins, such as p53 and 
WIZ. For instances, both G9a and GLP have been found to be able to di-methylate the 
lysine 373 within the tumour suppressor transcription factor protein p53, resulting in an 
inactive form of p53 (Huang et al., 2010).  
In addition to the establishment and maintenance of the H3K9me2, G9a also plays 
a role in the tumorigenesis. It has been found that G9a is overexpressed in different types 
of cancers, including leukaemia, hepatocellular carcinoma, prostate carcinoma and the 
lung cancer (Huang et al., 2010; Kondo et al., 2007; Yamashita et al., 2008). Moreover, it 
has also been found that knockdown of G9a prevents the growth of the cancer cells. 
Since G9a is also associated with the cocaine addiction (Maze et al., 2010), the mental 
retardation (Schaefer et al., 2009), the maintenance of HIV-1 latency (Imai et al., 2010) 
and affects the DNA methylation in mouse ES cells (Dong et al., 2008; Link et al., 2009; 
Tachibana et al., 2008), increasing investigations are focusing on the roles of G9a and its 
associated H3K9me2.  
In mammalian cells, H3K9me2 often co-localizes with the DNA methylation at the 
heterochromatin regions. To separately decipher the underlying molecular functions of 
G9a protein and H3K9me2, selective pharmacological inhibitors of G9a and GLP have 
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been generated, including the small-molecules BIX01294 and UNC 0638 (Chang et al., 
2009; Vedadi et al., 2011). Since the structures of these G9a inhibitors mimic the tail of 
histone H3, it has been shown that once the cells are treated with these inhibitors, the 
SET domain within either G9a or GLP is occupied and consequently, these enzymes lose 
their catalytic activity to maintain the H3K9me2. As shown in several cell lines, 
BIX01294 reduces both the abundance of the global H3K9me2 and the levels of 
H3K9me2 at the G9a target regions (Kubicek et al., 2007). However, as BIX01294 is 
toxic to the cells at the concentrations above 4.1 µM (Kubicek et al., 2007), it is not an 
ideal inhibitor to investigate the functions of G9a and GLP in vivo. By contrast, UNC 
0638 displays lower cellular toxicity and the global level of H3K9me2 in the UNC 0638 
treated cells is equivalent to the level that observed in the short hairpin RNA (shRNA) 
knockdown of G9a or GLP cells (Vedadi et al., 2011). In addition, the levels of 
H3K9me2 at the G9a target loci are also reduced in the UNC 0638 treated cells (Vedadi 
et al., 2011). Therefore, UNC 0638 is an ideal G9a inhibitor for investigation the role of 
G9a by depositing of H3K9me2.  
In the previous chapter, my observations have demonstrated that both the levels of 
DNA methylation and H3K9me2 are impaired at ICRs in G9a deficient ES cells (Chapter 
4). However, it is still unclear that how does G9a protect ICRs from loss of imprinted 
DNA methylation in ES cells. One hypothesis was that G9a maintains imprinted DNA 
methylation by directly recruitment of DNMTs to ICRs, since G9a per se was shown to 
be able to interact with DNMTs directly (Esteve et al., 2006, Epsztejn-Litman et al., 
2008). Another hypothesis was that G9a maintains imprinted DNA methylation via the 
establishment of H3K9me2 at ICRs, since it has been found that nuclear protein STELLA 
is able to bind to H3K9me2 and protect DNA methylation that is present at the maternal 
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and paternal ICRs in zygote (Nakamura et al., 2007, 2012). Therefore, the aim of this 
chapter is to investigate whether G9a directly functions at ICRs and is heterochromatin 
mark H3K9me2 essential for the maintenance of imprinted DNA methylation in ES cells 
by G9a.  
5.2 Results 
5.2.1 H3K9me2 is selectively present at the ICRs on the 
methylated allele 
To investigate whether G9a play a directly role at ICRs in ES cells, I performed 
precipitation with H3K9me2 antibody followed by bisulfite DNA sequencing of 
precipitated DNA (Figure 5.1A). I then compared the patterns of DNA methylation at 
ICRs of H3K9me2 antibody precipitated and input DNA. As expected, all the 
investigated ICRs, including Igf2r, Snrpn and H19-Igf2 ICRs, displayed approximately 
half of the precipitated DNA fragments were methylated (Figure 5.1B). By contrast, 
bisulfite DNA sequencing results of H3K9me2 antibody precipitated DNA fragments at 
these ICRs displayed nearly all the precipitated DNA fragments were methylated (Figure 
5.1B). These observations clearly indicate that imprinted DNA methylation is present 
exclusively on the H3K9me2-marked allele at ICRs in ES cells. In other word, H3K9me2 
is selectively established on the methylated allele at ICRs in ES cells.  
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Since G9a functions as the main modifier for depositing of H3K9me2 in 
mammalian cells and either knockout or knockdown of G9a leads to the loss of 
H3K9me2 at ICRs, precipitation with H3K9me2 antibody followed by bisulfite DNA 
sequencing data suggest that G9a directly functions on the methylated allele at ICRs and 
G9a seems to protect imprinted DNA methylation by preventing of actions of the DNA 
demethylase enzymes, such as TET1 and TET2, via establishment of heterochromatin 
mark H3K9me2. In addition, the presence of H3K9me2 on the methylated allele at ICRs 
also raises the question that whether H3K9me2 is essential for the maintenance of 
imprinted DNA methylation by G9a in ES cells. 	  
5.2.2 Treatment of ES cells with G9a/GLP inhibitor leads to the 
reduction of the global H3K9me2 and the levels of H3K9me2 at the ICRs 
To investigate whether H3K9me2 is essential for the maintenance of imprinted 
DNA methylation by G9a in ES cells, I treated wild-type ES cells with a G9a/GLP 
inhibitor, UNC0638, and investigated the patterns of imprinted DNA methylation in these 
cells. The results indicated that, in UNC0638 treated cells, the levels of G9a and GLP 
remain stable and are comparable with the levels in control ES cells treated with DMSO. 
However, 2 days afterwards, the level of H3K9me2 is significantly reduced in the 
inhibitor treated cells (Figure 5.2A). Actually, cells that treated with inhibitor reduced 
90% of H3K9me2 within two days and the residual amount of H3K9me2 was 
comparable to those observed in G9a-/- ES cells (Figure 5.2A). In addition, there was no 
further reduction of H3K9me2 in ES cells that treated with the inhibitor for 4, 6, 8 and 10 
days.  
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In contrast to H3K9me2, the global level of H3K9me1 was not significantly 
reduced in inhibitor treated ES cells when compared with control cells (Figure 5.2A). 
This result is consistent with my previous observation, which showed that knockdown of 
G9a only reduces the level of H3K9me2, but not H3K9me1, in ES cells. Admittedly, the 
stability of H3K9me1 indicates that apart from G9a and GLP, some other histone 
modifiers are involved in the establishment and maintenance of H3K9me1 in ES cells 
(Pinheiro et al., 2012).  
As expected, the level of H3K9me3 was also reduced in UNC 0638 treated ES 
cells and the level left is comparable with the level observed in G9a-/- ES cells (Figure 
5.2A). This was expected as the H3K9me2 serves as the substrate for histone 
methyltransferases of H3K9me3, such as SETDB1 and SUV39H1/2, which could convert 
H3K9me2 to H3K9me3.  
Apart from investigation of the global level of H3K9me2 in UNC 0638 treated ES 
cells, I also examined the levels of H3K9me2 at ICRs by ChIP. Compared with control 
ES cells, UNC 0638 treated ES cells displayed reduced levels of H3K9me2 at all the 
investigated ICRs, including Igf2r, Snrpn, H19-Igf2, Zac1, Peg3 and Peg10, as well as at 
the non-imprinted promoter of G9a target gene Wfdc15. In addition, the levels of 
H3K9me2 at ICRs in UNC 0638 treated ES cells were very similar to those in shG9a ES 
cells (Figure 5.2B). Taken together, without altering the protein level of G9a, UNC 0638 
treated ES cell is a decent model for the downstream investigations about whether G9a 
protects imprinted DNA methylation via its catalytic activity.  
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5.2.3 Maintenance of the imprinted DNA methylation does not 
require the catalytic activity of G9a and GLP  
To investigate whether H3K9me2 is required for the maintenance of imprinted 
DNA methylation in ES cells, I investigated the patterns of imprinted DNA methylation 
at ICRs in both UNC 0638 and DMSO treated control ES cells by 5meC MeDIP and 
bisulfite DNA sequencing. I first examined the patterns of imprinted DNA methylation at 
Igf2r, Snrpn, H19-Igf2, Zac1, Peg3 and Peg10 ICRs by 5meC MeDIP in control and 
UNC 0638 treated ES cells at day 0, 4, 8 and 12 after addition of inhibitor. For 5meC 
MeDIP, Ndufa and Dpep3 promoters served as negative and positive control regions, 
respectively. The MeDIP experiments clearly showed that there is no reduction of 
imprinted DNA methylation in ES cells that have been treated with UNC 0638 (Figure 
5.3). In addition, DNA methylation that present at Dpep3 promoter also remained stable. 
I further confirmed 5meC MeDIP experiments by bisuflite DNA sequencing at Igf2r and 
Snrpn ICRs in ES cells that treated with UNC 0638 for 12 days (Figure 5.4A).  
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Since generation of single clonal shG9a ES cells took approximately 4 weeks, it 
was possible that the reduced level of H3K9me2 induced by G9a/GLP inhibitor for 12 
days is not sufficient for the loss of imprinted DNA methylation in ES cells. Therefore, I 
treated ES cells with UNC 0638 for 28 days and performed bisulfite DNA sequencing at 
Igf2r and Snrpn ICRs. These results clearly showed that even treated with inhibitor for 28 
days, imprinted DNA methylation was still stably maintained in ES cells (Figure 5.4). 
These data demonstrate that G9a/GLP complex is essential for the maintenance of 
imprinted DNA methylation in ES cells, while its catalytic activity and heterochromatin 
mark H3K9me2 are completely dispensable.  
5.2.4 G9a and GLP bind to the chromatin independently of 
H3K9me2  
The data described above suggest that G9a is likely to maintain imprinted DNA 
methylation by directly recruitment of DNMTs to ICRs in ES cells. Since H3K9me2 is 
dramatically reduced in UNC 0638 treated ES cells and both of ANK domains within 
G9a/GLP complex are involved in recognising and binding to H3K9me1/2 (Collins et al., 
2008), G9a might dissociate or partially dissociate from chromatin in UNC 0638 treated 
ES cells.  
To investigate whether G9a still binds to chromatin in UNC 0638 treated ES cells 
and further ask whether H3K9me2 is essential for the chromatin loading of G9a in vivo, I 
carried out step-wise salt extraction of nuclear proteins from ES cells with buffers 
containing increasing concentrations of NaCl - 100, 200, 300, 400 and 500 mM, the last 
one preceded by benzonase nuclease treatment (Figure 5.5A). I then investigated 
dissociation patterns of G9a and other control chromatin binding proteins by Western 
blotting assays.  
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I found that there were more STELLA dissociated from chromatin at 300mM 
NaCl concentration when compared to other NaCl concentration fractions in wild-type 
ES cells that were treated with DMSO, whereas in UNC 0638 treated and G9a-/- ES 
cells, I found that there were more STELLA dissociated from chromatin at 100 mM NaCl 
concentration when compared to other NaCl concentration fractions (Figure 5.5B). This 
observation is consistent with previous study, which suggested that the chromatin loading 
patterns of STELLA depends on the presence of H3K9me2 (Nakamura et al, 2007, 
Nakamura et al, 2012). As expected, histones dissociated from chromatin at 500mM 
NaCl in all the investigated ES cell lines (Figure 5.5B). Taken together, these results 
indicate that step-wise salt extraction of nuclear proteins worked well.  
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Interestingly, only a small proportion of G9a and GLP dissociated from chromatin 
at low salt concentration in UNC 0638 treated ES cells when compared with control ES 
cells (Figure 5.5B), whereas the vast majority of G9a and GLP dissociated from 
chromatin at high salt concentration (500 mM NaCl). This observation suggests that 
histone methyltransferases G9a and GLP are still able to tightly bind to chromatin when 
the level of H3K9me2 is reduced. In addition, this observation also suggests that G9a and 
GLP are likely to maintain imprinted DNA methylation by directly recruitment of 
DNMTs to ICRs in ES cells. However, to investigate whether interaction between G9a 
and DNMTs is essential for the maintenance of imprinted DNA methylation in ES cells, 
further experiments have to be carried out.  
5.3 Discussion 
In this chapter, I first carried out precipitation with H3K9me2 antibody followed 
by bisulfite DNA sequencing at ICRs and found that imprinted DNA methylation is 
exclusively present on the H3K9me2-marked allele at ICR in ES cells (Figure 5.1B). 
Since the majority of global H3K9me2 in mammalian cells is established by histone 
methyltransferases G9a and GLP (Tachibana et al., 2005; Ueda et al., 2006), this 
observation indicated that G9a/GLP complex either could discriminate the methylated 
alleles from the unmethylated ones and directly bind to the methylated allele at ICRs or 
the unmethylated allele at ICRs are protected from binding of G9a/GLP complex. Since 
a C2H2 zinc finger protein, WIZ, is also present in G9a/GLP complex and knockdown 
of Wiz leads to instability of the G9a/GLP complex in vivo (Tachibana et al., 2005; Ueda 
et al., 2006), WIZ might function as a potential methylated DNA binding protein and 
recruit G9a/GLP complex to the methylated allele at ICRs. In addition, long non-coding 
RNAs (lncRNAs) might also play a role in the recruitment of G9a/GLP complex to the 
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methylated allele at ICRs, since previous studies have shown that G9a protein per se 
could interact with mono-allelically expressed imprinted lncRNAs, such as Airn 
(Nagano et al., 2008) and Kcnq1ot1 (Pandey et al., 2008).  
Moreover, since G9a/GLP complex is able to recognize and bind to the modified 
N-terminal tail of histone H3 via ankyrin repeat (ANK) domains, it would be interesting 
to investigate whether the unmethylated allele at ICRs contains any specific histone 
modifications, which might prevent the binding of G9a/GLP complex to chromatin. One 
study has revealed that in patient-derived cells, the asymmetric distribution of histone 
modifications on the paternally and maternally derived chromosomes is impaired. In 
normal cells, H3K9me3 and H4K20me3 exist on the methylated allele, whereas 
H3K4me2, H3K27me3 and H3K9Ac present on the unmethylated allele at IGF2-H19 
ICR. However, in patient derived cells, H3K9me3 and H4K20me3 biallelically exist in 
the BWS and H3K4me2, H3K27me3 and H3K9Ac biallelically present in the SRS 
(Nativio et al., 2011).  
I next investigated whether H3K9me2 plays a role in the maintenance of 
imprinted DNA methylation by G9a in ES cells. I employed a G9a/GLP specific 
pharmacological inhibitor (UNC 0638) and found that imprinted DNA methylation was 
still stably maintained when the level of H3K9me2 was dramatically reduced (Figure 5.3 
and 5.4). This observation suggests that G9a protein, rather than heterochromatin mark 
H3K9me2, is essential for the maintenance of imprinted DNA methylation in ES cells. 
Since previous studies have shown that G9a protein itself could interact with DNMTs via 
its ANK domain (Esteve et al., 2006, Epsztejn-Litman et al., 2008) and precipitation with 
H3K9me2 antibody followed by bisulfite DNA sequencing results suggested that G9a 
could directly bind to the methylated allele at ICRs, it is likely that G9a maintains 
	   152	  
imprinted DNA methylation by directly recruitment of DNMTs to ICRs in ES cells. To 
further investigate whether ANK domain within the G9a protein is essential for the 
maintenance of imprinted DNA methylation, patterns of imprinted DNA methylation 
need to be investigated in ES cells that only expressing an ANK domain deleted form of 
G9a.  
In addition, since previous studies have shown that G9a protein per se could 
interact with DNMT3A and DNMT3B in ES cells (Epsztejn-Litman et al., 2008), it is 
necessary to further investigate which DNMT is essential for the maintenance of 
imprinted DNA methylation by G9a in ES cells. Actually, it has also been found that G9a 
protein itself could also interact with DNMT1 in cancer cells (Espada et al., 2004). 
Therefore, it is also possible that G9a could interact with DNMT1 in ES cells and 
maintains the imprinted DNA methylation through recruitment of DNMT1 to ICRs in ES 
cells (Espada et al., 2004). To address these questions, co-immunoprecipitation (Co-IP) 
experiments of G9a and DNMTs and chromatin immunoprecipitation (ChIP) assays of 
different DNMTs at ICRs are required in both wild-type and G9a deficient ES cells.  
Furthermore, I preformed step-wise salt extraction of nuclear proteins and 
combined with Western blotting assays and found that the majority of G9a still tightly 
binds to chromatin in G9a/GLP inhibitor treated ES cells (Figure 5.5B). This observation 
indicates that G9a is able to bind to chromatin independently of H3K9me2. In addition, 
this observation also confirms that chromatin binding of G9a/GLP complex is essential 
for the maintenance of imprinted DNA methylation in ES cells.  
As described in Chapter 3 and 4, I have found that H3K9me1 is not significantly 
reduced in G9a deficient ES cells (Figure 3.4A, 4.1C and 4.7B). In addition, I also 
showed that H3K9me2 is present at ICRs (Figure 4.2). Considering that G9a/GLP 
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complex could recognise and bind to H3K9me2 as well as to H3K9me1 via a loop 
between ankyrin repeat four and five (Collins et al., 2008), it is possible that when the 
level of H3K9me2 is reduced, G9a/GLP complex binds to chromatin, including ICRs, by 
recognising of H3K9me1.  
Actually, it has been found that four amino acids within ANK domain of G9a, 
including W839, W844, W877 and E847, are essential for the interaction between G9a or 
GLP and H3K9me1 or H3K9me2 (Collins et al., 2007). To further investigate whether 
H3K9me1 is essential for the recruitment of G9a/GLP complex to ICRs when the level of 
H3K9me2 is reduced, patterns of imprinted DNA methylation need to be investigated in 
the ES cells that only expressing an ANK domain mutant form of G9a, which is unable to 
bind to the methylated tail of histone H3. On the other hand, since zinc finger protein 
WIZ serves as another stable component within G9a/GLP complex (Tachibana et al., 
2005; Ueda et al., 2006), it is possible that WIZ plays a role in the recruitment of 
G9a/GLP complex to ICRs in ES cells. Therefore, it would be necessary to investigate 
whether WIZ is able to bind to DNA and is there any sequence specific motif within 
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Chapter 6 G9a maintains imprinted DNA methylation via its 
ANK domain and directly recruits DNMTs to ICRs 
6.1 Introduction 
G9a and its partner protein GLP serve as the main writers of H3K9me1 and 
H3K9me2 in mammalian cells and G9a/GLP complex is the predominant form of either 
G9a or GLP that exist in vivo (Tachibana et al., 2005; Ueda et al., 2006). Biochemically, 
the catalytic SET domain of G9a alone could bind efficiently to un-modified and 
H3K9me1-marked histone H3 tails (Collins et al., 2008). Since full-length G9a displays 
higher affinity for H3K9me1 and H3K9me2 than for unmodified histone H3 tail (Collins 
et al., 2008), it is believed that apart from SET domain, there must be another functional 
domain within G9a protein, which is essential for recognising and binding to H3K9me1 
and H3K9me2.  
Actually, previous study has shown that G9a contains another functional domain 
that located from 730aa to 965aa, named ankyrin repeat (ANK) domain, including six 
identical helix-turn-helix-β-turn repeats (Collins et al., 2008). In addition, it has also been 
shown that the fourth and the fifth helix-turn-helix-β-turn repeats within ANK domain is 
essential for recognising and binding to H3K9-methylated histone H3 tail. By contrast, 
they display very low affinity to H3K4-methylated, H3K27-methylated or unmethylated 
histone H3 tails (Collins et al., 2008). In order to further determine which amino acids 
within the ANK domain are essential for the interaction between G9a and H3K9me2-
modified H3 tail, structural analysis has been performed. This study showed that three 
tryptophans (Try839, Try844 and Try877) and one glutamine acid residue (Glu847) 
within ANK domain of G9a form a hydrophobic cage, which is able to bind to H3K9me2 
peptide. In addition, it has also been found that replacement of any one of these amino 
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acids that involved in methyl-lysine cage formation could abrogate the interaction 
between G9a and H3K9me2-modified H3 tail (Collins et al., 2007).  
As discussed previously, G9a and GLP are the predominant histone lysine 
euchromatic methyltransferases of H3K9me2 in mammalian cells (Tachibana et al., 2002; 
Peters et al., 2003; Rice et al., 2003). Interestingly, apart from the levels of H3K9me2, 
the levels of DNA methylation is also reduced in either G9a or GLP deficient ES cells 
and G9a/GLP associated DNA methylation can be partially restored in G9a-null cells by 
re-expression of a catalytically inactive G9a (Dong et al., 2008; Epsztejn-Litman et al., 
2008; Tachibana et al., 2008). In addition, G9a has also been shown to interact with 
DNMT1 at replication forks in human cells (Esteve et al., 2006). These observations 
suggest a role for G9a in the maintenance of correct patterns of DNA methylation and 
H3K9me2 during DNA replication. In addition to DNMT1, G9a also interacts with 
DNMT3A and DNMT3B via its ANK domain in mouse ES cells (Epsztejn-Litman et al., 
2008). Since DNMT3A and DNMT3B also play a role in the maintenance of DNA 
methylation (Liang et al., 2002), a role for G9a in coupling the maintenance of DNA 
methylation with heterochromatin has been proposed.  
In the previous chapter, I showed that G9a maintains imprinted DNA methylation 
independently of its catalytic activity and G9a could bind to chromatin when the level of 
H3K9me2 is reduced. However, since G9a inhibitor-treated ES cells still contain 
H3K9me1 and both the ANK domains within G9a and GLP could bind to H3K9me1, it is 
possible that G9a binds to ICRs and maintains imprinted DNA methylation by 
recognising H3K9me1 in the G9a inhibitor treated ES cells. To investigate whether 
H3K9me1 is essential for the maintenance of imprinted DNA methylation in G9a 
inhibitor treated ES cells, I aimed to generate a mutant form of G9a, which is unable to 
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bind to methylated histone H3 tail and investigate the patterns of imprinted DNA 
methylation after removal of endogenous G9a. To investigate whether G9a maintains 
imprinted DNA methylation by direct recruitment of DNMTs to ICRs in ES cells, I also 
aimed to generate a mutant form of G9a that carrying ANK domain deletion and 
investigate whether imprinted DNA methylation is affected after endogenous G9a is 
removed.  
6.2 Results 
6.2.1 Mutant forms of G9a are stably expressed in ES cells after 
the endogenous G9a was knocked down  
My previous observations have shown that G9a is essential for the maintenance of 
imprinted DNA methylation in ES cells and once imprinted DNA methylation reduced, 
neither wild-type nor catalytically inactive G9a can restore imprinted DNA methylation 
at ICRs in G9a deficient ES cells. Therefore, to investigate the functions of mutant forms 
of G9a (the ANK domain mutation and deletion) on imprinted DNA methylation, it was 
essential to first express the mutant forms of G9a in wild-type ES cells and then remove 
of endogenous G9a.  
To establish ES cell lines of interest, expression plasmids, which encode for 
shRNA resistant forms of G9a that carrying either the mutations in H3K9me2 binding 
amino acids or the ANK domain deletion, first had to be generated. The strategy for 
generation of these expression plasmids is shown in Figure 6.1. First, I generated an 
shRNA resistant form of wild-type G9a cDNA by replacement of seven nucleotides 
corresponding to the shRNA targeted sequences. These mutations were silent and should 
not change the sequences of amino acids within G9a protein. Next, I mutated and deleted 
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ANK domain in shRNA resistant form of wild-type G9a cDNA. Finally, I confirmed 
these mutations/deletions within G9a cDNA by DNA sequencing (Figure 6.2).  
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Next, these expression plasmids were linearized and transfected into wild-type ES 
cells (see material and method) and Western blotting assays were performed in order to 
investigate the expression of exogenous mutant forms of G9a. These analyses showed 
that all the exogenous mutant forms of G9a were stably expressed in wild-type ES cells 
(Figure 6.3A). In addition, GLP and H3K9 methylation levels were also stable in shRNA 
resistant (shR), ANK domain mutant (ANKm) and ANK domain deleted (ANKdel) ES 
cell lines (Figure 6.3A).  
To specifically investigate the effect of exogenous forms of G9a on imprinted DNA 
methylation, I then knocked down of endogenous G9a in ES cells that expressing shR, 
ANKm and ANKdel forms of G9a. The mRNA levels of endogenous G9a in established 
clonal cell lines were tested by quantitative PCR (q-PCR) with primers that anneal across 
the mutated shRNA targeted sequences, which differs between endogenous and shRNA 
resistant exogenous forms of G9a. The best three endogenous G9a knockdown clonal cell 
lines for each shR, ANKm and ANKdel expressing ES cells were selected (Figure 6.3B) 
and investigated for the levels of G9a, GLP and H3K9 methylation.  
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These experiments showed that the levels of exogenous G9a and H3K9me3 in all 
these clonal cell lines were similar (Figure 6.3C). However, the levels of GLP and 
H3K9me2 varied among these ES cell lines. Compared with ANKdel ES cells, both shR 
and ANKm ES cells display higher levels of GLP and H3K9me2 (Figure 6.3C). 
However, compared with wild-type ES cells, ANKdel ES cells still contain similar levels 
of GLP, but less amount of H3K9me2 (Figure 6.3C). Taken together, after endogenous 
G9a was knocked down, all the exogenous forms of G9a can be stably expressed in ES 
cells. However, since only the level of H3K9me2 in ANKdel ES cells was impaired, 
different mutants within exogenous forms of G9a might exert distinct influences in 
function of G9a.   
6.2.2 ANK domain mutant and deleted forms of G9a stably bind 
to chromatin 
Before carrying out investigation of imprinted DNA methylation in shR, ANKm 
and ANKdel ES cells, I examined chromatin binding patterns of shRNA resistant wild-
type, ANKm and ANKdel forms of G9a protein by step-wise salt extraction of nuclear 
proteins followed by Western blotting assays (Figure 6.4). These experiments showed 
that, in all these ES cell lines, the majority of histones dissociated from chromatin in 500 
mM NaCl fraction, which indicated that step-wise salt extraction of nuclear proteins 
worked as expected. In addition, the levels of histone H4 were comparable among these 
cell lines in 500 mM NaCl fraction and the levels of H3K9me2 were consistent with my 
previous Western blotting results (Figure 5.5B). Furthermore, these experiments also 
showed that similar to wild-type G9a, both ANKm and ANKdel forms of G9a still tightly 
bind to chromatin in ES cells, since the majority of these mutant G9a proteins were 
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present in the fraction that extracted with benzonase and 500 mM NaCl (Figure 6.4). 
Taken together, these observations indicated that mutations that I generated have no 
effect on the chromatin loading patterns of G9a protein and also raised the question: will 
these mutant forms of G9a still play a role in the maintenance of imprinted DNA 
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6.2.3 Imprinted DNA methylation is stable in ES cells that 
expressing ANKm G9a  
To investigate the patterns of imprinted DNA methylation in ES cells that 
express ANKm G9a, I first carried out bisulfite DNA sequencing in shR and ANKm ES 
cells. At Igf2r and Snrpn ICRs, the results in shR ES cells displayed normal patterns of 
imprinted DNA methylation (Figure 6.5). Interestingly, ANKm ES cells also display 
normal patterns of imprinted DNA methylation at these ICRs (Figure 6.5).  
To validate bisulfite DNA sequencing results and further investigate the patterns 
of imprinted DNA methylation at more ICRs, I performed 5meC MeDIP in shR and 
ANKm ES cells at two paternal ICRs: H19-Igf2 and Rasgrf1 and eight maternal ICRs: 
Igf2r, Snrpn, Zac1, Peg3, Peg10, Peg13, GnasXL and Kcnq1ot1. For 5meC MeDIP, 
Ndufa and Dpep3 again served as negative and positive control regions, respectively. 
Interestingly, compared with shR ES cells, seven ICRs displayed similar levels of 
imprinted DNA methylation in ANKm ES cells (Figure 6.6). However, three ICRs 
showed loss of imprinted DNA methylation in ANKm ES cells. This might due to less 
number of CpG sites involved in these DMRs and consequently, loss of DNA 
methylation at one or several CpG sites might influence the result of 5meC MeDIP. 
Taken together, these observations indicate that ANKm G9a, which is unable to bind to 
H3K9-methylated H3 tail (Collins et al., 2007), still plays a role in the maintenance of 
imprinted DNA methylation in ES cells.  
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6.2.4 Imprinted DNA methylation is reduced in ES cells that 
expressing ANKdel G9a  
I also investigated patterns of imprinted DNA methylation in ANKdel ES cells. I 
first performed bisulfite DNA sequencing and found that compared with shR ES cells, 
ANKdel ES cells displayed reduction of imprinted DNA methylation at Igf2r and Snrpn 
ICRs (Figure 6.5). Additionally, I also found that all the ICRs that investigated by 5meC 
MeDIP displayed hypo-methylation in ANKdel ES cells, including Igf2r, Snrpn, H19-
Igf2, Zac1, Peg3, Peg10, Peg13, GnasXL, Kcnq1ot1 and Rasgrf1 (Figure 6.6). These 
results indicate that ANK domain of G9a is essential for the maintenance of imprinted 
DNA methylation in ES cells and G9a is likely to protect ICRs from loss of DNA 
methylation via directly interacts with DNMTs as reported previously (Esteve et al., 
2006; Epsztejn-Litman et al., 2008).  
6.2.5 Both ANKm and ANKdel forms of G9a interact with 
DNMTs 
To investigate whether ANKm or ANKdel forms of G9a interact with DNMTs, I 
carried out co-immunoprecipitation (Co-IPs) experiments with antibodies against G9a 
and DNMTs using nuclear extracts that prepared from shR, ANKm and ANKdel ES 
cells. The results showed that in all these ES cells, antibodies against G9a could pull 
down GLP and vice versa (Figure 6.7A). This observation indicates that mutations within 
G9a protein had no effect on dimerization between G9a and GLP in vivo.  
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Moreover, Co-IP experiments also showed that both ANKm and ANKdel forms of 
G9a could interact with DNMTs, including DNMT1, DNMT3A and DNMT3B (Figure 
6.7A). Additionally, the ratio of DNMTs/G9a showed that compared with wild-type 
(shR) G9a, there were similar amounts of DNMT3B interacted with either ANKm or 
ANKdel forms of G9a (Figure 6.7B). By contrast, the amount of DNMT1 and DNMT3A 
that interacted with ANKdel form of G9a is less than the amount that interacted with shR 
and ANKm forms of G9a (Figure 6.7B). These observations indicated that interaction 
between G9a and DNMT3A or DNMT1 might play an important role in the maintenance 
of imprinted DNA methylation in ES cells.  
6.3 Discussion 
After removal of endogenous G9a in ANKm ES cells, I found that among ten 
investigated ICRs, seven of them still contain normal patterns of imprinted DNA 
methylation (Figure 6.6). This observation indicates that abolishing of interaction 
between ANK domain of G9a protein and H3K9-methylated histone H3 tail does not 
affect imprinted DNA methylation that is present at most of ICRs in ES cells. Since 
compared with wild-type ES cells, there is more GLP in ANKm ES cells (Figure 6.3C), it 
is possible that imprinted DNA methylation is maintained by GLP/GLP homodimers. 
Alternatively, since ANKm G9a still forms a dimer with GLP and the intact ANK 
domain within GLP protein could recognise H3K9-methylated histone H3 tail and bind to 
chromatin, ANKm G9a might indirectly bind to ICRs and maintain imprinted DNA 
methylation by recruitment of DNMTs to ICRs via the ANK domain of GLP.  
Actually, previous studies have shown that apart from ANK domain, SET domain 
of G9a could also recognise and bind to unmethylated or H3K9me1 modified histone H3 
tail (Collins et al., 2008). Since there is no reduction of H3K9me1 in ANKm ES cells, the 
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interaction between SET domain of G9a and H3K9me1 might play a role in the 
recruitment of ANKm G9a to chromatin. However, compared with ANK domain of G9a, 
the interaction between SET domain of G9a and histone H3 tail is more unstable and 
transient (Collins et al., 2007). In addition, since GLP displays similar chromatin binding 
property to G9a (Collins et al., 2008) and ANKm G9a still interacts with GLP, the 
chromatin binding of ANKm G9a might occur indirectly through the interaction between 
G9a partner protein GLP and H3K9me1/2. Moreover, since G9a/GLP/WIZ tri-molecular 
complex is the predominant form of G9a that exist in vivo (Tachibana et al., 2005; 2008 
Ueda et al., 2006) and C2H2 zinc finger WIZ might function as a potential DNA-binding 
protein, the chromatin loading of ANKm G9a might also depend on the interaction 
between WIZ and DNA.  
To investigate how ANKm G9a binds to chromatin, amino acids within the pre-
SET domain of G9a, which are essential for dimerization between G9a and GLP, would 
need to be mutated in ANKm G9a. Step-wise salt extraction of nuclear proteins combined 
with Western blotting assays would then have to be carried out to investigate whether 
ANKm G9a binds to chromatin depending on its own SET domain or the other functional 
domain(s) within G9a/GLP complex.  
In this chapter, I also investigated the patterns of imprinted DNA methylation in 
ANKdel ES cells and found that all the investigated ICRs reduced the levels of imprinted 
DNA methylation (Figure 6.6). This observation indicated that ANK domain of G9a is 
essential for the maintenance of imprinted DNA methylation in ES cells. However, step-
wise salt extraction of nuclear proteins followed by Western blottings assays as well as 
Co-IP experiments using antibodies against G9a and DNMTs indicate that ANKdel G9a 
is still able to bind to chromatin and interacts with DNMTs (Figure 6.4 and 6.7A). 
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However, the levels of DNMT3A and DNMT1 that interact with ANKdel G9a are less 
than the levels that interact with shR and ANKm G9a. These observations indicated that 
G9a is likely to maintain imprinted DNA methylation in ES cells via its ANK domain 
directly recruits of DNMT3A or DNMT1 to ICRs.  
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Since previous studies have shown that both ANK domain and SET domain 
within G9a or GLP could interact with histone H3 tail (Collins et al., 2008) and either 
G9a or GLP could interact with DNMTs through their ANK domains (Epsztejn-Litman et 
al., 2008), in theory, G9a/GLP complex could bind to ICRs through one of the ANK 
domains and meanwhile interacts with DNMTs via the other ANK domain in wild-type 
ES cells (Figure 6.8). However, in ANKdel ES cells, since G9a-ANKdel/GLP complex 
contains only one ANK domain, the only possibly for G9a-ANKdel/GLP complex binds 
to chromatin is via the interaction between ANK domain of GLP and H3K9me1. In 
addition, this hypothesis could also explain why imprinted DNA methylation is reduced 
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Chapter 7   Dimerization between G9a with GLP is essential 
for the maintenance of the imprinted DNA methylation in ES 
cells 
7.1 Introduction 
G9a/GLP complex serves as the predominant form of either G9a or GLP that 
exist in ES cells (Tachibana et al., 2005; Ueda et al., 2006). In addition, re-expression of 
either mutant G9a or GLP in corresponding knockout ES cells identified that NHLC 
(1165-1168) and NHHC (1198-1201) motifs within pre-SET domain of G9a and GLP 
respectively, are essential for dimerization between G9a and GLP (Tachibana et al., 
2008). Moreover, it has also been found that replacement of NH (1165-1166) by LE in 
G9a protein is sufficient to abolish more than 95% of dimerization between G9a and GLP 
in ES cells (Tachibana et al., 2008).  
In my previous chapter, I have shown that ANKm G9a still could maintain 
imprinted DNA methylation at many ICRs, which raised the question that how does 
ANKm G9a protect ICRs from loss of DNA methylation in ES cells. In previous chapter, 
I also carried out co-immunoprecipitation experiments using antibodies against G9a and 
GLP and found that ANKm G9a is still able to form a dimer with GLP. Since GLP also 
contains an ANK domain and displays similar chromatin loading patterns to those of G9a, 
it is likely that ANK domain of GLP plays a key role for ANKm G9a in the maintenance 
of imprinted DNA methylation in ES cells. In addition, my previous observations also 
indicate that dimerization between G9a and GLP might be required for the maintenance 
of imprinted DNA methylation in ES cells.  
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To further study how ANKm G9a maintain imprinted DNA methylation and 
whether dimerization between G9a and GLP is essential for the maintenance of imprinted 
DNA methylation in ES cells, I aimed to disrupt of dimerization between G9a and GLP 
and investigate the role of dimerization mutant G9a at imprinted loci without effects of 
GLP.  
7.2 Results 
7.2.1 The dimerization deficient forms of G9a are unstable in the 
ES cells  
Since deletion of whole NHLC motif within pre-SET domain of G9a protein 
might affect structure of the SET domain, to disrupt dimerization between G9a and GLP, 
I replaced NH that within dimerization association motif by LE in G9a protein (Figure 
7.1). Together with nucleotide mutations that used for generation of shR, ANKm and 
ANKdel forms of G9a, all created mutants within G9a cDNA were confirmed by DNA 
sequencing (Figure 7.2). 
Next, since my previous data have shown that neither wild-type nor catalytic 
inactive G9a can restore loss of imprinted DNA methylation in G9a-/- ES cells (see 
chapter 3), to investigate the role of dimerization-deficient G9a on imprinted DNA 
methylation, I initiated studies by using wild-type ES cells. I first linearized dimerization-
deficient G9a expression plasmids and transfected these plasmids into wild-type ES cells. 
Then, I knocked down endogenous G9a by shRNA and picked four single clonal ES cell 
lines in each of dimerization-deficient ANKm and ANKdel G9a (dmANKm and 
dmANKdel) pool clonal ES cells (see Materials and Methods) (Figure 7.3A).  
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I then carried out Western blotting assays on wild-type and all single clonal ES 
cell lines that expressing either dmANKm or dmANKdel forms of G9a. The results 
showed that there was less G9a protein in the clonal ES cell lines that expressing 
dimerization-deficient form of G9a. This is consistent with published observations 
(Tachibana et al, 2008) and together suggests that without forming a dimer with GLP, 
G9a monomer cannot exist stably in vivo. To select the ideal dmANKm and dmANKdel 
single clonal ES cell lines, which express comparable levels of exogenous G9a, I chose 
dmANKm-3 and dmANKdel-3 for downstream experiments. 	  
7.2.2 The levels of GLP and H3K9me2 were reduced in the 
dmANKm and dmANKdel ES cells  
In chapter 6, I showed that compared with wild-type ES cells, ANKm ES cells 
contain normal levels of GLP and H3K9me2 (Figure 6.3C). However, in dmANKm ES 
cells, Western blotting results showed that both the levels of GLP and H3K9me2 are 
reduced (Figure 7.3B). These observations suggest that disruption of dimerization 
between G9a and GLP not only affects stability of G9a, but also destabilises GLP. These 
observations are consistent with previous studies, which conclude that G9a/GLP complex 
is the predominant form of either G9a or GLP in vivo (Tachibana et al., 2002, 2005). In 
addition, these observations also suggest that reduced levels of G9a and GLP are not 
sufficient for the maintenance of H3K9me2 in the ES cells, which is consistent with that 
G9a and GLP function as main writers for the establishment and maintenance of 
H3K9me2 in mammalian cells (Tachibana et al., 2005; Ueda et al., 2006).  
Interestingly, the global level of H3K9me3 in dmANKm and dmANKdel ES 
cells displayed slight reduction when compared to wild-type ES cells, while the levels of 
H3K9me1 remained unchanged (Figure 7.3B). These observations suggest that 
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G9a/GLP-mediated H3K9me2 is required as the partial subtracts for histone modifiers of 
H3K9me3 in ES cells. In addition, these observations and my previous data (Figure 3.4A, 
4.1C and 4.7B) are conflicted with previous studies (Tachibana et al., 2002; Peters et al., 
2003; Rice et al., 2003) and indicate that apart from G9a and GLP, some other histone 
modifiers must play a role in the regulation of level of H3K9me1 in ES cells.  
7.2.3 Dimerization-deficient forms of G9a stably bind to the 
chromatin 
My previous experiments described in Chapter 6 have suggested that G9a is 
likely to protect ICRs from loss of imprinted DNA methylation by directly recruitment of 
DNMTs via its ANK domain. Therefore, I first investigated whether dimerization-
deficient forms of G9a could bind to chromatin by performing step-wise extraction of 
nuclear proteins combined with Western blotting assays (Figure 7.4).  
LSH is a chromatin remodelling helicase (Myant et al., 2011), which displayed 
step-wise dissociation from chromatin at NaCl concentrations higher than 200 mM. The 
patterns of LSH dissociation from chromatin in shR, dmANKm and dmANKdel ES cells 
were identical (Figure 7.4). STELLA is another chromatin binding protein and its 
chromatin loading depends on the presence of H3K9me2 (Nakamura et al., 2007, 2012). 
Western blotting for STELLA showed that in shR ES cells, the majority of STELLA 
dissociated from the chromatin at 200-300 mM NaCl concentration, whereas in 
dmANKm and dmANKdel ES cells, some of STELLA protein dissociated from 
chromatin at 0 mM salt concentration. This observation is consistent with reduced levels 
of H3K9me2 in these ES cells (Figure 7.3). In addition, RAN is another nuclear protein, 
which is unable to bind to chromatin and plays a role in nuclear transport through nuclear 
pores. The results showed that the majority of RAN is extracted from nuclei at low salt 
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concentration, which is as expected (Figure 7.4). Moreover, Western blottings for 
histones H3 and H4 indicated, as expected, that histones did not dissociate from 
chromatin at salt concentration below 500 mM (Figure 7.4). This is consistent with that 
histones serve as core components of chromatin. Taken together, Western blotting results 
of all the above control proteins, including LSH, STELLA, RAN and histones, indicated 
that step-wise extraction of nuclear proteins that performed in these ES cells worked as 
expected.  
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Strikingly, Western blotting results indicate that both dmANKm and dmANKdel 
G9a as well as GLP are still tightly bound to chromatin, since the majority of 
dimerization-deficient G9a and GLP dissociated from chromatin at 300-500 mM NaCl 
concentration (Figure 7.4). In addition, these observations indicate that monomeric forms 
of G9a and GLP are still able to bind to chromatin. In the case of G9a, such binding can 
even occur in the absence of ANK domain.   
7.2.4 Dimerization-deficient forms of G9a do not interact with the 
GLP and DNMTs  
  To investigate whether dmANKm and dmANKdel forms of G9a have lost ability 
to form a dimer with GLP, I carried out co-immunoprecipitation experiments (Co-IPs) 
using antibodies against G9a and GLP in shR, dmANKm and ANKdel ES cells. The 
results showed that in dmANKm and dmANKdel ES cells, antibodies against G9a could 
not pull down GLP and vice versa (Figure 7.5). These data confirm that dmANKm and 
dmANKdel forms of G9a are indeed unable to interact with GLP.  
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In addition, to investigate whether monomeric forms of G9a and GLP could 
interact with DNMTs, I also carried out Co-IP experiments using antibodies against G9a, 
GLP and DNMTs. These experiments showed that in dmANKm and dmANKdel ES 
cells, GLP is still able to interact with DNMTs, whereas dmANKm and dmANKdel 
forms of G9a dramatically lost their interactions with DNMTs (Figure 7.5). These 
observations indicated that GLP does not require G9a to interact with DNMTs in either 
dmANKm or dmANKdel ES cells (Figure 7.5). Taken together, these observations 
clearly showed that without forming a dimer with GLP, both ANKm and the ANKdel 
forms of G9a are unable to interact with DNMTs in ES cells.  
7.2.5 Imprinted DNA methylation is reduced in dmANKm ES 
cells  
I next investigated the patterns of imprinted DNA methylation in dmANKm ES 
cells by performing bisulfite DNA sequencing. At all the investigated ICRs, Igf2r, Snrpn 
and H19-Igf2, the levels of the imprinted DNA methylation were reduced when 
compared to the levels in ANKm ES cells (Figure 7.6 and Figure 6.5, 6.6). In addition, to 
validate bisulfite DNA sequencing results and further investigate the patterns of 
imprinted DNA methylation at more ICRs, I carried out 5meC MeDIP at Igf2r, Snrpn, 
H19-Igf2, Zac1, Peg3, Peg10, Peg13, GnasXL, Rasgrf1 and Kcnq1ot1 imprinted loci in 
shR, dmANKm and dmANKdel ES cells. Compared with shR ES cells, all the 
investigated ICRs displayed hypo-methylation in dmANKdel ES cells (Figure 7.7). This 
observation is consistent with previous 5meC MeDIP results that carried out in ANKdel 
ES cells (Figure 6.6).  
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Strikingly, unlike in ANKm ES cells (Figure 6.6), nearly all the investigated 
ICRs, except Snrpn, Peg13 and GnasXL, displayed hypo-methylation in dmANKm ES 
cells (Figure 7.7). This observation suggests that without forming a dimer with GLP, 
dmANKm G9a cannot efficiently maintain imprinted DNA methylation in ES cells. 
Furthermore, this observation also confirms my previous hypothesis, which indicates that 
in ANKm ES cells, the patterns of imprinted DNA methylation is likely to be protected 
by GLP-mediated recruitment of DNMTs to ICRs.  
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7.3 Discussion 
In this Chapter, I described experiments aiming to investigate how does ANKm 
G9a maintain imprinted DNA methylation in ES cells. Since previous co-
immunoprecipitation assays have shown that ANKm G9a still forms a dimer with GLP 
and through ANK domain of GLP, ANKm-G9a/GLP complex could also interact with 
DNMTs, it is likely that ANKm G9a maintains imprinted DNA methylation by 
recruitment of DNMTs to ICRs via the ANK domain of GLP.  
To eliminate the role of GLP in the maintenance of imprinted DNA methylation 
in ANKm ES cells, I generated dmANKm ES cell line (Figure 7.3). Step-wise salt 
extraction of nuclear proteins followed by Western blottings showed that without forming 
a dimer with GLP, dimerization-deficient ANKm (dmANKm) G9a are still tightly bound 
to chromatin in ES cells (Figure 7.4). Published data have reported that the catalytic SET 
domain of G9a can interact with H3K9me0/1 to perform its methyltransferase function 
(Collins et al., 2008). However, these interactions are likely to be short-lived and 
therefore it seems that interaction between ANK domain and H3K9me0/1 would stabilise 
the binding of G9a to chromatin. In addition, since dmANKm G9a should not be able to 
bind to either H3K9me1 or H3K9me2 in ES cells, it is unclear that how dmANKm G9a 
binds to chromatin. Since G9a/GLP complex contains a third stable component, the 
C2H2 zinc-finger protein WIZ, it is likely that WIZ might bind to DNA directly and 
plays a role in the recruitment of monomeric G9a to chromatin. It would therefore be 
important to investigate whether dmANKm G9a still interacts with WIZ and whether 
zinc-fingers protein WIZ binds to DNA, especially in a sequence-specific context.  
To investigate the patterns of imprinted DNA methylation in dmANKm ES cells, 
I carried out bisulfite DNA sequencing and 5meC MeDIP and found that the levels of 
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imprinted DNA methylation is reduced in dmANKm ES cells (Figure 7.6 and 7.7). 
Compared with ANKm ES cells, where the majority of the ICRs carry normal patterns of 
the imprinted DNA methylation, loss of the imprinted DNA methylation in dmANKm ES 
cells suggests that without forming a dimer with GLP, dmANKm G9a is unable to 
maintain DNA methylation that present at ICRs. In addition, this observation also 
suggests that the stable patterns of imprinted DNA methylation in ANKm ES cells is 
likely to be maintained by ANKm G9a interaction with GLP, which could recruit 
DNMTs to ICRs via its ANK domain (Figure 7.8).  
Taken together, G9a/GLP complex is likely to maintain imprinted DNA 
methylation in ES cells via binding to DNA and/or chromatin at ICRs mediated by WIZ 
or ANK domain-dependent recognition of H3K9me2, while simultaneously recruit 
DNMTs by ANK domain(s) within G9a, GLP or both proteins (Figure 7.8). Whether a 
single ANK domain can bind to chromatin and at the same time recruit DNMTs to ICRs 
is yet to be determined. In addition, it is also possible that G9a/GLP complex indirectly 
binds to ICRs via the interactions with other yet unknown chromatin binding proteins. 
However, this must occur only on the allele that carries DNA methylation.  
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Furthermore, 5meC MeDIP results also showed that some of the ICRs, such as 
Snrpn, Peg13 and GnasXL, still displayed normal patterns of imprinted DNA methylation 
in dmANKm ES cells, One possibility could be GLP/GLP homodimers play a role in the 
maintenance of imprinted DNA methylation at limited imprinted loci, since in theory, 
GLP/GLP homodimers should also be able to interact and recruit DNMTs to ICRs in 
dmANKm ES cells. In addition, another possibility could be the existence of trace 
amount of G9a/GLP heterodimers prefers to bind to the limited number of ICRs and 
maintain imprinted DNA methylation at these loci, since endogenous wild-type G9a is 
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Chapter 8  Discussion 
8.1 DNA methylation and imprinted DNA methylation  
   In animals, DNA methylation refers to an addition of a methyl group to the 5-
position carbon within cytosine pyrimidine ring. From plants to mammals, the proportion 
of methylated cytosine within the genome varies dramatically among species. Even for a 
given species, methylated cytosine is not evenly distributed within the genome. Take 
mouse genome for instance, repetitive elements, such as the LINEs, SINEs and IAPs, are 
highly methylated, whereas there is no DNA methylation at promoters of house keeping 
genes. Since DNA methylation is essential for the normal development and is also 
associated with a number of crucial biological processes (Smith and Meissner, 2013), 
genomic regions that contain differentially methylated cytosine have attracted increasing 
attention.  
A differentially methylated region (DMR) refers to a locus within the genome, 
which contains patterns of DNA methylation that vary between cell types or alleles of the 
same gene. For instance, some tumour-specific DMRs are only identified in cancer cells, 
but not in healthy tissues (Doi et al., 2009). In contrast, another category of DMRs, which 
displays allele-specific differentially methylated patterns, is found in all types of tissues 
at imprinting control regions (ICRs). Since removal of DNA methylation from these 
DMRs leads to aberrant expression of adjacent imprinted genes, DNA methylation 
presents at these DMRs plays an essential cis-acting regulatory role in the regulation of 
imprinted genes (Ziller et al., 2013).  
As discussed previously, imprinted DNA methylation is established during the 
developing of gametes (Figure 1.4) (Davis et al., 1999; Lucifero et al., 2002) and unlike 
the DNA methylation that located at non-imprinted loci, once established, imprinted 
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DNA methylation is stably maintained throughout life, even during DNA demethylation 
that occurs in pre-implantation embryos (Lionel et al., 2010). Since imprinted DNA 
methylation is essential for accurate expression of imprinted genes and abnormal 
expression of imprinted genes leads to clinical phenotypes and human disorders, it is 
essential to investigate the underlying mechanisms that involved in the maintenance of 
imprinted DNA methylation.  
Previous studies have found that DNMTs and other chromatin and/or DNA 
binding proteins play a role in the maintenance of imprinted DNA methylation (Okano et 
al., 1999; Chen et al., 2003; Hirasawa et al., 2008; Li et al., 2008; Liang et al., 2002; 
Nakamura et al., 2007; Nakamura et al., 2012; Quenneville et al., 2011). The experiments 
described in this thesis identify that G9a/GLP complex of histone methyltransferases as 
an additional important component in the maintenance of genomic imprinting, 
specifically in mouse ES cells. In course of my work, I characterised in detail underlying 
mechanisms by which G9a/GLP complex maintains imprinted DNA methylation in ES 
cells.  
8.2 Impairment of imprinted DNA methylation in either G9a or GLP 
deficient ES cells 
   Experiments carried out in our lab have identified that approximate 170 
promoters showed hypomethylated specifically in G9a-/- ES cells and among these 
promoters, some of the maternal imprinted loci were involved (Figure 1.9, Ausma 
Termanis, unpublished). To confirm this observation, I validated the microarray results 
and found that DNA methylation is lost from nearly all of the investigated ICRs in G9a-/- 
ES cells compared to wild-type cells (Figure 3.1 and 3.2). In addition, the loss of DNA 
methylation at ICRs is also apparent when Glp is absent from the ES cells (Figure 3.3). 
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Since G9a/GLP heterodimer serves as the predominant form of G9a complex in ES cells 
(Ueda et al., 2002), these observations suggest that both H3K9me2 associated histone 
methyltransferases, G9a and GLP, are required for the protection of imprinted DNA 
methylation.  
Since G9a-/- ES cells are derived from wild-type ES cells by gene conversions 
(Tachibana et al., 2002), it is likely that these ES cells carried normal patterns of 
imprinted DNA methylation originally. In addition, since de novo DNA methylation at 
germline ICRs occurs during the developing of gametes (Figure 1.4) (Davis et al., 1999; 
Lucifero et al., 2002), loss of imprinted DNA methylation in G9a-/- ES cells also 
suggested that G9a plays a role in the maintenance of imprinted DNA methylation in ES 
cells. To confirm this hypothesis, I knocked down G9a in wild-type ES cells and found 
that imprinted DNA methylation is reduced in shG9a ES cells and reduction of imprinted 
DNA methylation is not due to prolonged culturing of ES cells in vitro (Figure 4.5 and 
4.6). Furthermore, to ensure that the reduction of imprinted DNA methylation is 
independent of genetic background of ES cells, I also knocked down G9a in another 
separate ES cell line (Figure 4.7) and found that imprinted DNA methylation is also 
reduced from all the investigated ICRs (Figure 4.8A and B). These observations indicate 
that the maintenance of imprinted DNA methylation by G9a is independent of genetic 
background of ES cells.  
A previous study suggested that G9a plays a role in the protection of imprinted 
DNA methylation at Prader-Willi syndrome-imprinting centre (PWS-IC) in ES cells (Xin 
et al., 2003). My experiments extend these observations and demonstrate that G9a is 
required for the maintenance of imprinted DNA methylation at nearly all the ICRs in ES 
cells. As G9a and GLP serve as the main modifiers for the establishment of H3K9me1/2 
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in ES cells (Tachibana et al., 2002; Peters et al., 2003; Rice et al., 2003) and STELLA, an 
H3K9me2 binding protein, has been found to protect DNA methylation that present at the 
maternally derived genome and at certain paternal ICRs in zygotes (Nakamura et al., 
2007; Nakamura et al., 2012), one hypothesis for the maintenance of imprinted DNA 
methylation by G9a/GLP complex was that G9a and GLP indirectly maintain the 
imprinted DNA methylation at ICRs and other regions of the genome through 
establishment of H3K9me2, which attracts STELLA and/or other proteins involved in the 
heterochromatin compaction that may protect against de-methyltransferase activities, 
such as TET enzymes. On the other hand, since G9a and GLP are able to directly interact 
with DNMTs in vitro and in vivo (Esteve et al., 2006; Epsztejn-Litman et al., 2008) and 
DNMTs are essential for the maintenance of imprinted DNA methylation (Tucker et al., 
1996; Kaneda et al., 2004), another hypothesis for protection of imprinted DNA 
methylation by G9a/GLP complex was that it occurs through direct recruitment of 
DNMTs by G9a and/or GLP to ICRs in ES cells.  
8.3 Aberrant expression of the imprinted genes in G9a-/- ES cells 
   Previous studies have shown that DNA methylation at ICRs is required for 
accurate regulation of imprinted genes (Li et al., 1993). Since my observations have 
shown that imprinted DNA methylation is either lost or reduced in G9a knockout and 
knockdown ES cells, it would be expected that the expression levels of imprinted genes 
would also change in these G9a deficient ES cells.  
Most imprinted genes are not expressed in ES cells, but transcription commences 
upon differentiation. Therefore Ausma Termanis, a former PhD student in our lab 
investigated the expression of imprinted genes in wild-type and G9a-/- ES cells 
differentiated into embryonic bodies after withdrawal of leukemia inhibitory factor (LIF). 
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These experiments showed that several imprinted genes from Dlk1/Dio3 and Kcnq1 
imprinting clusters displayed aberrant expression, Dlk1, Rtl1, Rian, Dio3, Kcnq1, 
Kcnq1ot1, Cdkn1c, Phlda2 and Osbpl5 (Ausma Termanis, unpublished). This 
observation is consistent with previous studies, which indicated that in mouse placenta, 
the presence of histone methyltransferase G9a is required for silencing of Kcnq1 cluster 
on the paternally derived chromosome (Wagschal et al., 2008). Taken together, these 
observations demonstrate that loss of imprinted DNA methylation in G9a deficient ES 
cells results in aberrant expression of imprinted genes. 	  
8.4 G9a is not essential for the maintenance of the imprinted DNA 
methylation in MEFs and early embryos 
As my work has shown that histone methyltransferases G9a and GLP are essential 
for the maintenance of imprinted DNA methylation in ES cells, it would be important to 
investigate whether imprinted DNA methylation in somatic cells and embryos also 
requires G9a/GLP complex. To investigate whether G9a plays a similar role in mouse 
embryonic fibroblasts (MEFs), we generated the stable cell line expressing G9a shRNA 
and found that imprinted DNA methylation was stably maintained at ICRs (Irina 
Stancheva and Tuo Zhang, unpublished). The possible explanation for this observation is 
that imprinted DNA methylation might be maintained by GLP/GLP homodimer, since, 
unlike in shG9a ES cells, the levels of GLP were not dependent on G9a in shG9a MEFs 
and remained similar between shG9a and shCont MEFs (Tuo Zhang, unpublished). As 
G9a/GLP heterodimer serves as the predominant form of G9a complex in ES cells 
(Tachibana et al., 2005; Ueda et al., 2006) and my previous observations have shown that 
deletion or reduction of G9a also leads to significant degradation of GLP in ES cells 
(Figure 4.1 and 4.7), the stable levels of GLP in shG9a MEFs raises another question: 
	   199	  
what is the predominant form of G9a and/or GLP complexes in MEFs and how is the 
formation of homo-/heterodimers regulated in different cell types? In other words, do 
G9a and GLP prefer to form homodimer rather than the heterodimer in MEFs and why? 
To answer these questions, G9a pulls down combined with Western blotting assays and 
mass spectrometry would need to be carried out from extracts of both ES cells and MEFs. 
Furthermore, to investigate whether GLP/GLP homodimers play a role in the 
maintenance of imprinted DNA methylation in shG9a MEFs, MEFs deficient in both G9a 
and GLP have to be generated followed by the investigations of imprinted DNA 
methylation.  
8.5 G9a is not essential for the maintenance of the imprinted DNA 
methylation in early embryos 
In mammals, the presence of H3K9 methylations always co-exists with DNA 
methylation. One of the best examples is germline DMR, since my study and previous 
studies have demonstrated that both H3K9me2 and H3K9me3 exist at the imprinted loci 
within the genome (Tuo Zhang, unpublished; Li et al., 2008; Quenneville et al., 2011; 
Wagschal et al., 2007; Nakamura et al., 2007). As deletion of H3K9 methyltransferases 
causes reduction of both H3K9me2/3 and imprinted DNA methylation (see chapter 3 and 
4), a role for these methyltransferases in coupling the maintenance of DNA methylation 
with heterochromatin in ES cells has been proposed. By using a G9a inhibitor, I found 
that the role for G9a in the maintenance of imprinted DNA methylation in ES cells is 
independent of its catalytic activity (see chapter 5).   
However, in G9a-/- embryos, my results have shown that imprinted loci still 
contain normal patterns of DNA methylation (data not shown here) and previous study 
that carried out by Xin et al has shown that removal of G9a from embryos led to 
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abnormal expression, but not the patterns of DNA methylation at imprinted loci (Xin et 
al., 2003). In addition, although the levels of H3K9me2 and H3K9me3 were impaired in 
G9a knockout embryos, the placenta-specific imprinted genes still contains normal 
patterns of DNA methylation (Wagschal et al., 2007). Taken together, these observations 
suggest that in embryos, G9a is not essential for the maintenance of imprinted DNA 
methylation or at least, in addition to G9a, some other factors might also play a role in the 
maintenance of imprinted DNA methylation. Since ES cells are generally used as the 
models for understanding early development, these observations also raised the question, 
to what extent ES cells could reflect the early developing embryos and do ES cells serve 
as the good example for the investigation of genomic imprinting?   
Another possible explanation for the stable imprinted DNA methylation in G9a 
knockout embryos is that passive DNA demethylation that requires many cell divisions 
may have occurred in these embryos. As embryonic cells in E6.5 embryos undergo fewer 
cell divisions than ES cells under selection in culture, they could maintain imprinted 
DNA methylation more successfully than ES cells. To investigate how the DNA 
methylation lost from ICRs and other regions of the genome in G9a deficient ES cells, 
G9a has to be removed from DNA demethylation associated protein deficient ES cells, 
such as TET1, TET2, AID or TDG, followed by the investigations of imprinted and non-
imprinted DNA methylation.  
8.6 Neither the wild-type nor the catalytically inactive G9a can restore 
the imprinted DNA methylation in G9a-/- ES cells 
To investigate whether loss of imprinted DNA methylation can be restored, I 
investigated the patterns of imprinted DNA methylation in G9a-/- ES cells, in which 
either wild-type or catalytically inactive G9a were expressed from stably integrated 
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plasmids (Figure 3.4A) and found that neither wild-type nor catalytically inactive G9a 
could restore imprinted DNA methylation in G9a-/- ES cells (Figure 3.4B, 3.4C and 3.5). 
This observation is consistent with previous studies (Tucker et al., 1996) and taken 
together, these observations indicate that once lost, imprinted DNA methylation could not 
be restored in ES or somatic cells.  
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There are several possibilities that may explain why imprinted DNA methylation 
cannot be restored in G9a-/- ES cells (Figure 8.1). First, once imprinted DNA 
methylation is lost, proteins that bind to the unmethylated DNA may now occupy both 
ICRs and thus prevent DNMTs or some other factors to restore imprinted DNA 
methylation. Second, it has been suggested that non-coding transcripts expressed in 
immature gametes play a role in the establishment of imprinted DNA methylation 
(Chotalia et al., 2009). Therefore, the failure to re-establish imprinted DNA methylation 
might be due to absence of such non-coding transcripts in ES cells. Third, since both 
DNMT3A and DNMT3L are required for the establishment of imprinted DNA 
methylation in gametes (Arnaud et al., 2006; Kaneda et al., 2004) and full-length 
DNMT3L seems to exists only in the growing oocytes (Bourc’his et al., 2001), 
insufficient amount of DNMT3A/DNMT3L complex might also prevent re-establishment 
of imprinted DNA methylation in G9a-/- ES cells. Finally, changes of histone 
modifications at ICRs might also serve as a barrier for the re-establishment of imprinted 
DNA methylation, since DNMT3L is unable to bind to chromatin that methylated at 
H3K4 (Bock et al., 2011). To confirm this hypothesis, H3K4me2 or H3K4me3 ChIP 
assays have to be carried out at ICRs in G9a-/- ES cells.  
8.7 DNA methylation is present only on the H3K9me2-marked allele at 
imprinted loci in ES cells  
Previous study has shown that positioning of H3K9 methylation at ICRs is parent-
specific and associated with the presence of imprinted DNA methylation (Umlauf et al, 
2004). In addition, Quenneville et al have shown that H3K9me3 is selectively presents on 
the methylated allele at ICRs (Quenneville et al., 2011). To investigate whether 
H3K9me2 coincides with imprinted DNA methylation in ES cells and further ask 
	   204	  
whether G9a could discriminate methylated from unmethylated allele, I performed 
H3K9me2 ChIP combined with bisulfite DNA sequencing and found that in ES cells, 
DNA methylation is present only on H3K9me2-marked allele at ICRs (Figure 5.1B). This 
observation indicates that G9a/GLP complex could either somehow discriminate 
methylated allele from unmethylated one or unmethylated allele is protected from the 
action of G9a and DNMTs. Furthermore, since my previous observations have shown 
that imprinted DNA methylation is impaired in G9a deficient ES cells, taken together, 
these observations also suggests that G9a plays a direct role in the maintenance of 
imprinted DNA methylation in ES cells.  
The presence of H3K9me2 on the methylated allele at ICRs raised another 
question: which is deposited first: imprinted DNA methylation or H3K9me2? Since a 
zinc finger protein WIZ is another stable component of G9a/GLP complex (Tachibana et 
al., 2005; Ueda et al., 2006) and it is able to bind to DNA directly (Burak Ozkan, 
unpublished), it is possible that G9a/GLP complex is selectively recruited to the 
methylated allele at ICRs via a direct interaction between WIZ and DNA. In this scenario, 
DNA methylation must be established prior to H3K9me2 and WIZ would function as a 
factor, which facilitates recruitment of G9a/GLP complex and allow discrimination of 
methylated alleles from unmethylated ones. To address this hypothesis, DNA binding 
affinity of WIZ towards methylated and unmethylated DNA must be examined.  
On the other hand, since some non-coding transcripts might also play a role in the 
establishment of imprinted DNA methylation (Kelsey and Feil, 2013) and G9a has been 
found to interact with such transcripts directly (Nagano et al., 2008; Pandey et al., 2008), 
it is also possible that during the maturation of gametes, the G9a/GLP complex is 
selectively recruited by non-coding transcripts to the allele, which has to be methylated 
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later. Therefore, in this scenario, H3K9me2 would be established prior or concomitantly 
with imprinted DNA methylation. Whether in addition to the maintenance of DNA 
methylation, G9a/GLP complex also plays a role in the establishment of DNA 
methylation at ICRs in ES cells is unknown. To address this question, G9a and/or GLP 
must be depleted conditionally from developing gametes. 	  
8.8 G9a maintains the imprinted DNA methylation independently of its 
catalytic activity 
My work has shown that imprinted DNA methylation is selectively present on 
H3K9me2-marked allele at ICRs. As discussed above, since my previous work also 
showed that imprinted DNA methylation is impaired in G9a deficient ES cells and G9a 
and GLP are the main writers for H3K9me2 (Tachibana et al., 2005; Ueda et al., 2006), 
taken together, these observations indicate that G9a/GLP complex may play a direct role 
in the maintenance of imprinted DNA methylation in ES cells. To investigate whether the 
catalytic activity of G9a is essential for the maintenance of imprinted DNA methylation 
in ES cells, I employed a G9a inhibitor and found that imprinted DNA methylation is 
stably maintained in G9a inhibitor treated ES cells (Figure 5.3 and 5.4). This observation 
suggests that G9a maintains imprinted DNA methylation independently of its catalytic 
activity. In other words, H3K9me2 is not essential for the maintenance of imprinted DNA 
methylation by G9a/GLP complex in ES cells.  
Furthermore, I also found that G9a is still bound to chromatin when the level of 
H3K9me2 is dramatically reduced (Figure 5.5). Together with previous studies, which 
showed that G9a could interact directly with DNMTs (Esteve et al., 2006; Epsztejn-
Litman et al., 2008), these observations suggest that G9a protects imprinted DNA 
methylation by recruitment of DNMTs directly to ICRs via its ANK domain. In addition, 
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this observation raises a question that how G9a binds to ICRs in G9a inhibitor-treated ES 
cells. Since the C2H2 zinc finger protein, WIZ, is another stable component of G9a/GLP 
complex (Tachibana et al., 2005; Ueda et al., 2006) and it is able to bind to DNA directly 
(Burak Ozkan, unpublished), WIZ might play a role in the recruitment of G9a/GLP 
complex to ICRs in G9a inhibitor treated ES cells. Whether there is a sequence specific 
motif within ICRs that WIZ prefers to bind to and whether WIZ prefers to bind to 
methylated or unmethylated DNA is not yet known. Addressing this question would be 
important for understanding recruitment of G9a/GLP complex to DNA/chromatin.  
In addition, other chromatin or DNA binding proteins might also play a role in the 
recruitment of G9a/GLP complex to ICRs, since mass spectrometry experiments carried 
out on G9a that purified from ES cells indicate that, apart from WIZ, other potential 
chromatin or DNA binding proteins are present in G9a/GLP complex (Burak Ozkan, 
unpublished). Moreover, long non-coding RNAs (lncRNA) might also play a role in the 
recruitment of G9a/GLP complex to ICRs, since it has been shown that long non-coding 
transcripts, such as Airn and Kcnq1ot1, which are encoded by imprinted genes within two 
separate imprinting clusters (ICs), could directly interact with G9a protein (Nagano et al., 
2008; Pandey et al., 2008).   
8.9 Disruption of the interaction between the ANK domain of G9a and 
H3K9 methylation has no effect on the patterns of imprinted DNA 
methylation 
To investigate whether the recognition and binding of G9a to H3K9me1/2 via its 
ANK domain is essential for the maintenance of imprinted DNA methylation in ES cells, 
I generated ANKm ES cell line (Figure 6.1, 6.2 and 6.3) and found that DNA methylation 
is stable at the majority of ICRs in these cells (Figure 6.5 and 6.6). This observation 
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indicates that interaction between ANK domain of G9a and H3K9 methylation is not 
required for the maintenance of imprinted DNA methylation in ES cells. Since ANKm 
G9a still interacts with DNMTs (Figure 6.7A) and compared with the control cells, a 
similar amount of DNMTs interact with ANKm G9a (Figure 6.7B), it is likely that 
without binding to H3K9me1/2 via its ANK domain, ANKm G9a is still able to recruit 
DNMTs to ICRs and maintain imprinted DNA methylation in ES cells.  
Additionally, I also found that the majority of ANKm G9a is tightly bound to 
chromatin (Figure 6.4). This observation indicates that, apart from recognising and 
binding to H3K9 methylation via its ANK domain, G9a indirectly binds to chromatin via 
some other mechanisms. Since ANKm G9a still forms a complex with GLP (Figure 
6.7A) and GLP displays similar binding affinity towards methylated H3 peptides to that 
of G9a (Collins et al., 2008), the ANK domain of GLP might be responsible for indirect 
recruitment of ANKm G9a to chromatin.  
On the other hand, as discussed earlier a C2H2 zinc finger protein WIZ might also 
play a role in the indirect recruitment of ANKm G9a to chromatin. Further experiments 
need to be carried out in order to investigate whether disruption of interaction between 
ANK domain of G9a and H3K9 methylation influences the stability of ANKm-
G9a/GLP/WIZ tri-molecular complex in ES cells.   
8.10 Removal of the ANK domain from G9a protein reduces the 
imprinted DNA methylation in ES cells  
To investigate whether G9a maintains imprinted DNA methylation via its ANK 
domain-dependent recruitment of DNMTs to ICRs, I generated ANKdel ES cell line 
(Figure 6.1, 6.2 and 6.3) and found that DNA methylation is reduced at all the 
investigated ICRs (Figure 6.5 and 6.6). This observation indicates that deletion of ANK 
	   208	  
domain from G9a protein leads to impairment of imprinted DNA methylation in ES cells. 
Since ANKdel G9a still interacts with GLP (Figure 6.7A) and GLP also contains an ANK 
domain (Collins et al., 2008), reduction of imprinted DNA methylation in ANKdel ES 
cells also indicates that G9a/GLP complex, containing of one ANK domain, is not able to 
maintain normal patterns of imprinted DNA methylation in ES cells.  
In ANKdel ES cells, I also found that ANKdel G9a still interacts with DNMTs 
(Figure 6.7A). Considering that GLP also contains an ANK domain and displays similar 
chromatin binding patterns to those of G9a (Collins et al., 2008), it is likely that ANKdel 
G9a indirectly interacts with DNMTs via ANK domain of GLP. In addition, compared 
with wild-type (shR) and ANKm forms of G9a, I found that less DNMT3A and DNMT1 
interacted with ANKdel form of G9a (Figure 6.7B). Therefore, the local concentration of 
DNMTs, which are recruited to ICRs by G9a/GLP complex, might play an essential role 
in the maintenance of imprinted DNA methylation in ES cells.  
Moreover, I also found that the majority of ANKdel G9a is still tightly bound to 
chromatin (Figure 6.4). This observation indicates that deletion of ANK domain from 
G9a has no effect on chromatin binding stability of G9a/GLP complex. As discussed 
above, it is likely that ANKdel-G9a/GLP complex binds to chromatin via ANK domain 
of GLP or WIZ. 	  
8.11 Dimerization of G9a and GLP is essential for the maintenance of 
imprinted DNA methylation in ES cells 
To investigate whether ANKm G9a maintains imprinted DNA methylation via the 
ANK domain of GLP, and further study whether the dimerization between G9a and GLP 
is essential for the maintenance of imprinted DNA methylation in ES cells, I generated 
dmANKm ES cell line (Figure 7.1, 7.2 and 7.3) and found that without forming a dimer 
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with GLP, dmANKm G9a is unable to maintain imprinted DNA methylation. These 
observations suggest that ANKm G9a maintains imprinted DNA methylation via ANK 
domain of GLP and dimerization of G9a and GLP is essential for the maintenance of 
imprinted DNA methylation in ES cells.  
In addition, I found that dmANKm G9a still binds to the chromatin (Figure 7.4), 
which raised the question of how does dmANKm G9a bind to chromatin. Furthermore, I 
also found that dmANKm G9a lost interaction with DNMTs (Figure 7.5). However, in 
both dmANKm and dmANKdel ES cells, GLP still interacts with DNMTs (Figure 7.5), 
although the levels of GLP are significantly reduced in these cell lines (Figure 7.3 A and 
B). These observations indicate that the reduction of the imprinted DNA methylation in 
dmANKm ES cells could be caused by insufficient amount of DNMTs that are recruited 
to ICRs by G9a monomer or GLP/GLP homodimer, although in theory, the remaining 
GLP/GLP homodimer could interact with DNMTs and recruit them to ICRs. To confirm 
this hypothesis, ChIP assays of DNMTs at the ICRs in the ANKm and dmANKm ES 
cells have to be carried out to provide a conclusive answer.  
8.12 G9a is also essential for the maintenance of DNA methylation at non-
imprinted loci.  
H3K9 methylations function as the repressive marks for gene expression and 
these marks is widespread within the genome. For instances, both H3K9me2 and 
H3K9me3 are present at nuclear peripheral (Barski et al., 2007) and centromere 
heterochromatin regions (Lam et al., 2006). In mammals, the main histone 
methyltransferase for the establishment and maintenance of H3K9me2 is G9a. In mouse 
ES cells, since G9a protein, but not its catalytic activity, is required for the maintenance 
of DNA methylation at repetitive elements (Dong et al., 2008) and my results indicate 
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that removal of G9a also had no effect on the patterns of imprinted DNA methylation 
(Tuo Zhang, unpublished), these observations suggest that G9a protein per se somehow is 
sufficient for the maintenance of DNA methylation that coexists with H3K9me2. Since 
several studies have demonstrated that through its N-terminal domain or ANK domain, 
G9a protein is able to directly interact with DNMTs (Esteve et al., 2006; Epsztejn-Litman 
et al, 2008), it is likely that G9a maintains H3K9me2-associated DNA methylation via 
recruitment of DNMTs to its target loci.  
Actually, in my study, apart from imprinted loci, I found that some other genomic 
regions also displayed hypo-methylation in G9a deficient ES cells, since compared with 
wild-type ES cells, the level of global DNA methylation reduced 50% in G9a-/- ES cells 
(data not shown here) and the microarray data indicated that 170 promoter showed hypo-
methylation in G9a-/- ES cells, among which only 8 were maternal ICRs (Ausma 
Termanis, unpublished). These observations are consistent with previous studies, which 
indicates that G9a also plays a role for the maintenance of DNA methylation at repetitive 
elements within the genome (Dong et al., 2008).  
The mechanisms that involved in the maintenance of DNA methylation by G9a at 
different genomic loci might variant. At nuclear periphery, the role for G9a in the 
maintenance of DNA methylation seems associated with lamina A, since in human cells, 
lamina-associated chromatin domains are suppressed and highly methylated with 
H3K9me2 (Guelen et al., 2008). By contrast, since knockdown of G9a causes not only 
reduction of H3K9me2, but also decreased in HP1 binding at some of the promoters in 
human cells (EI Gazzar et al., 2008), HP1 might also facilitate G9a in the maintenance of 
DNA methylation. However, the mechanisms that involved in the maintenance of 
imprinted DNA methylation by G9a might be different from the above mechanisms, 
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since after fertilization, imprinted loci are the unique regions that escape from global 
DNA demethylation. To decipher whether G9a maintains imprinted DNA methylation 
depending on the presence of lamina A or HP1, Co-IP assays and ChIP assays at 
imprinted loci that using antibodies against G9a, lamina A or HP1 are required.  
8.13 Summary  
Taken together, my work revealed that in addition to the establishment and 
maintenance of H3K9 methylation, the histone methyltransferases G9a and GLP also 
play an important role in the maintenance of imprinted DNA methylation in ES cells. In 
addition, I also revealed that the presence of H3K9me2 at ICRs is not essential for the 
maintenance of genomic imprinting. It is likely that G9a/GLP complex maintains 
imprinted DNA methylation via the ANK domain-dependent recruitment of DNMTs to 
ICRs in ES cells.  
Previous studies have shown that in ES cells, zinc finger protein ZFP57 is able to 
bind to the methylated cytosine within TGCCGC motif and that ZFP57 and its partner 
KAP1 are required for the maintenance of imprinted DNA methylation via recruitment of 
histone methyltransferase SETDB1, which exclusively establishes the H3K9me3 on the 
methylated allele at the ICRs (Quenneville et al., 2011). In my study, since both the 
patterns of imprinted DNA methylation and the levels of H3K9me2/3 at ICRs are 
impaired in G9a deficient ES cells (Chapter 3 and 4), my observations also suggest that 
binding of ZFP57 at the ICRs would be also dependent on the maintenance of imprinted 
DNA methylation by histone methyltransferase G9a. To decipher the link between ZFP57 
and G9a, the chromatin binding patterns of ZFP57 and SETDB1 have to be analysed in 
G9a deficient ES cells.  
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Abbreviations  
AML Acute myeloid leukemia  
ANK Ankyrin repeat 
ANKdel G9a  ANK domain deleted G9a  
ANKm G9a  ANK domain mutant G9a 
AR Androgen receptor 
AS Angelman syndrome 
AS-IC Angelman syndrome imprinting center 
BWS Beckwith-Wiedemann syndrome 
Cdkn1c Cyclin dependent kinase inhibitor 1C 
CGI CpG island 
ChIP Chromatin immunoprecipitation 
CLBC   Claudin-low breast cancer 
Co-IP Co-immunoprecipitation 
Dlk1 Delta-like homolog 1 
dmANKdel G9a Dimerization-deficient ANKdel G9a  
dmANKm G9a Dimerization-deficient ANKm G9a 
DMR Differentially methylated region 
DNMT1 DNA methyltransferase 1 
DNMT1o Oocyte-specific isoform of DNMT1 
DNMT3A DNA methyltransferases 3A 
DNMT3B DNA methyltransferases 3B 
DNMT3L DNA methyltransferases 3L 
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DNMTs DNA methyltransferases 
E11.5/9.5/6.5 Embryonic day 11.5/9.5/6.5 
EMT Epithelial-mesenchymal transition 
Epigenetic mark Post-translational protein modifications or post-
replication nucleotide modifications, which may 
change expression status of genes without altering 
DNA sequences 
Epigenetic phenomenon Inheritable changes of phenotype(s) caused by 
epigenetic marks but not the alternation of DNA 
sequences  
ES cell Embryonic stem cell 
EST Expressed sequence tag 
FBS Fetal bovine serum 
FSHD Facioscapulohumeral muscular dystrophy 
HKMTs Histone lysine methyltransferases 
HP1 gamma Heterochromatin protein 1 gamma 
HPTMs Histone posttranslational modifications 
ICF syndrome Immunodeficiency, centromere instability and facial 
anomalies syndrome 
ICM  Inner cell mass 
Imprinting cluster (IC) A genomic region which contains imprinted genes 
that are mono-allelically expressed in the somatic 
tissue  
Imprinting control region 
(ICR) 
A genomic region that contains parent-of-origin-
specific epigenetic marks and is required for the 
regulation of mono-allelic expression of imprinted 
genes that within the same imprinting cluster  
Imprinted genes Genes whose expression is determined by the 
parental inherited allele-specific patterns of 
epigenetic marks  
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KDMs Histone lysine demethylases 
KMTs Lysine methyltransferases 
KYP Kryptonite 
LIF Leukemia inhibitory factor 
LINEs Long interspersed repeats 
lncRNAs Long non-coding RNAs 
LSD1 Lysine-specific demethylase 1 
Maternal ICR Imprinting control region that inherited from the 
maternally derived chromosomes 
MBD1 Methylated DNA binding protein 1 
MeDIP Methylated DNA immunoprecipitation 
MEFs Mouse embryonic fibroblasts 
MEM Minimum essential medium 
MLL Mixed lineage leukemia 
MTD Methyltransferase domain 
NDRs Nucleosome-depleted regions 
NLS Nuclear localization signal 
Paternal ICR Imprinting control region that inherited from the 
paternally derived chromosomes  
PBD Proliferating cell nuclear antigen-binding domain 
PBS Phosphate buffered saline 
PCNA Proliferating cell nuclear antigen 
PCR Polymerase chain reaction 
PGCs Primordial germ cells 
PHD Plant homeo-domain 
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PHD Polybromo homology domain 
Pol II RNA polymerase II 
PRC1 Polycomb repressive complex 1 
PRC2 Polycomb repressive complex 2 
PSG Penicillin-streptomycin-glutamine 
PTHMs Post-translational histone modifications 
PWS Prader-Willi syndrome 
PWS-IC Prader-Willi syndrome imprinting center 
qPCR Quantitative PCR 
RT-qPCR Reverse transcription quantitative PCR 
SAM S-adenosyl-L-methionine 
shCont Non-targeting control shRNA 
shG9a shRNA knockdown of G9a 
shRNA short hairpin RNA 
SINEs Short interspersed repeats 
snoRNA Small nuclear RNA 
SNPs Single nucleotide polymorphisms 
SRS Silver-Russell syndrome 
TDG Thymine DNA glycosylase 
TE Trophectoderm 
TET Ten-eleven translocation 
TF Transcription factor 
TND Transient neonatal diabetes 
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tRNA-Asp Anticodon loop of the aspartic acid transfer RNA 
TSS Transcription start site 
UPD Uniparental disomy 
Xi Inactive X chromosome 
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